data_1zjq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zjq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.169 0.509 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.49 116.17 4.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.04 -102.26 2.55 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.05 -5.03 22.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.523 -0.986 . . . . 0.0 111.177 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -143.0 47.62 1.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.096 -1.003 . . . . 0.0 110.022 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 29' ' ' CYS . . . -76.1 -157.89 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.567 -0.708 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 117.82 3.81 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.42 24.17 12.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.639 -0.918 . . . . 0.0 110.189 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 30.8 t70 -69.77 -28.94 66.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.15 -13.78 76.42 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.66 9.65 6.1 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.012 0.906 . . . . 0.0 111.156 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -159.42 36.78 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.001 -1.062 . . . . 0.0 110.678 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 14.9 t -76.28 164.99 25.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.236 -0.915 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.48 8.49 16.5 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.23 -0.919 . . . . 0.0 111.162 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 m 50.74 -152.57 0.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 t -102.68 -72.92 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 0.0 110.157 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -159.84 114.51 2.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.081 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.23 45.45 8.85 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -144.94 120.27 10.25 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.477 -1.014 . . . . 0.0 110.115 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -90.55 151.47 21.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.369 -0.832 . . . . 0.0 109.383 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -89.05 142.06 27.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.07 -1.018 . . . . 0.0 110.816 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -110.25 127.68 26.63 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.784 -0.572 . . . . 0.0 110.297 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.2 -31.17 6.17 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.99 1.521 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -77.05 -29.36 55.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.463 -0.773 . . . . 0.0 110.701 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 59.8 m95 -100.69 -18.36 16.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.347 -0.846 . . . . 0.0 110.935 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 16.0 tptt 67.41 32.93 5.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.52 -0.737 . . . . 0.0 112.009 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -159.75 158.17 30.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.054 -1.029 . . . . 0.0 110.53 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 67.9 m -69.43 139.06 54.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.915 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.65 -168.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -66.44 140.1 58.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.431 -0.793 . . . . 0.0 110.713 -179.253 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.929 0.395 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.54 -77.39 0.53 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.81 -149.84 17.12 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.04 -1.53 52.07 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.492 -1.005 . . . . 0.0 111.132 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.78 42.05 1.45 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.22 -161.68 0.53 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.551 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.96 117.93 4.17 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 51.5 m -108.27 48.6 0.85 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.99 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.55 91.15 3.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.422 -0.799 . . . . 0.0 110.008 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.36 137.3 4.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -71.17 -4.7 26.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.384 -1.068 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -115.27 31.97 6.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.077 -1.015 . . . . 0.0 110.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -84.89 179.78 7.24 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.197 -0.939 . . . . 0.0 110.682 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.26 150.31 39.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -0.85 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.2 m -112.75 -145.2 0.4 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.559 -0.713 . . . . 0.0 109.747 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -91.02 -60.14 1.98 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.044 -1.035 . . . . 0.0 110.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -123.41 -126.64 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.634 -0.666 . . . . 0.0 109.47 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.46 -11.91 65.73 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 26.1 m-85 -38.81 112.45 0.24 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.799 -0.824 . . . . 0.0 111.297 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -89.61 -176.41 4.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.2 m -111.05 147.59 34.46 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.748 -1.22 . . . . 0.0 110.204 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -85.95 144.51 39.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.376 -0.827 . . . . 0.0 110.189 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -23.54 19.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 124.025 1.54 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.455 HG21 ' CD1' ' A' ' 26' ' ' TRP . 3.1 t -116.94 -25.19 7.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.247 -0.908 . . . . 0.0 111.683 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.629 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 m0 -85.6 -18.1 34.3 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.012 -1.055 . . . . 0.0 111.197 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt 60.2 21.93 11.27 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.594 -0.691 . . . . 0.0 112.092 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.629 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.03 159.18 41.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.168 . . . . 0.0 110.37 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 96.1 m -68.79 135.35 51.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 110.915 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 34.4 m -124.5 163.84 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.681 -0.637 . . . . 0.0 109.568 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.13 145.73 52.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.453 -0.779 . . . . 0.0 110.294 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.083 0.468 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.49 -113.39 3.75 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.84 -138.6 8.16 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -15.35 18.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.535 -0.98 . . . . 0.0 110.558 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.56 43.96 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -161.97 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.388 -0.82 . . . . 0.0 110.593 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.91 100.46 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HA ' HG22 ' A' ' 14' ' ' THR . 18.9 p -108.71 40.18 1.85 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.51 -0.994 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.623 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 20.6 t70 -67.02 163.38 20.04 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.078 -1.014 . . . . 0.0 110.206 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.47 -13.43 18.39 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? 58.07 19.88 6.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.499 -1.001 . . . . 0.0 110.587 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -172.58 37.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.441 -0.787 . . . . 0.0 110.355 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 9' ' ' CYS . 7.2 t -99.92 176.03 5.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -129.27 137.11 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 m -80.93 -144.46 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -71.45 0.47 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.013 -1.054 . . . . 0.0 110.061 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -167.42 112.15 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.765 -0.584 . . . . 0.0 110.088 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.4 21.33 38.21 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -130.7 137.96 49.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.4 -1.059 . . . . 0.0 109.538 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 6.4 t30 -108.78 175.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -113.27 138.64 49.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 45.5 t -91.02 137.26 26.65 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.393 -0.817 . . . . 0.0 110.076 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 -18.5 22.95 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.941 1.495 . . . . 0.0 111.468 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -106.52 -29.06 9.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.113 -0.992 . . . . 0.0 111.11 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.649 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 31.1 m0 -89.43 -26.07 21.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.238 -0.914 . . . . 0.0 110.565 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.623 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.35 9.68 7.04 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.837 -0.539 . . . . 0.0 111.886 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.649 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -124.59 161.24 26.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.878 -1.139 . . . . 0.0 110.009 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 16.7 m -75.16 147.01 40.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.143 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.03 -174.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.76 132.21 47.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 109.968 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.697 -0.627 . . . . 0.0 110.376 -179.684 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.004 0.43 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -93.03 0.09 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.3 -159.34 27.11 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.19 -4.16 49.56 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.985 . . . . 0.0 110.598 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.9 mtt -150.85 29.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.387 -0.821 . . . . 0.0 109.739 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.6 33.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -0.852 . . . . 0.0 110.716 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.93 122.61 30.76 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.2 m -84.13 -59.74 2.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.64 -0.918 . . . . 0.0 109.899 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.6 t70 51.15 78.68 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.253 0.549 . . . . 0.0 111.031 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.2 141.97 4.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 2.4 24.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -1.024 . . . . 0.0 110.747 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.86 23.66 9.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.276 -0.89 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.531 HG21 ' SG ' ' A' ' 22' ' ' CYS . 10.9 t -73.76 165.27 25.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.876 . . . . 0.0 109.943 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.03 149.81 50.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.0 111.054 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.65 -150.42 0.46 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.665 -0.647 . . . . 0.0 109.445 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -91.4 -70.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.029 -1.044 . . . . 0.0 110.273 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -172.17 92.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.91 -35.56 4.01 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -70.35 125.08 25.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.405 -1.056 . . . . 0.0 110.15 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.8 m120 -107.89 166.55 10.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.998 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 14' ' ' THR . 41.7 m -88.76 132.12 34.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.132 -0.98 . . . . 0.0 110.571 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 26' ' ' TRP . 11.9 p -67.76 142.91 96.2 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.65 -19.03 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.808 1.425 . . . . 0.0 111.887 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.1 m -122.54 -33.35 3.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.965 -1.084 . . . . 0.0 111.858 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 48.1 m0 -79.04 -12.84 60.03 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.013 . . . . 0.0 111.466 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? 66.16 11.09 7.6 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.474 -0.766 . . . . 0.0 113.002 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.587 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.8 164.2 23.55 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.448 -1.408 . . . . 0.0 111.126 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -70.38 147.45 49.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.448 -0.783 . . . . 0.0 110.922 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.61 169.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.766 -0.584 . . . . 0.0 109.428 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -66.25 132.82 49.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.0 110.069 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 110.259 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 2.2 t . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.075 0.464 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.05 -75.16 1.28 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.8 -156.68 18.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -88.65 -4.21 58.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.444 -1.033 . . . . 0.0 110.992 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.96 40.97 1.27 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.105 -0.997 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -82.71 -157.62 0.23 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 110.385 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.45 100.15 0.76 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 t -74.24 -76.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.48 -1.012 . . . . 0.0 110.358 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 t70 52.32 61.34 3.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 163.56 142.32 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -10.36 59.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.547 -0.972 . . . . 0.0 110.87 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -142.07 49.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 t -69.05 176.48 3.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.421 -0.8 . . . . 0.0 110.545 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.26 104.26 11.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -0.8 . . . . 0.0 110.144 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -86.39 -149.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.782 . . . . 0.0 109.575 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 1.5 t -79.24 -56.68 4.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 -81.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.15 -27.2 28.89 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.407 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 4.0 m-85 -48.44 124.45 8.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.635 -0.92 . . . . 0.0 110.605 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.57 -169.99 2.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.447 -0.783 . . . . 0.0 109.628 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 110.275 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -112.11 133.14 21.75 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.676 . . . . 0.0 110.048 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.907 1.478 . . . . 0.0 111.197 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -74.86 -21.08 59.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.497 -0.752 . . . . 0.0 110.73 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.55 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 41.7 m95 -101.1 -16.5 17.05 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.439 -0.788 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm 59.06 22.62 10.71 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.508 -0.745 . . . . 0.0 112.707 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.54 161.33 39.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.706 -1.246 . . . . 0.0 110.616 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 91.8 m -69.49 138.57 53.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.353 -0.842 . . . . 0.0 110.286 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.69 170.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.682 -0.636 . . . . 0.0 109.93 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.3 p90 -61.55 173.36 0.97 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.408 -0.807 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.111 -0.993 . . . . 0.0 110.709 179.792 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.172 0.511 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.26 -121.13 1.45 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.35 -155.71 26.89 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -8.02 52.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.453 -1.028 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.73 31.7 0.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.45 120.28 29.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -0.771 . . . . 0.0 110.436 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.48 111.15 2.97 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.607 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 9.0 p -84.7 -35.86 22.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.518 -0.99 . . . . 0.0 110.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 9.4 t70 54.35 70.08 0.65 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.646 -0.659 . . . . 0.0 111.122 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.34 134.08 3.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -6.76 44.3 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.541 -0.976 . . . . 0.0 110.763 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 m -106.16 29.36 6.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.396 -0.815 . . . . 0.0 110.117 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.607 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.93 162.54 26.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.517 -0.739 . . . . 0.0 110.462 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.74 99.33 5.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 110.03 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.39 -157.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.296 -0.878 . . . . 0.0 110.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -78.92 0.07 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.122 -0.986 . . . . 0.0 110.321 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -165.48 114.73 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.671 -0.643 . . . . 0.0 109.606 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.75 24.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.518 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 39.5 m-85 -129.48 118.21 21.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.385 -1.068 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -108.76 156.65 19.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.81 . . . . 0.0 110.419 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.4 t -89.46 134.47 34.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 110.508 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 8.5 t -80.59 141.92 52.88 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.673 -0.642 . . . . 0.0 110.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.17 -18.65 23.48 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.931 1.49 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 m -106.1 -25.85 11.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.203 -0.935 . . . . 0.0 111.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.596 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 28.8 m0 -95.2 -18.89 20.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 0.0 111.16 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.53 12.06 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.525 -0.735 . . . . 0.0 112.451 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.596 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -129.44 164.98 22.5 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.71 -1.244 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -74.82 142.21 44.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.387 -0.82 . . . . 0.0 110.535 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 29.2 m -129.11 168.99 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.726 -0.609 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.46 121.68 26.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.267 -0.896 . . . . 0.0 110.42 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.842 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 17.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.821 0.343 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.32 -105.95 0.05 OUTLIER Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.56 -171.25 23.85 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.1 mt -76.12 -9.01 58.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.489 -1.006 . . . . 0.0 111.459 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.3 ttt -144.09 42.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.802 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.28 102.87 15.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.34 119.23 13.82 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 14' ' ' THR . 4.0 p -117.21 -46.8 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.538 -0.978 . . . . 0.0 110.833 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 51.79 67.22 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.563 -0.711 . . . . 0.0 110.468 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.38 127.38 0.91 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -66.12 -13.13 59.59 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.679 -0.895 . . . . 0.0 111.078 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.16 21.43 11.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.104 -0.998 . . . . 0.0 110.674 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 9' ' ' CYS . 9.1 t -81.1 169.7 17.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.131 -0.981 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -128.58 142.31 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.3 m -126.88 -151.35 0.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.611 -0.681 . . . . 0.0 110.038 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -68.09 -66.93 0.5 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.186 -0.946 . . . . 0.0 110.791 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -150.66 -76.37 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.81 13.28 62.42 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.51 119.62 17.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -1.222 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -106.07 153.82 21.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.466 -0.771 . . . . 0.0 110.5 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 m -89.41 135.8 33.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.341 -0.849 . . . . 0.0 110.75 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -86.29 140.47 34.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.72 -25.9 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.827 1.435 . . . . 0.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.424 HG21 ' N ' ' A' ' 26' ' ' TRP . 9.8 t -91.04 -23.92 20.21 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.317 -0.864 . . . . 0.0 111.236 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.653 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.0 m0 -101.37 -22.12 14.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.123 -0.986 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER 69.96 9.34 7.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.964 -0.46 . . . . 0.0 112.025 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -126.19 171.6 10.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.848 -1.157 . . . . 0.0 110.435 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -82.21 147.42 28.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.408 -0.807 . . . . 0.0 110.929 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.23 -169.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -93.96 138.46 32.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 110.33 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 26.7 p . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.132 0.491 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.55 -149.14 24.45 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 -113.03 0.34 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -109.54 -15.88 14.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.476 -1.014 . . . . 0.0 111.07 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt -150.48 32.44 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.369 -0.832 . . . . 0.0 109.707 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -71.68 -163.71 0.11 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.496 -0.752 . . . . 0.0 110.245 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.31 116.23 5.45 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.513 ' HB2' ' CA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -111.5 42.8 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.768 -0.842 . . . . 0.0 110.272 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -71.9 81.39 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.227 -0.921 . . . . 0.0 109.52 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.79 124.76 1.39 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -10.41 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.497 -1.002 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -110.06 28.2 8.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.22 -0.925 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 t -90.97 154.31 19.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.91 155.09 28.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.42 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.1 m -103.54 -165.51 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.586 -0.696 . . . . 0.0 110.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.85 -70.26 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.363 -0.835 . . . . 0.0 110.288 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.9 124.33 1.55 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.0 30.61 60.98 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.9 m-85 -129.79 132.23 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -97.79 140.24 32.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.728 . . . . 0.0 109.874 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 40.6 t -88.8 132.58 34.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.92 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.11 120.03 49.19 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.674 -0.641 . . . . 0.0 109.858 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.84 -31.01 10.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.806 1.424 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.5 m -78.9 -28.73 44.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.745 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.488 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 76.3 m95 -96.87 -12.89 22.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 111.089 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt 64.06 27.6 14.18 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.372 -0.83 . . . . 0.0 112.002 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.513 ' CA ' ' HB2' ' A' ' 9' ' ' CYS . 1.5 p90 -157.69 150.36 22.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.04 -1.038 . . . . 0.0 109.84 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.4 t -82.07 146.84 29.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.216 -0.928 . . . . 0.0 110.161 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 34.8 m -129.99 -167.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.39 151.3 47.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.344 -0.847 . . . . 0.0 109.871 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.758 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 120.991 0.424 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.84 -87.4 0.42 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.36 -161.77 28.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -2.71 55.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.491 -1.006 . . . . 0.0 111.282 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 34.75 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 109.793 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.91 104.93 15.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 110.555 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -55.32 113.53 3.84 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 14' ' ' THR . 28.6 p -104.7 -36.18 7.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.4 -1.059 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t70 55.16 77.44 0.22 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.624 -0.673 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.28 5.95 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -1.32 57.02 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.487 -1.008 . . . . 0.0 110.911 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 p -148.56 49.57 1.01 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.294 -0.879 . . . . 0.0 109.76 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.569 HG23 ' SG ' ' A' ' 22' ' ' CYS . 8.7 t -74.62 -169.46 0.86 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.656 -0.652 . . . . 0.0 110.767 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.96 100.05 6.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 1.1 t -98.67 -146.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 0.0 109.752 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -94.49 -105.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.009 -1.057 . . . . 0.0 110.003 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 21.18 2.07 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.859 -1.151 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.22 42.06 0.15 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 79.8 m-85 -138.08 138.85 39.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.961 . . . . 0.0 110.07 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -121.1 153.37 37.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.569 ' SG ' HG23 ' A' ' 14' ' ' THR . 16.4 m -89.11 134.98 33.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.184 -0.948 . . . . 0.0 110.822 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -91.82 146.81 33.72 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.768 -0.583 . . . . 0.0 110.187 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 -35.57 3.95 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.911 1.479 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 m -87.49 -37.11 17.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 110.417 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.723 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 35.5 m0 -82.68 -29.71 29.75 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 19.0 tptt 69.07 11.2 8.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.959 -0.463 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.723 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.83 167.09 17.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.808 -1.182 . . . . 0.0 111.064 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -77.54 129.79 36.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.698 -0.626 . . . . 0.0 111.154 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 28' ' ' TRP . 21.4 m -129.55 169.63 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.777 -0.577 . . . . 0.0 109.478 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -52.92 155.17 2.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.355 -0.841 . . . . 0.0 110.453 -179.824 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.035 0.445 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.94 -124.56 1.55 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -134.36 3.0 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -7.29 25.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.596 -0.943 . . . . 0.0 111.358 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.8 ttm -149.93 32.85 0.68 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.15 -0.968 . . . . 0.0 110.122 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.23 136.91 44.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.69 119.81 19.39 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.0 t -95.33 -77.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.676 -0.897 . . . . 0.0 109.851 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.55 73.94 0.28 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.761 -0.587 . . . . 0.0 111.119 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.38 120.7 1.6 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -14.26 44.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.866 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -105.88 27.44 8.52 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 0.0 110.454 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -69.4 -178.2 1.33 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.245 -0.91 . . . . 0.0 110.462 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.99 146.74 45.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -131.98 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.68 -0.637 . . . . 0.0 110.005 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -67.88 0.73 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 p -168.51 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.568 -0.708 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.07 28.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 53.6 m-85 -122.86 129.9 52.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.291 -1.123 . . . . 0.0 109.872 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.64 163.11 16.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.461 -0.774 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -89.23 137.24 32.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.362 -0.836 . . . . 0.0 110.801 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.56 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -93.22 143.18 26.31 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.48 -0.763 . . . . 0.0 110.099 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.83 -21.81 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.916 1.482 . . . . 0.0 111.665 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 m -109.59 -38.67 5.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.171 -0.956 . . . . 0.0 111.369 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 40.8 m0 -72.64 -20.59 61.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 65.02 15.66 10.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.707 -0.62 . . . . 0.0 111.869 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.686 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -141.02 162.89 34.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.777 -1.202 . . . . 0.0 110.704 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.76 138.65 46.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.49 -0.756 . . . . 0.0 110.546 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 5.3 m -136.1 -178.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -58.55 153.48 16.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.348 -0.845 . . . . 0.0 110.464 -179.388 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.058 0.456 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 7' ' ' ALA . . . -78.59 -152.09 6.02 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.86 46.82 0.06 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.42 -7.37 1.02 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.899 -0.765 . . . . 0.0 112.512 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.87 25.81 0.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.945 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . . . -64.66 114.22 4.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.9 120.12 15.92 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.7 m -79.32 -73.53 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.986 . . . . 0.0 109.88 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 50.51 56.5 7.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.491 0.663 . . . . 0.0 109.744 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.13 123.78 1.2 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -14.73 52.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.999 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.31 14.0 23.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 110.8 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -71.11 146.76 49.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.101 -0.999 . . . . 0.0 110.25 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -126.36 137.85 53.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.395 -0.816 . . . . 0.0 110.677 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.09 -154.28 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.648 -0.657 . . . . 0.0 109.73 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -73.04 0.35 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 110.436 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.3 -44.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 0.0 110.526 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.56 28.7 14.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 30.0 m-85 -124.62 131.83 53.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.979 . . . . 0.0 110.078 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -109.74 149.95 29.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.327 -0.858 . . . . 0.0 109.777 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.8 t -88.91 136.0 33.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.187 -0.945 . . . . 0.0 111.012 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.35 130.5 23.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.634 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.04 -31.39 9.8 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.887 1.467 . . . . 0.0 111.521 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -81.68 -31.96 31.98 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.897 . . . . 0.0 110.684 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.634 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -91.25 -17.73 25.52 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.381 -0.825 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tptm 67.7 17.35 9.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.689 -0.632 . . . . 0.0 111.656 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.634 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -144.66 168.39 20.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 110.549 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -84.56 150.95 24.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.515 -0.741 . . . . 0.0 111.041 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 28.2 m -140.15 178.63 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -58.06 151.74 18.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.356 -0.84 . . . . 0.0 110.312 -179.674 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.484 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 9.1 t . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 121.31 0.576 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.52 -80.67 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.09 -133.63 4.22 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.76 -5.01 21.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.453 -1.028 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 ttm -149.59 33.87 0.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.05 -167.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.393 -0.817 . . . . 0.0 110.231 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.31 88.58 0.47 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' HG21 ' A' ' 14' ' ' THR . 17.5 p -99.61 53.31 0.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.93 . . . . 0.0 110.029 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.87 100.0 2.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.6 126.51 1.36 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -63.53 -14.38 50.56 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.585 -0.95 . . . . 0.0 111.028 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -108.62 30.0 6.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.5 t -96.49 169.12 10.12 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.358 -0.839 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.57 145.86 27.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -90.19 -144.29 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.376 -0.827 . . . . 0.0 110.027 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.484 ' CA ' ' HA ' ' A' ' 2' ' ' CYS . 1.7 t -81.8 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.951 -1.093 . . . . 0.0 110.795 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 t -164.92 -48.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.441 -0.787 . . . . 0.0 110.494 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 23.93 33.79 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 145.07 50.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.314 -1.11 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -122.42 157.95 30.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 t -88.48 141.26 28.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.957 -1.089 . . . . 0.0 110.551 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.94 133.48 20.26 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -29.46 10.52 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.97 1.51 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 m -87.13 -37.08 17.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.398 -0.814 . . . . 0.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 70.7 m95 -89.63 -15.04 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.486 -0.758 . . . . 0.0 111.013 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 60.33 14.27 4.57 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.612 -0.68 . . . . 0.0 112.672 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.625 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -135.43 159.17 42.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.778 -1.201 . . . . 0.0 110.537 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.5 m -67.38 132.35 47.49 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.446 -0.784 . . . . 0.0 110.081 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 m -116.9 179.73 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.678 . . . . 0.0 109.815 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -76.19 142.66 41.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.802 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.019 0.438 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.76 -88.18 0.65 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.27 -144.98 14.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.68 -4.34 33.95 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.511 -0.994 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -149.94 41.78 0.85 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.53 -165.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.507 -0.746 . . . . 0.0 110.658 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 112.73 2.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -80.32 -77.52 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.458 -1.025 . . . . 0.0 110.018 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.94 68.16 0.79 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.677 -0.64 . . . . 0.0 110.483 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.9 121.52 1.92 Allowed Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -61.97 -15.88 47.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.93 . . . . 0.0 110.536 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.37 9.46 41.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.385 -0.822 . . . . 0.0 110.953 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.477 HG22 ' SG ' ' A' ' 22' ' ' CYS . 12.2 t -72.0 158.37 36.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.029 -1.045 . . . . 0.0 110.042 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.64 143.32 41.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.307 -0.871 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -95.31 -138.59 0.24 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.728 . . . . 0.0 109.98 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -91.3 -85.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 110.779 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 m -146.86 -47.63 0.18 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.162 -0.961 . . . . 0.0 110.773 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.77 25.88 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.1 133.87 39.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -1.006 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.77 149.86 26.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.357 -0.839 . . . . 0.0 109.195 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.0 124.21 33.5 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.909 -1.119 . . . . 0.0 110.334 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.36 128.35 40.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.786 -0.571 . . . . 0.0 110.443 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.97 -37.02 3.04 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.941 1.495 . . . . 0.0 110.661 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.6 m -71.81 -37.75 70.32 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.59 -0.694 . . . . 0.0 110.402 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.9 m95 -90.74 -12.06 37.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.588 -0.695 . . . . 0.0 110.64 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 61.38 19.34 10.13 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.561 -0.712 . . . . 0.0 112.256 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -147.58 157.7 43.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.81 -1.182 . . . . 0.0 110.838 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 67.3 m -67.2 136.02 54.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.677 -0.639 . . . . 0.0 110.798 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.2 -172.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -69.54 148.63 49.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 110.278 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.227 0.537 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.54 -119.03 4.55 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.09 -126.65 1.34 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 4.1 mp -104.54 -2.79 24.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.57 -0.959 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.73 31.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 109.944 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 130.16 35.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 109.727 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.27 118.43 10.27 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.76 -74.44 0.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.911 . . . . 0.0 109.935 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.09 92.08 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.419 0.628 . . . . 0.0 110.561 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . 142.5 -13.18 2.49 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 2.5 mtmp? 60.6 20.11 10.0 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.387 -1.067 . . . . 0.0 110.976 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -170.31 48.02 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 22' ' ' CYS . 5.3 t -83.72 158.3 21.83 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.23 120.41 34.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.399 -0.813 . . . . 0.0 110.199 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -100.77 -170.26 1.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.499 -0.751 . . . . 0.0 110.354 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.6 m -64.31 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.397 -0.814 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 p -158.99 88.77 0.91 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.418 -0.801 . . . . 0.0 109.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.06 8.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.447 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 32.1 m-85 -84.5 145.3 28.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -1.122 . . . . 0.0 109.91 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 17.0 t-20 -125.22 154.69 41.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.737 . . . . 0.0 110.235 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' HB2' HG23 ' A' ' 14' ' ' THR . 1.7 t -88.11 134.25 33.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.543 -0.723 . . . . 0.0 110.334 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -100.86 133.39 21.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.754 -0.591 . . . . 0.0 110.089 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.25 -28.12 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.9 1.474 . . . . 0.0 110.953 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -88.4 -36.48 16.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 0.0 110.544 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.707 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.9 m0 -88.3 -14.64 37.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 110.55 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 1.4 mmpp? 60.82 20.44 10.61 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.687 -0.633 . . . . 0.0 111.967 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.707 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -145.25 168.8 19.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.933 -1.105 . . . . 0.0 111.0 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -78.6 150.61 32.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.585 -0.697 . . . . 0.0 110.92 -179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 11.9 m -149.39 172.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.702 -0.624 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -69.06 135.26 50.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 0.0 109.858 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 110.172 -179.598 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.069 0.461 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.86 -136.62 5.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.43 -141.47 5.52 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.97 -12.14 29.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.592 -0.946 . . . . 0.0 111.114 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mtt -150.22 32.45 0.66 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.214 -0.929 . . . . 0.0 110.145 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.38 147.52 42.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.75 123.13 28.03 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 t -90.66 -71.33 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.48 99.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.333 0.587 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.14 -11.57 6.85 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm 59.57 19.96 8.5 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.287 -1.125 . . . . 0.0 110.736 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -170.22 45.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.36 -0.837 . . . . 0.0 110.0 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -82.47 165.43 20.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.465 -0.772 . . . . 0.0 110.833 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.37 105.34 15.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.01 -141.78 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.549 -0.72 . . . . 0.0 110.31 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -75.59 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.235 -0.916 . . . . 0.0 110.076 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -145.25 63.96 1.27 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 109.939 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.42 -46.18 0.55 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HD1' ' HA ' ' A' ' 31' ' ' TYR . 22.3 m-85 -55.96 128.5 35.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.606 -0.938 . . . . 0.0 110.242 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -106.12 159.24 16.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.773 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.3 t -89.27 132.67 34.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 110.714 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.12 128.47 36.92 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.9 -25.17 16.87 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.803 1.423 . . . . 0.0 111.169 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 m -87.82 -30.0 20.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.324 -0.86 . . . . 0.0 110.812 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 29.9 m0 -98.48 -15.25 19.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.285 -0.884 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.64 14.73 9.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.564 -0.71 . . . . 0.0 112.075 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.578 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -136.21 165.27 26.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.762 -1.211 . . . . 0.0 110.602 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 t -79.65 136.1 36.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.764 . . . . 0.0 110.542 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.68 -167.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.06 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.532 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 24.0 p90 -88.29 165.08 15.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.442 -0.787 . . . . 0.0 110.261 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.515 -0.741 . . . . 0.0 110.213 179.725 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.167 0.508 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.93 173.0 55.21 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 -119.62 1.08 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.3 7.16 22.94 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.491 -1.006 . . . . 0.0 111.474 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.31 29.98 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.96 119.06 19.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.214 -0.929 . . . . 0.0 110.046 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.06 128.53 17.19 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HA ' HG23 ' A' ' 14' ' ' THR . 5.3 t -109.44 23.72 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.741 -0.858 . . . . 0.0 110.38 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.38 -21.01 66.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -76.31 -3.79 77.68 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 4.4 mtmp? 59.57 23.15 11.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -1.073 . . . . 0.0 111.02 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -176.3 38.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.382 -0.824 . . . . 0.0 110.702 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 9' ' ' CYS . 5.8 t -71.14 105.96 3.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.127 -0.983 . . . . 0.0 110.078 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.03 104.8 2.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.93 -166.25 1.08 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 0.0 110.62 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -65.8 0.63 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.318 -0.864 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.29 -45.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.552 -0.718 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.12 30.69 9.86 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 48.7 m-85 -123.16 120.74 34.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -1.007 . . . . 0.0 110.284 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -110.99 167.37 10.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.47 144.16 26.26 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.827 -1.171 . . . . 0.0 110.948 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -90.37 147.65 37.17 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.595 -0.691 . . . . 0.0 110.136 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.88 -24.56 11.37 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.876 1.461 . . . . 0.0 111.634 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -111.32 -30.74 7.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.259 -0.901 . . . . 0.0 111.462 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.643 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 40.8 m0 -80.57 -20.53 43.16 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.166 -0.959 . . . . 0.0 110.842 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.59 21.41 11.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.612 -0.68 . . . . 0.0 112.113 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.643 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -143.75 166.81 23.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.737 -1.227 . . . . 0.0 110.932 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.3 t -69.9 138.06 52.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.572 -0.705 . . . . 0.0 111.013 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.2 m -134.66 -179.94 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -61.36 158.87 13.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.0 109.982 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.336 -0.852 . . . . 0.0 110.084 179.847 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.019 0.438 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.95 -118.12 4.11 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.17 -127.9 1.48 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.89 -7.4 17.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -1.0 . . . . 0.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.8 29.41 0.83 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.95 146.61 27.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 0.0 110.2 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.04 124.31 36.3 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -125.34 20.41 8.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.489 -1.006 . . . . 0.0 110.614 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -49.79 106.53 0.12 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.406 -0.809 . . . . 0.0 110.757 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.09 2.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -12.97 61.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.484 -1.009 . . . . 0.0 111.066 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.59 38.05 3.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.29 -0.881 . . . . 0.0 110.64 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -69.16 151.04 46.84 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.729 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -109.4 127.34 54.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.357 -0.84 . . . . 0.0 110.598 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.19 -156.55 0.57 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.17 -0.956 . . . . 0.0 110.405 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -169.39 127.88 0.98 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.496 -0.753 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.92 21.96 79.44 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.9 m-85 -131.18 131.26 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.253 -1.145 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.3 t-20 -117.83 164.86 14.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.346 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -88.79 137.76 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.59 135.3 19.76 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.688 -0.632 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.81 -34.44 3.18 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.829 1.436 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.26 -35.36 61.39 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.0 110.71 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.601 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.0 m95 -97.98 -20.02 17.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.734 . . . . 0.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.43 12.64 8.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.716 -0.615 . . . . 0.0 112.376 179.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.601 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -135.02 164.23 28.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.235 . . . . 0.0 110.676 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -68.21 137.77 55.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.747 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 26.7 m -136.14 -176.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.733 -0.604 . . . . 0.0 109.472 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 137.65 50.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.207 -0.933 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 21' ' ' ASN . . . . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.0 110.123 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.04 0.448 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.91 -113.15 0.69 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 -114.34 0.52 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.48 10.43 19.7 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.56 -0.965 . . . . 0.0 111.034 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.2 ttt -148.58 35.87 0.79 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.225 -0.922 . . . . 0.0 110.078 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.21 125.48 27.85 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.14 115.71 6.46 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -93.57 -82.8 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.927 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.05 59.59 4.43 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.573 -0.704 . . . . 0.0 110.593 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.71 -142.99 3.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.15 5.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.44 -1.035 . . . . 0.0 111.108 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.35 58.75 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.955 . . . . 0.0 110.013 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -59.16 147.24 35.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.52 129.78 34.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -126.02 -162.7 1.15 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.78 -0.575 . . . . 0.0 110.194 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.3 m -80.91 -86.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 125.67 4.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.314 -0.867 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.56 60.67 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.1 m120 -112.04 167.64 10.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.8 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -88.7 134.71 33.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.418 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 134.11 19.9 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.52 -33.83 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.794 1.418 . . . . 0.0 110.786 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.0 m -74.44 -44.78 50.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.636 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 85.8 m95 -88.27 -13.47 40.83 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.587 -0.696 . . . . 0.0 110.592 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.39 19.22 10.04 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.631 -0.668 . . . . 0.0 112.4 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.636 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.12 166.04 26.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.877 -1.14 . . . . 0.0 110.713 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -67.18 133.52 49.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.44 -0.787 . . . . 0.0 111.103 -178.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.89 176.88 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.13 137.16 58.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 0.0 110.502 -179.825 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.159 0.504 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.02 -95.77 1.57 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.6 -131.94 5.04 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 -5.76 20.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.975 . . . . 0.0 110.839 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.6 ttm -145.61 36.79 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -73.29 -165.71 0.27 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.386 -0.822 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.65 96.32 0.54 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' HG22 ' A' ' 14' ' ' THR . 77.8 m -70.92 -77.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.913 . . . . 0.0 110.427 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.09 58.16 5.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.674 -0.641 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.78 139.07 2.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -8.29 55.47 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.421 -1.046 . . . . 0.0 110.727 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 2.31 39.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.329 -0.857 . . . . 0.0 110.657 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 9' ' ' CYS . 11.2 t -66.72 146.63 54.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.32 127.25 48.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -0.792 . . . . 0.0 110.335 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -87.31 -155.24 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 110.051 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.66 -92.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.14 123.26 14.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 109.844 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.33 35.56 76.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -130.05 120.8 25.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -1.044 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.7 t-20 -98.01 -170.95 2.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.3 m -118.68 139.02 52.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.15 -0.969 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 3.1 t -84.79 140.11 37.7 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.775 . . . . 0.0 110.028 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.48 -25.52 25.16 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.945 1.497 . . . . 0.0 111.297 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 m -103.29 -36.63 7.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.261 -0.899 . . . . 0.0 111.242 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.687 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 32.1 m0 -79.88 -21.27 44.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.253 -0.904 . . . . 0.0 111.093 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.4 OUTLIER 63.34 11.59 5.57 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.495 -0.753 . . . . 0.0 112.408 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.687 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -125.98 160.79 29.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.7 -1.25 . . . . 0.0 110.572 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 69.4 m -66.13 138.81 57.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.72 . . . . 0.0 111.438 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 m -139.17 -179.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.56 135.09 57.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.086 -1.009 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 110.349 -179.471 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 120.924 0.392 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 16' ' ' CYS . . . -55.46 117.02 7.74 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.08 47.13 0.95 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER 68.26 -3.96 1.18 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.876 -0.779 . . . . 0.0 112.113 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.42 27.68 0.66 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.914 -1.116 . . . . 0.0 110.277 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 142.67 27.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.344 -0.848 . . . . 0.0 110.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 119.27 14.79 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -123.76 28.59 6.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.497 -1.002 . . . . 0.0 110.91 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.91 112.09 0.72 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.873 . . . . 0.0 110.282 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.08 137.35 3.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -8.06 49.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.454 -1.027 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -139.86 47.44 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 t -76.71 -176.23 3.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.482 -0.762 . . . . 0.0 110.578 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.29 147.88 51.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 73.4 m -129.5 -162.33 1.19 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.593 -0.692 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -76.99 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 110.567 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 p -158.2 123.7 4.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.19 31.36 63.95 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.474 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 23.4 m-85 -124.8 132.06 53.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -1.141 . . . . 0.0 110.123 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -112.42 159.32 18.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.0 110.127 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.1 t -89.56 137.57 32.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.006 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 m -103.21 128.91 26.57 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.613 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.57 -27.1 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.877 1.462 . . . . 0.0 111.196 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.4 m -84.12 -35.5 23.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.274 -0.891 . . . . 0.0 110.653 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 39.0 m0 -94.46 -13.06 26.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.363 -0.836 . . . . 0.0 111.0 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.08 11.75 7.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.525 -0.734 . . . . 0.0 112.234 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.96 166.45 23.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.792 -1.192 . . . . 0.0 110.803 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.5 t -75.37 143.64 42.71 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.513 -0.742 . . . . 0.0 110.51 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 33.9 m -124.38 -169.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 109.932 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.452 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 20.7 t80 -93.34 133.85 36.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 110.326 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.605 -0.685 . . . . 0.0 110.432 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.439 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 116.63 25.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -1.013 . . . . 0.0 110.2 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.49 116.17 4.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.04 -102.26 2.55 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.05 -5.03 22.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.523 -0.986 . . . . 0.0 111.177 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -143.0 47.62 1.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.096 -1.003 . . . . 0.0 110.022 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 29' ' ' CYS . . . -76.1 -157.89 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.567 -0.708 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 117.82 3.81 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.42 24.17 12.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.639 -0.918 . . . . 0.0 110.189 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 30.8 t70 -69.77 -28.94 66.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.15 -13.78 76.42 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.66 9.65 6.1 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.012 0.906 . . . . 0.0 111.156 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -159.42 36.78 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.001 -1.062 . . . . 0.0 110.678 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 14.9 t -76.28 164.99 25.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.236 -0.915 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.48 8.49 16.5 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.23 -0.919 . . . . 0.0 111.162 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 m 50.74 -152.57 0.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 t -102.68 -72.92 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 0.0 110.157 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -159.84 114.51 2.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.081 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.23 45.45 8.85 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -144.94 120.27 10.25 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.477 -1.014 . . . . 0.0 110.115 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -90.55 151.47 21.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.369 -0.832 . . . . 0.0 109.383 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -89.05 142.06 27.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.07 -1.018 . . . . 0.0 110.816 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -110.25 127.68 26.63 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.784 -0.572 . . . . 0.0 110.297 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.2 -31.17 6.17 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.99 1.521 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -77.05 -29.36 55.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.463 -0.773 . . . . 0.0 110.701 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 59.8 m95 -100.69 -18.36 16.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.347 -0.846 . . . . 0.0 110.935 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 16.0 tptt 67.41 32.93 5.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.52 -0.737 . . . . 0.0 112.009 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -159.75 158.17 30.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.054 -1.029 . . . . 0.0 110.53 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 67.9 m -69.43 139.06 54.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.915 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.9 m -132.65 -168.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -66.44 140.1 58.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.53 150.6 22.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.431 -0.793 . . . . 0.0 110.713 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.46 65.64 60.18 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.645 -0.659 . . . . 0.0 110.098 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.253 0 O-C-N 123.644 1.339 . . . . 0.0 110.655 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.2 125.65 14.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.488 -1.007 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.54 -77.39 0.53 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.81 -149.84 17.12 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.04 -1.53 52.07 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.492 -1.005 . . . . 0.0 111.132 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.78 42.05 1.45 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.22 -161.68 0.53 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.551 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.96 117.93 4.17 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 51.5 m -108.27 48.6 0.85 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.99 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.55 91.15 3.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.422 -0.799 . . . . 0.0 110.008 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.36 137.3 4.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -71.17 -4.7 26.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.384 -1.068 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -115.27 31.97 6.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.077 -1.015 . . . . 0.0 110.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -84.89 179.78 7.24 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.197 -0.939 . . . . 0.0 110.682 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.26 150.31 39.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -0.85 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.2 m -112.75 -145.2 0.4 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.559 -0.713 . . . . 0.0 109.747 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -91.02 -60.14 1.98 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.044 -1.035 . . . . 0.0 110.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -123.41 -126.64 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.634 -0.666 . . . . 0.0 109.47 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.46 -11.91 65.73 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 26.1 m-85 -38.81 112.45 0.24 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.799 -0.824 . . . . 0.0 111.297 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -89.61 -176.41 4.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.2 m -111.05 147.59 34.46 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.748 -1.22 . . . . 0.0 110.204 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -85.95 144.51 39.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.376 -0.827 . . . . 0.0 110.189 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -23.54 19.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 124.025 1.54 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.455 HG21 ' CD1' ' A' ' 26' ' ' TRP . 3.1 t -116.94 -25.19 7.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.247 -0.908 . . . . 0.0 111.683 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.629 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 m0 -85.6 -18.1 34.3 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.012 -1.055 . . . . 0.0 111.197 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt 60.2 21.93 11.27 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.594 -0.691 . . . . 0.0 112.092 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.629 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.03 159.18 41.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.168 . . . . 0.0 110.37 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 96.1 m -68.79 135.35 51.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 110.915 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 34.4 m -124.5 163.84 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.681 -0.637 . . . . 0.0 109.568 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.13 145.73 52.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.62 99.93 9.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -0.779 . . . . 0.0 110.294 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.58 125.56 1.25 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.76 . . . . 0.0 110.634 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.314 -1.268 0 O-C-N 123.711 1.374 . . . . 0.0 110.672 179.658 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.7 t -145.97 139.0 25.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.978 . . . . 0.0 110.094 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.49 -113.39 3.75 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.84 -138.6 8.16 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -15.35 18.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.535 -0.98 . . . . 0.0 110.558 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.56 43.96 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -161.97 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.388 -0.82 . . . . 0.0 110.593 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.91 100.46 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HA ' HG22 ' A' ' 14' ' ' THR . 18.9 p -108.71 40.18 1.85 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.51 -0.994 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.623 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 20.6 t70 -67.02 163.38 20.04 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.078 -1.014 . . . . 0.0 110.206 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.47 -13.43 18.39 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? 58.07 19.88 6.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.499 -1.001 . . . . 0.0 110.587 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -172.58 37.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.441 -0.787 . . . . 0.0 110.355 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 9' ' ' CYS . 7.2 t -99.92 176.03 5.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -129.27 137.11 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 m -80.93 -144.46 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -71.45 0.47 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.013 -1.054 . . . . 0.0 110.061 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -167.42 112.15 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.765 -0.584 . . . . 0.0 110.088 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.4 21.33 38.21 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -130.7 137.96 49.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.4 -1.059 . . . . 0.0 109.538 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 6.4 t30 -108.78 175.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -113.27 138.64 49.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 45.5 t -91.02 137.26 26.65 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.393 -0.817 . . . . 0.0 110.076 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 -18.5 22.95 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.941 1.495 . . . . 0.0 111.468 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -106.52 -29.06 9.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.113 -0.992 . . . . 0.0 111.11 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.649 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 31.1 m0 -89.43 -26.07 21.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.238 -0.914 . . . . 0.0 110.565 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.623 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.35 9.68 7.04 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.837 -0.539 . . . . 0.0 111.886 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.649 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -124.59 161.24 26.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.878 -1.139 . . . . 0.0 110.009 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 16.7 m -75.16 147.01 40.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.143 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.03 -174.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.76 132.21 47.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 109.968 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.91 132.67 35.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.697 -0.627 . . . . 0.0 110.376 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -74.12 115.29 41.33 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 109.712 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 O-C-N 123.823 1.433 . . . . 0.0 110.693 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 m -107.88 157.9 17.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.569 -0.959 . . . . 0.0 110.174 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -93.03 0.09 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.3 -159.34 27.11 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.19 -4.16 49.56 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.985 . . . . 0.0 110.598 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.9 mtt -150.85 29.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.387 -0.821 . . . . 0.0 109.739 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.6 33.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -0.852 . . . . 0.0 110.716 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.93 122.61 30.76 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.2 m -84.13 -59.74 2.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.64 -0.918 . . . . 0.0 109.899 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.6 t70 51.15 78.68 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.253 0.549 . . . . 0.0 111.031 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.2 141.97 4.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 2.4 24.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -1.024 . . . . 0.0 110.747 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.86 23.66 9.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.276 -0.89 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.531 HG21 ' SG ' ' A' ' 22' ' ' CYS . 10.9 t -73.76 165.27 25.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.876 . . . . 0.0 109.943 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.03 149.81 50.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.0 111.054 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.65 -150.42 0.46 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.665 -0.647 . . . . 0.0 109.445 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -91.4 -70.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.029 -1.044 . . . . 0.0 110.273 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -172.17 92.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.91 -35.56 4.01 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -70.35 125.08 25.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.405 -1.056 . . . . 0.0 110.15 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.8 m120 -107.89 166.55 10.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.998 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 14' ' ' THR . 41.7 m -88.76 132.12 34.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.132 -0.98 . . . . 0.0 110.571 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 26' ' ' TRP . 11.9 p -67.76 142.91 96.2 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.65 -19.03 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.808 1.425 . . . . 0.0 111.887 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.1 m -122.54 -33.35 3.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.965 -1.084 . . . . 0.0 111.858 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 48.1 m0 -79.04 -12.84 60.03 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.013 . . . . 0.0 111.466 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? 66.16 11.09 7.6 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.474 -0.766 . . . . 0.0 113.002 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.587 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.8 164.2 23.55 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.448 -1.408 . . . . 0.0 111.126 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -70.38 147.45 49.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.448 -0.783 . . . . 0.0 110.922 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.61 169.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.766 -0.584 . . . . 0.0 109.428 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -66.25 132.82 49.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.0 110.069 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.21 168.97 9.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.67 82.58 0.22 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.628 -0.67 . . . . 0.0 110.583 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 C--N 1.314 -1.255 0 O-C-N 123.792 1.417 . . . . 0.0 110.604 179.727 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 2.2 t -93.87 131.08 39.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.518 -0.99 . . . . 0.0 110.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.05 -75.16 1.28 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.8 -156.68 18.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -88.65 -4.21 58.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.444 -1.033 . . . . 0.0 110.992 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.96 40.97 1.27 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.105 -0.997 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -82.71 -157.62 0.23 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 110.385 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.45 100.15 0.76 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 t -74.24 -76.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.48 -1.012 . . . . 0.0 110.358 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 t70 52.32 61.34 3.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 163.56 142.32 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -10.36 59.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.547 -0.972 . . . . 0.0 110.87 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -142.07 49.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 t -69.05 176.48 3.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.421 -0.8 . . . . 0.0 110.545 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.26 104.26 11.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -0.8 . . . . 0.0 110.144 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -86.39 -149.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.782 . . . . 0.0 109.575 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 1.5 t -79.24 -56.68 4.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 -81.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.15 -27.2 28.89 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.407 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 4.0 m-85 -48.44 124.45 8.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.635 -0.92 . . . . 0.0 110.605 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.57 -169.99 2.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.447 -0.783 . . . . 0.0 109.628 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 110.275 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -112.11 133.14 21.75 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.676 . . . . 0.0 110.048 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.907 1.478 . . . . 0.0 111.197 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -74.86 -21.08 59.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.497 -0.752 . . . . 0.0 110.73 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.55 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 41.7 m95 -101.1 -16.5 17.05 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.439 -0.788 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm 59.06 22.62 10.71 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.508 -0.745 . . . . 0.0 112.707 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.54 161.33 39.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.706 -1.246 . . . . 0.0 110.616 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 91.8 m -69.49 138.57 53.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.353 -0.842 . . . . 0.0 110.286 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.69 170.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.682 -0.636 . . . . 0.0 109.93 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.3 p90 -61.55 173.36 0.97 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.408 -0.807 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.19 47.94 2.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.111 -0.993 . . . . 0.0 110.709 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 47.58 80.4 0.3 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.911 -0.493 . . . . 0.0 110.948 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.313 -1.319 0 O-C-N 123.87 1.458 . . . . 0.0 110.624 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 t -155.73 138.91 15.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -1.042 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.26 -121.13 1.45 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.35 -155.71 26.89 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -8.02 52.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.453 -1.028 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.73 31.7 0.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.45 120.28 29.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -0.771 . . . . 0.0 110.436 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.48 111.15 2.97 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.607 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 9.0 p -84.7 -35.86 22.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.518 -0.99 . . . . 0.0 110.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 9.4 t70 54.35 70.08 0.65 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.646 -0.659 . . . . 0.0 111.122 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.34 134.08 3.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -6.76 44.3 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.541 -0.976 . . . . 0.0 110.763 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 m -106.16 29.36 6.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.396 -0.815 . . . . 0.0 110.117 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.607 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.93 162.54 26.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.517 -0.739 . . . . 0.0 110.462 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.74 99.33 5.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 110.03 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.39 -157.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.296 -0.878 . . . . 0.0 110.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -78.92 0.07 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.122 -0.986 . . . . 0.0 110.321 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -165.48 114.73 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.671 -0.643 . . . . 0.0 109.606 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.75 24.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.518 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 39.5 m-85 -129.48 118.21 21.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.385 -1.068 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -108.76 156.65 19.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.81 . . . . 0.0 110.419 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.4 t -89.46 134.47 34.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 110.508 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 8.5 t -80.59 141.92 52.88 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.673 -0.642 . . . . 0.0 110.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.17 -18.65 23.48 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.931 1.49 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 m -106.1 -25.85 11.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.203 -0.935 . . . . 0.0 111.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.596 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 28.8 m0 -95.2 -18.89 20.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 0.0 111.16 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.53 12.06 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.525 -0.735 . . . . 0.0 112.451 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.596 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -129.44 164.98 22.5 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.71 -1.244 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -74.82 142.21 44.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.387 -0.82 . . . . 0.0 110.535 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 29.2 m -129.11 168.99 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.726 -0.609 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.46 121.68 26.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.267 -0.896 . . . . 0.0 110.42 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.8 69.42 6.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.842 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.81 70.35 36.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 109.736 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.275 0 O-C-N 123.755 1.397 . . . . 0.0 110.729 -179.537 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.537 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 17.9 p -86.63 -155.75 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.468 -1.019 . . . . 0.0 110.225 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.32 -105.95 0.05 OUTLIER Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.56 -171.25 23.85 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.1 mt -76.12 -9.01 58.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.489 -1.006 . . . . 0.0 111.459 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.3 ttt -144.09 42.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.802 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.28 102.87 15.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.34 119.23 13.82 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 14' ' ' THR . 4.0 p -117.21 -46.8 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.538 -0.978 . . . . 0.0 110.833 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 51.79 67.22 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.563 -0.711 . . . . 0.0 110.468 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.38 127.38 0.91 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -66.12 -13.13 59.59 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.679 -0.895 . . . . 0.0 111.078 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.16 21.43 11.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.104 -0.998 . . . . 0.0 110.674 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 9' ' ' CYS . 9.1 t -81.1 169.7 17.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.131 -0.981 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -128.58 142.31 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.3 m -126.88 -151.35 0.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.611 -0.681 . . . . 0.0 110.038 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -68.09 -66.93 0.5 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.186 -0.946 . . . . 0.0 110.791 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -150.66 -76.37 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.81 13.28 62.42 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.51 119.62 17.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -1.222 . . . . 0.0 109.695 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -106.07 153.82 21.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.466 -0.771 . . . . 0.0 110.5 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 m -89.41 135.8 33.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.341 -0.849 . . . . 0.0 110.75 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -86.29 140.47 34.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.72 -25.9 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.827 1.435 . . . . 0.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.424 HG21 ' N ' ' A' ' 26' ' ' TRP . 9.8 t -91.04 -23.92 20.21 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.317 -0.864 . . . . 0.0 111.236 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.653 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.0 m0 -101.37 -22.12 14.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.123 -0.986 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER 69.96 9.34 7.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.964 -0.46 . . . . 0.0 112.025 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -126.19 171.6 10.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.848 -1.157 . . . . 0.0 110.435 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -82.21 147.42 28.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.408 -0.807 . . . . 0.0 110.929 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.23 -169.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -93.96 138.46 32.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.0 143.68 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 110.33 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 2.8 mmt180 -52.31 -54.82 37.7 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.692 -0.63 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' ARG . 45.0 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.541 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 26.7 p -94.98 -176.54 3.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.515 -0.991 . . . . 0.0 110.444 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.55 -149.14 24.45 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 -113.03 0.34 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -109.54 -15.88 14.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.476 -1.014 . . . . 0.0 111.07 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt -150.48 32.44 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.369 -0.832 . . . . 0.0 109.707 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -71.68 -163.71 0.11 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.496 -0.752 . . . . 0.0 110.245 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.31 116.23 5.45 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.513 ' HB2' ' CA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -111.5 42.8 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.768 -0.842 . . . . 0.0 110.272 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -71.9 81.39 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.227 -0.921 . . . . 0.0 109.52 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.79 124.76 1.39 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -10.41 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.497 -1.002 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -110.06 28.2 8.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.22 -0.925 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 t -90.97 154.31 19.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.91 155.09 28.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.42 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.1 m -103.54 -165.51 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.586 -0.696 . . . . 0.0 110.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.85 -70.26 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.363 -0.835 . . . . 0.0 110.288 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.9 124.33 1.55 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.0 30.61 60.98 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.9 m-85 -129.79 132.23 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -97.79 140.24 32.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.728 . . . . 0.0 109.874 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 40.6 t -88.8 132.58 34.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.92 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.11 120.03 49.19 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.674 -0.641 . . . . 0.0 109.858 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.84 -31.01 10.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.806 1.424 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.5 m -78.9 -28.73 44.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.745 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.488 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 76.3 m95 -96.87 -12.89 22.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 111.089 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt 64.06 27.6 14.18 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.372 -0.83 . . . . 0.0 112.002 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.513 ' CA ' ' HB2' ' A' ' 9' ' ' CYS . 1.5 p90 -157.69 150.36 22.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.04 -1.038 . . . . 0.0 109.84 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.4 t -82.07 146.84 29.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.216 -0.928 . . . . 0.0 110.161 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 34.8 m -129.99 -167.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.39 151.3 47.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.344 -0.847 . . . . 0.0 109.871 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.34 120.43 30.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 92.1 44.03 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.314 -1.265 0 O-C-N 123.822 1.433 . . . . 0.0 110.475 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.5 m -85.8 143.52 28.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.986 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.84 -87.4 0.42 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.36 -161.77 28.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -2.71 55.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.491 -1.006 . . . . 0.0 111.282 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 34.75 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 109.793 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.91 104.93 15.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 110.555 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -55.32 113.53 3.84 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 14' ' ' THR . 28.6 p -104.7 -36.18 7.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.4 -1.059 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t70 55.16 77.44 0.22 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.624 -0.673 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.28 5.95 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -1.32 57.02 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.487 -1.008 . . . . 0.0 110.911 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 p -148.56 49.57 1.01 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.294 -0.879 . . . . 0.0 109.76 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.569 HG23 ' SG ' ' A' ' 22' ' ' CYS . 8.7 t -74.62 -169.46 0.86 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.656 -0.652 . . . . 0.0 110.767 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.96 100.05 6.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 1.1 t -98.67 -146.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 0.0 109.752 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -94.49 -105.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.009 -1.057 . . . . 0.0 110.003 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 21.18 2.07 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.859 -1.151 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.22 42.06 0.15 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.475 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 79.8 m-85 -138.08 138.85 39.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.961 . . . . 0.0 110.07 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -121.1 153.37 37.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.569 ' SG ' HG23 ' A' ' 14' ' ' THR . 16.4 m -89.11 134.98 33.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.184 -0.948 . . . . 0.0 110.822 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -91.82 146.81 33.72 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.768 -0.583 . . . . 0.0 110.187 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 -35.57 3.95 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.911 1.479 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 m -87.49 -37.11 17.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 110.417 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.723 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 35.5 m0 -82.68 -29.71 29.75 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 19.0 tptt 69.07 11.2 8.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.959 -0.463 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.723 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.83 167.09 17.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.808 -1.182 . . . . 0.0 111.064 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -77.54 129.79 36.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.698 -0.626 . . . . 0.0 111.154 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 28' ' ' TRP . 21.4 m -129.55 169.63 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.777 -0.577 . . . . 0.0 109.478 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -52.92 155.17 2.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.86 123.54 47.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.355 -0.841 . . . . 0.0 110.453 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.58 124.98 32.3 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.582 -0.699 . . . . 0.0 110.198 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.313 -1.309 0 O-C-N 123.883 1.465 . . . . 0.0 111.007 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t -78.57 135.43 37.28 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.407 -1.055 . . . . 0.0 110.034 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.94 -124.56 1.55 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -134.36 3.0 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -7.29 25.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.596 -0.943 . . . . 0.0 111.358 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.8 ttm -149.93 32.85 0.68 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.15 -0.968 . . . . 0.0 110.122 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.23 136.91 44.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.69 119.81 19.39 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.0 t -95.33 -77.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.676 -0.897 . . . . 0.0 109.851 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.55 73.94 0.28 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.761 -0.587 . . . . 0.0 111.119 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.38 120.7 1.6 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -14.26 44.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.866 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -105.88 27.44 8.52 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 0.0 110.454 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -69.4 -178.2 1.33 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.245 -0.91 . . . . 0.0 110.462 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.99 146.74 45.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -131.98 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.68 -0.637 . . . . 0.0 110.005 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -67.88 0.73 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 p -168.51 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.568 -0.708 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.07 28.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 53.6 m-85 -122.86 129.9 52.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.291 -1.123 . . . . 0.0 109.872 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.64 163.11 16.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.461 -0.774 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -89.23 137.24 32.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.362 -0.836 . . . . 0.0 110.801 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.56 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -93.22 143.18 26.31 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.48 -0.763 . . . . 0.0 110.099 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.83 -21.81 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.916 1.482 . . . . 0.0 111.665 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 m -109.59 -38.67 5.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.171 -0.956 . . . . 0.0 111.369 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 40.8 m0 -72.64 -20.59 61.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 65.02 15.66 10.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.707 -0.62 . . . . 0.0 111.869 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.686 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -141.02 162.89 34.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.777 -1.202 . . . . 0.0 110.704 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.76 138.65 46.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.49 -0.756 . . . . 0.0 110.546 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 5.3 m -136.1 -178.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -58.55 153.48 16.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.85 122.19 31.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.348 -0.845 . . . . 0.0 110.464 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.49 143.11 14.6 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.71 -0.619 . . . . 0.0 110.216 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 O-C-N 123.779 1.41 . . . . 0.0 110.975 -179.743 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.3 t -122.81 149.35 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.559 -0.965 . . . . 0.0 110.106 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 7' ' ' ALA . . . -78.59 -152.09 6.02 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.86 46.82 0.06 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.42 -7.37 1.02 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.899 -0.765 . . . . 0.0 112.512 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.87 25.81 0.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.945 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . . . -64.66 114.22 4.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.9 120.12 15.92 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.7 m -79.32 -73.53 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.986 . . . . 0.0 109.88 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 50.51 56.5 7.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.491 0.663 . . . . 0.0 109.744 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.13 123.78 1.2 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -14.73 52.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.999 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.31 14.0 23.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 110.8 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -71.11 146.76 49.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.101 -0.999 . . . . 0.0 110.25 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -126.36 137.85 53.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.395 -0.816 . . . . 0.0 110.677 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.09 -154.28 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.648 -0.657 . . . . 0.0 109.73 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -73.04 0.35 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 110.436 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.3 -44.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 0.0 110.526 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.56 28.7 14.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 30.0 m-85 -124.62 131.83 53.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.979 . . . . 0.0 110.078 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -109.74 149.95 29.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.327 -0.858 . . . . 0.0 109.777 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.8 t -88.91 136.0 33.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.187 -0.945 . . . . 0.0 111.012 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.35 130.5 23.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.634 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.04 -31.39 9.8 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.887 1.467 . . . . 0.0 111.521 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -81.68 -31.96 31.98 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.897 . . . . 0.0 110.684 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.634 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -91.25 -17.73 25.52 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.381 -0.825 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tptm 67.7 17.35 9.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.689 -0.632 . . . . 0.0 111.656 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.634 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -144.66 168.39 20.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 110.549 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -84.56 150.95 24.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.515 -0.741 . . . . 0.0 111.041 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 28.2 m -140.15 178.63 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -58.06 151.74 18.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.91 127.7 43.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.356 -0.84 . . . . 0.0 110.312 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -155.31 133.65 7.07 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.58 -0.7 . . . . 0.0 110.208 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--N 1.313 -1.3 0 O-C-N 123.908 1.478 . . . . 0.0 110.847 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.484 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 9.1 t 54.24 75.84 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.856 -0.791 . . . . 0.0 110.808 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.52 -80.67 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.09 -133.63 4.22 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.76 -5.01 21.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.453 -1.028 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 ttm -149.59 33.87 0.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.05 -167.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.393 -0.817 . . . . 0.0 110.231 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.31 88.58 0.47 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' HG21 ' A' ' 14' ' ' THR . 17.5 p -99.61 53.31 0.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.93 . . . . 0.0 110.029 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.87 100.0 2.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.6 126.51 1.36 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -63.53 -14.38 50.56 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.585 -0.95 . . . . 0.0 111.028 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -108.62 30.0 6.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.5 t -96.49 169.12 10.12 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.358 -0.839 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.57 145.86 27.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -90.19 -144.29 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.376 -0.827 . . . . 0.0 110.027 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.484 ' CA ' ' HA ' ' A' ' 2' ' ' CYS . 1.7 t -81.8 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.951 -1.093 . . . . 0.0 110.795 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 t -164.92 -48.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.441 -0.787 . . . . 0.0 110.494 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 23.93 33.79 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 145.07 50.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.314 -1.11 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -122.42 157.95 30.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 t -88.48 141.26 28.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.957 -1.089 . . . . 0.0 110.551 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.94 133.48 20.26 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -29.46 10.52 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.97 1.51 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 m -87.13 -37.08 17.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.398 -0.814 . . . . 0.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 70.7 m95 -89.63 -15.04 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.486 -0.758 . . . . 0.0 111.013 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 60.33 14.27 4.57 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.612 -0.68 . . . . 0.0 112.672 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.625 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -135.43 159.17 42.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.778 -1.201 . . . . 0.0 110.537 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.5 m -67.38 132.35 47.49 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.446 -0.784 . . . . 0.0 110.081 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.7 m -116.9 179.73 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.678 . . . . 0.0 109.815 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -76.19 142.66 41.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.55 90.46 8.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.802 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -78.43 135.69 60.9 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 O-C-N 123.93 1.489 . . . . 0.0 110.763 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.485 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 m -130.03 128.18 41.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.516 -0.991 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.76 -88.18 0.65 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.27 -144.98 14.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.68 -4.34 33.95 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.511 -0.994 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -149.94 41.78 0.85 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.53 -165.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.507 -0.746 . . . . 0.0 110.658 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 112.73 2.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -80.32 -77.52 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.458 -1.025 . . . . 0.0 110.018 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.94 68.16 0.79 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.677 -0.64 . . . . 0.0 110.483 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.9 121.52 1.92 Allowed Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -61.97 -15.88 47.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.93 . . . . 0.0 110.536 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.37 9.46 41.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.385 -0.822 . . . . 0.0 110.953 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.477 HG22 ' SG ' ' A' ' 22' ' ' CYS . 12.2 t -72.0 158.37 36.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.029 -1.045 . . . . 0.0 110.042 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.64 143.32 41.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.307 -0.871 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -95.31 -138.59 0.24 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.728 . . . . 0.0 109.98 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -91.3 -85.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 110.779 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 m -146.86 -47.63 0.18 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.162 -0.961 . . . . 0.0 110.773 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.77 25.88 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.1 133.87 39.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -1.006 . . . . 0.0 110.105 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.77 149.86 26.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.357 -0.839 . . . . 0.0 109.195 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.0 124.21 33.5 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.909 -1.119 . . . . 0.0 110.334 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.36 128.35 40.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.786 -0.571 . . . . 0.0 110.443 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.97 -37.02 3.04 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.941 1.495 . . . . 0.0 110.661 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.6 m -71.81 -37.75 70.32 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.59 -0.694 . . . . 0.0 110.402 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.9 m95 -90.74 -12.06 37.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.588 -0.695 . . . . 0.0 110.64 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 61.38 19.34 10.13 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.561 -0.712 . . . . 0.0 112.256 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -147.58 157.7 43.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.81 -1.182 . . . . 0.0 110.838 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 67.3 m -67.2 136.02 54.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.677 -0.639 . . . . 0.0 110.798 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.2 -172.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -69.54 148.63 49.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.19 133.01 52.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.429 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -66.4 -55.52 19.24 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.473 -0.767 . . . . 0.0 110.644 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 33' ' ' ARG . 46.7 Cg_endo . . . . . 0 N--CA 1.487 1.1 0 O-C-N 123.63 1.331 . . . . 0.0 110.603 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.1 103.69 2.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -1.026 . . . . 0.0 110.284 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.54 -119.03 4.55 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.09 -126.65 1.34 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 4.1 mp -104.54 -2.79 24.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.57 -0.959 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.73 31.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 109.944 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 130.16 35.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 109.727 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.27 118.43 10.27 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.76 -74.44 0.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.911 . . . . 0.0 109.935 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.09 92.08 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.419 0.628 . . . . 0.0 110.561 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . 142.5 -13.18 2.49 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 2.5 mtmp? 60.6 20.11 10.0 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.387 -1.067 . . . . 0.0 110.976 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -170.31 48.02 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 22' ' ' CYS . 5.3 t -83.72 158.3 21.83 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.23 120.41 34.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.399 -0.813 . . . . 0.0 110.199 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -100.77 -170.26 1.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.499 -0.751 . . . . 0.0 110.354 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.6 m -64.31 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.397 -0.814 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 p -158.99 88.77 0.91 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.418 -0.801 . . . . 0.0 109.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.06 8.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.447 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 32.1 m-85 -84.5 145.3 28.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -1.122 . . . . 0.0 109.91 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 17.0 t-20 -125.22 154.69 41.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.737 . . . . 0.0 110.235 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' HB2' HG23 ' A' ' 14' ' ' THR . 1.7 t -88.11 134.25 33.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.543 -0.723 . . . . 0.0 110.334 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -100.86 133.39 21.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.754 -0.591 . . . . 0.0 110.089 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.25 -28.12 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.9 1.474 . . . . 0.0 110.953 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -88.4 -36.48 16.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 0.0 110.544 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.707 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.9 m0 -88.3 -14.64 37.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 110.55 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 1.4 mmpp? 60.82 20.44 10.61 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.687 -0.633 . . . . 0.0 111.967 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.707 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -145.25 168.8 19.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.933 -1.105 . . . . 0.0 111.0 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -78.6 150.61 32.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.585 -0.697 . . . . 0.0 110.92 -179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 11.9 m -149.39 172.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.702 -0.624 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -69.06 135.26 50.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 0.0 109.858 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.36 104.17 16.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 110.172 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ptt85 -140.01 159.19 65.37 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.533 -0.729 . . . . 0.0 110.515 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--N 1.314 -1.282 0 O-C-N 123.792 1.417 . . . . 0.0 110.627 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 139.19 41.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.501 -0.999 . . . . 0.0 110.048 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.86 -136.62 5.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.43 -141.47 5.52 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.97 -12.14 29.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.592 -0.946 . . . . 0.0 111.114 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mtt -150.22 32.45 0.66 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.214 -0.929 . . . . 0.0 110.145 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.38 147.52 42.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.75 123.13 28.03 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 t -90.66 -71.33 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.48 99.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.333 0.587 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.14 -11.57 6.85 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm 59.57 19.96 8.5 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.287 -1.125 . . . . 0.0 110.736 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -170.22 45.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.36 -0.837 . . . . 0.0 110.0 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -82.47 165.43 20.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.465 -0.772 . . . . 0.0 110.833 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.37 105.34 15.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.01 -141.78 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.549 -0.72 . . . . 0.0 110.31 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -75.59 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.235 -0.916 . . . . 0.0 110.076 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -145.25 63.96 1.27 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 109.939 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.42 -46.18 0.55 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HD1' ' HA ' ' A' ' 31' ' ' TYR . 22.3 m-85 -55.96 128.5 35.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.606 -0.938 . . . . 0.0 110.242 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -106.12 159.24 16.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.773 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.3 t -89.27 132.67 34.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 110.714 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.12 128.47 36.92 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.9 -25.17 16.87 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.803 1.423 . . . . 0.0 111.169 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 m -87.82 -30.0 20.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.324 -0.86 . . . . 0.0 110.812 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 29.9 m0 -98.48 -15.25 19.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.285 -0.884 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.64 14.73 9.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.564 -0.71 . . . . 0.0 112.075 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.578 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -136.21 165.27 26.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.762 -1.211 . . . . 0.0 110.602 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 t -79.65 136.1 36.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.764 . . . . 0.0 110.542 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.68 -167.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.06 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.532 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 24.0 p90 -88.29 165.08 15.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.442 -0.787 . . . . 0.0 110.261 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.08 -172.56 2.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.515 -0.741 . . . . 0.0 110.213 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.78 70.77 9.89 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.377 -0.827 . . . . 0.0 110.03 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.315 -1.211 0 O-C-N 123.719 1.379 . . . . 0.0 110.738 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 p -94.12 -170.54 2.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.533 -0.981 . . . . 0.0 110.659 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.93 173.0 55.21 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 -119.62 1.08 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.3 7.16 22.94 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.491 -1.006 . . . . 0.0 111.474 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.31 29.98 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.96 119.06 19.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.214 -0.929 . . . . 0.0 110.046 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.06 128.53 17.19 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HA ' HG23 ' A' ' 14' ' ' THR . 5.3 t -109.44 23.72 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.741 -0.858 . . . . 0.0 110.38 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.38 -21.01 66.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -76.31 -3.79 77.68 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 4.4 mtmp? 59.57 23.15 11.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -1.073 . . . . 0.0 111.02 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -176.3 38.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.382 -0.824 . . . . 0.0 110.702 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 9' ' ' CYS . 5.8 t -71.14 105.96 3.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.127 -0.983 . . . . 0.0 110.078 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.03 104.8 2.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.93 -166.25 1.08 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 0.0 110.62 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -65.8 0.63 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.318 -0.864 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.29 -45.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.552 -0.718 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.12 30.69 9.86 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 48.7 m-85 -123.16 120.74 34.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -1.007 . . . . 0.0 110.284 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -110.99 167.37 10.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.47 144.16 26.26 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.827 -1.171 . . . . 0.0 110.948 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -90.37 147.65 37.17 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.595 -0.691 . . . . 0.0 110.136 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.88 -24.56 11.37 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.876 1.461 . . . . 0.0 111.634 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -111.32 -30.74 7.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.259 -0.901 . . . . 0.0 111.462 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.643 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 40.8 m0 -80.57 -20.53 43.16 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.166 -0.959 . . . . 0.0 110.842 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.59 21.41 11.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.612 -0.68 . . . . 0.0 112.113 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.643 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -143.75 166.81 23.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.737 -1.227 . . . . 0.0 110.932 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.3 t -69.9 138.06 52.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.572 -0.705 . . . . 0.0 111.013 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.2 m -134.66 -179.94 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -61.36 158.87 13.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.0 109.982 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.24 172.81 11.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.336 -0.852 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -114.93 147.21 37.78 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 O-C-N 123.918 1.483 . . . . 0.0 110.607 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.5 t -151.3 127.13 10.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.54 -0.976 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.95 -118.12 4.11 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.17 -127.9 1.48 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.89 -7.4 17.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -1.0 . . . . 0.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.8 29.41 0.83 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.95 146.61 27.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 0.0 110.2 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.04 124.31 36.3 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -125.34 20.41 8.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.489 -1.006 . . . . 0.0 110.614 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -49.79 106.53 0.12 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.406 -0.809 . . . . 0.0 110.757 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.09 2.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -12.97 61.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.484 -1.009 . . . . 0.0 111.066 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.59 38.05 3.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.29 -0.881 . . . . 0.0 110.64 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -69.16 151.04 46.84 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.729 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -109.4 127.34 54.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.357 -0.84 . . . . 0.0 110.598 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.19 -156.55 0.57 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.17 -0.956 . . . . 0.0 110.405 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -169.39 127.88 0.98 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.496 -0.753 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.92 21.96 79.44 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.9 m-85 -131.18 131.26 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.253 -1.145 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.3 t-20 -117.83 164.86 14.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.346 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -88.79 137.76 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.59 135.3 19.76 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.688 -0.632 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.81 -34.44 3.18 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.829 1.436 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.26 -35.36 61.39 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.0 110.71 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.601 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.0 m95 -97.98 -20.02 17.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.734 . . . . 0.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.43 12.64 8.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.716 -0.615 . . . . 0.0 112.376 179.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.601 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -135.02 164.23 28.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.235 . . . . 0.0 110.676 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -68.21 137.77 55.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.747 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 26.7 m -136.14 -176.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.733 -0.604 . . . . 0.0 109.472 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 137.65 50.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.207 -0.933 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 21' ' ' ASN . . . -106.54 117.99 35.5 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.21 152.84 8.59 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.425 -0.797 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.312 -1.35 0 O-C-N 123.913 1.48 . . . . 0.0 110.729 179.791 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -85.19 -173.17 4.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.467 -1.019 . . . . 0.0 110.665 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.91 -113.15 0.69 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 -114.34 0.52 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.48 10.43 19.7 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.56 -0.965 . . . . 0.0 111.034 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.2 ttt -148.58 35.87 0.79 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.225 -0.922 . . . . 0.0 110.078 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.21 125.48 27.85 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.14 115.71 6.46 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -93.57 -82.8 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.927 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.05 59.59 4.43 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.573 -0.704 . . . . 0.0 110.593 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.71 -142.99 3.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.15 5.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.44 -1.035 . . . . 0.0 111.108 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.35 58.75 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.955 . . . . 0.0 110.013 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -59.16 147.24 35.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.52 129.78 34.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -126.02 -162.7 1.15 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.78 -0.575 . . . . 0.0 110.194 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.3 m -80.91 -86.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 125.67 4.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.314 -0.867 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.56 60.67 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.1 m120 -112.04 167.64 10.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.8 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -88.7 134.71 33.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.418 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 134.11 19.9 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.52 -33.83 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.794 1.418 . . . . 0.0 110.786 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.0 m -74.44 -44.78 50.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.636 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 85.8 m95 -88.27 -13.47 40.83 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.587 -0.696 . . . . 0.0 110.592 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.39 19.22 10.04 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.631 -0.668 . . . . 0.0 112.4 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.636 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.12 166.04 26.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.877 -1.14 . . . . 0.0 110.713 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -67.18 133.52 49.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.44 -0.787 . . . . 0.0 111.103 -178.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.89 176.88 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.13 137.16 58.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.48 155.89 18.42 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 0.0 110.502 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 122.62 10.24 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 O-C-N 123.869 1.457 . . . . 0.0 110.598 179.53 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -155.95 119.2 4.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.97 . . . . 0.0 110.284 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.02 -95.77 1.57 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.6 -131.94 5.04 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 -5.76 20.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.975 . . . . 0.0 110.839 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.6 ttm -145.61 36.79 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -73.29 -165.71 0.27 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.386 -0.822 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.65 96.32 0.54 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' HG22 ' A' ' 14' ' ' THR . 77.8 m -70.92 -77.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.913 . . . . 0.0 110.427 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.09 58.16 5.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.674 -0.641 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.78 139.07 2.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -8.29 55.47 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.421 -1.046 . . . . 0.0 110.727 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 2.31 39.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.329 -0.857 . . . . 0.0 110.657 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 9' ' ' CYS . 11.2 t -66.72 146.63 54.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.32 127.25 48.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -0.792 . . . . 0.0 110.335 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -87.31 -155.24 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 110.051 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.66 -92.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.14 123.26 14.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 109.844 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.33 35.56 76.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -130.05 120.8 25.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -1.044 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.7 t-20 -98.01 -170.95 2.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.3 m -118.68 139.02 52.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.15 -0.969 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 3.1 t -84.79 140.11 37.7 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.775 . . . . 0.0 110.028 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.48 -25.52 25.16 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.945 1.497 . . . . 0.0 111.297 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 m -103.29 -36.63 7.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.261 -0.899 . . . . 0.0 111.242 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.687 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 32.1 m0 -79.88 -21.27 44.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.253 -0.904 . . . . 0.0 111.093 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.4 OUTLIER 63.34 11.59 5.57 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.495 -0.753 . . . . 0.0 112.408 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.687 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -125.98 160.79 29.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.7 -1.25 . . . . 0.0 110.572 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 69.4 m -66.13 138.81 57.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.72 . . . . 0.0 111.438 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 m -139.17 -179.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.56 135.09 57.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.086 -1.009 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.11 107.73 19.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 110.349 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.7 tpt85 -155.36 66.95 4.92 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.358 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.314 -1.274 0 O-C-N 123.821 1.432 . . . . 0.0 110.682 179.817 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 t -75.34 164.36 26.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.56 -0.965 . . . . 0.0 110.385 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 16' ' ' CYS . . . -55.46 117.02 7.74 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.08 47.13 0.95 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER 68.26 -3.96 1.18 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.876 -0.779 . . . . 0.0 112.113 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.42 27.68 0.66 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.914 -1.116 . . . . 0.0 110.277 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 142.67 27.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.344 -0.848 . . . . 0.0 110.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 119.27 14.79 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -123.76 28.59 6.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.497 -1.002 . . . . 0.0 110.91 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.91 112.09 0.72 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.873 . . . . 0.0 110.282 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.08 137.35 3.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -8.06 49.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.454 -1.027 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -139.86 47.44 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 t -76.71 -176.23 3.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.482 -0.762 . . . . 0.0 110.578 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.29 147.88 51.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 73.4 m -129.5 -162.33 1.19 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.593 -0.692 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -76.99 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 110.567 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 p -158.2 123.7 4.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.19 31.36 63.95 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.474 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 23.4 m-85 -124.8 132.06 53.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -1.141 . . . . 0.0 110.123 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -112.42 159.32 18.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.0 110.127 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.1 t -89.56 137.57 32.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.006 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 m -103.21 128.91 26.57 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.613 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.57 -27.1 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.877 1.462 . . . . 0.0 111.196 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.4 m -84.12 -35.5 23.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.274 -0.891 . . . . 0.0 110.653 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 39.0 m0 -94.46 -13.06 26.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.363 -0.836 . . . . 0.0 111.0 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.08 11.75 7.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.525 -0.734 . . . . 0.0 112.234 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.96 166.45 23.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.792 -1.192 . . . . 0.0 110.803 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.5 t -75.37 143.64 42.71 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.513 -0.742 . . . . 0.0 110.51 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 33.9 m -124.38 -169.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 109.932 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.452 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 20.7 t80 -93.34 133.85 36.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 110.326 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.16 179.26 4.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.605 -0.685 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.499 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -162.62 -62.41 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 110.583 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 33' ' ' ARG . 45.9 Cg_endo . . . . . 0 N--CA 1.487 1.143 0 O-C-N 123.319 1.168 . . . . 0.0 110.74 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.169 0.509 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.678 ' CA ' ' HB2' ' A' ' 7' ' ' ALA . . . -81.49 116.17 4.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.04 -102.26 2.55 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 30' ' ' VAL . 1.4 mt -104.05 -5.03 22.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.523 -0.986 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -143.0 47.62 1.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.096 -1.003 . . . . 0.0 110.022 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' ' CA ' ' A' ' 3' ' ' GLY . . . -76.1 -157.89 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.567 -0.708 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 117.82 3.81 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -104.42 24.17 12.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.639 -0.918 . . . . 0.0 110.189 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 30.8 t70 -69.77 -28.94 66.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.15 -13.78 76.42 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.66 9.65 6.1 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.012 0.906 . . . . 0.0 111.156 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -159.42 36.78 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.001 -1.062 . . . . 0.0 110.678 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 14.9 t -76.28 164.99 25.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.236 -0.915 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.48 8.49 16.5 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.23 -0.919 . . . . 0.0 111.162 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 m 50.74 -152.57 0.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 t -102.68 -72.92 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 0.0 110.157 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -159.84 114.51 2.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.081 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.23 45.45 8.85 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -144.94 120.27 10.25 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.477 -1.014 . . . . 0.0 110.115 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -90.55 151.47 21.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.369 -0.832 . . . . 0.0 109.383 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -89.05 142.06 27.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.07 -1.018 . . . . 0.0 110.816 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -110.25 127.68 26.63 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.784 -0.572 . . . . 0.0 110.297 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.2 -31.17 6.17 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.99 1.521 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -77.05 -29.36 55.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.463 -0.773 . . . . 0.0 110.701 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.643 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 59.8 m95 -100.69 -18.36 16.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.347 -0.846 . . . . 0.0 110.935 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 16.0 tptt 67.41 32.93 5.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.52 -0.737 . . . . 0.0 112.009 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.643 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -159.75 158.17 30.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.054 -1.029 . . . . 0.0 110.53 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.558 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 67.9 m -69.43 139.06 54.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.915 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 25.9 m -132.65 -168.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -66.44 140.1 58.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.431 -0.793 . . . . 0.0 110.713 -179.253 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.929 0.395 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.54 -77.39 0.53 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.81 -149.84 17.12 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -95.04 -1.53 52.07 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.492 -1.005 . . . . 0.0 111.132 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.78 42.05 1.45 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.22 -161.68 0.53 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.551 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.96 117.93 4.17 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 51.5 m -108.27 48.6 0.85 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.99 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.55 91.15 3.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.422 -0.799 . . . . 0.0 110.008 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.36 137.3 4.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -71.17 -4.7 26.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.384 -1.068 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -115.27 31.97 6.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.077 -1.015 . . . . 0.0 110.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -84.89 179.78 7.24 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.197 -0.939 . . . . 0.0 110.682 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.26 150.31 39.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -0.85 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.2 m -112.75 -145.2 0.4 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.559 -0.713 . . . . 0.0 109.747 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -91.02 -60.14 1.98 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.044 -1.035 . . . . 0.0 110.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -123.41 -126.64 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.634 -0.666 . . . . 0.0 109.47 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.46 -11.91 65.73 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 26.1 m-85 -38.81 112.45 0.24 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.799 -0.824 . . . . 0.0 111.297 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -89.61 -176.41 4.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.2 m -111.05 147.59 34.46 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.748 -1.22 . . . . 0.0 110.204 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -85.95 144.51 39.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.376 -0.827 . . . . 0.0 110.189 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -23.54 19.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 124.025 1.54 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.832 HG23 ' CD1' ' A' ' 26' ' ' TRP . 3.1 t -116.94 -25.19 7.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.247 -0.908 . . . . 0.0 111.683 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.832 ' CD1' HG23 ' A' ' 25' ' ' THR . 38.3 m0 -85.6 -18.1 34.3 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.012 -1.055 . . . . 0.0 111.197 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt 60.2 21.93 11.27 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.594 -0.691 . . . . 0.0 112.092 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.652 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.03 159.18 41.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.168 . . . . 0.0 110.37 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 96.1 m -68.79 135.35 51.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 110.915 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 34.4 m -124.5 163.84 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.681 -0.637 . . . . 0.0 109.568 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.13 145.73 52.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.453 -0.779 . . . . 0.0 110.294 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.083 0.468 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.49 -113.39 3.75 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.84 -138.6 8.16 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 ' HE2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -100.24 -15.35 18.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.535 -0.98 . . . . 0.0 110.558 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.56 43.96 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -161.97 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.388 -0.82 . . . . 0.0 110.593 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.91 100.46 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.572 ' CA ' HG21 ' A' ' 14' ' ' THR . 18.9 p -108.71 40.18 1.85 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.51 -0.994 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.621 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 20.6 t70 -67.02 163.38 20.04 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.078 -1.014 . . . . 0.0 110.206 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.47 -13.43 18.39 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? 58.07 19.88 6.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.499 -1.001 . . . . 0.0 110.587 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -172.58 37.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.441 -0.787 . . . . 0.0 110.355 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.572 HG21 ' CA ' ' A' ' 9' ' ' CYS . 7.2 t -99.92 176.03 5.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -129.27 137.11 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 m -80.93 -144.46 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -71.45 0.47 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.013 -1.054 . . . . 0.0 110.061 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -167.42 112.15 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.765 -0.584 . . . . 0.0 110.088 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.4 21.33 38.21 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HE2' HD23 ' A' ' 5' ' ' LEU . 38.3 m-85 -130.7 137.96 49.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.4 -1.059 . . . . 0.0 109.538 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 6.4 t30 -108.78 175.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -113.27 138.64 49.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 45.5 t -91.02 137.26 26.65 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.393 -0.817 . . . . 0.0 110.076 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 -18.5 22.95 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.941 1.495 . . . . 0.0 111.468 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -106.52 -29.06 9.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.113 -0.992 . . . . 0.0 111.11 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 31.1 m0 -89.43 -26.07 21.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.238 -0.914 . . . . 0.0 110.565 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.35 9.68 7.04 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.837 -0.539 . . . . 0.0 111.886 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.672 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -124.59 161.24 26.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.878 -1.139 . . . . 0.0 110.009 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 16.7 m -75.16 147.01 40.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.143 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 5' ' ' LEU . 27.0 m -139.03 -174.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.76 132.21 47.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 109.968 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.697 -0.627 . . . . 0.0 110.376 -179.684 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.004 0.43 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -93.03 0.09 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.3 -159.34 27.11 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.19 -4.16 49.56 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.985 . . . . 0.0 110.598 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.9 mtt -150.85 29.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.387 -0.821 . . . . 0.0 109.739 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.6 33.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -0.852 . . . . 0.0 110.716 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.93 122.61 30.76 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.764 ' HB3' HG21 ' A' ' 14' ' ' THR . 99.2 m -84.13 -59.74 2.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.64 -0.918 . . . . 0.0 109.899 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.6 t70 51.15 78.68 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.253 0.549 . . . . 0.0 111.031 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.2 141.97 4.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 2.4 24.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -1.024 . . . . 0.0 110.747 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.86 23.66 9.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.276 -0.89 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 9' ' ' CYS . 10.9 t -73.76 165.27 25.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.876 . . . . 0.0 109.943 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.03 149.81 50.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.0 111.054 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.65 -150.42 0.46 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.665 -0.647 . . . . 0.0 109.445 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -91.4 -70.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.029 -1.044 . . . . 0.0 110.273 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -172.17 92.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 117.91 -35.56 4.01 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -70.35 125.08 25.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.405 -1.056 . . . . 0.0 110.15 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.8 m120 -107.89 166.55 10.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.998 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.7 m -88.76 132.12 34.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.132 -0.98 . . . . 0.0 110.571 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 26' ' ' TRP . 11.9 p -67.76 142.91 96.2 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.65 -19.03 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.808 1.425 . . . . 0.0 111.887 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.1 m -122.54 -33.35 3.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.965 -1.084 . . . . 0.0 111.858 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.611 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 48.1 m0 -79.04 -12.84 60.03 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.013 . . . . 0.0 111.466 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? 66.16 11.09 7.6 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.474 -0.766 . . . . 0.0 113.002 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.611 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.8 164.2 23.55 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.448 -1.408 . . . . 0.0 111.126 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -70.38 147.45 49.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.448 -0.783 . . . . 0.0 110.922 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.61 169.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.766 -0.584 . . . . 0.0 109.428 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -66.25 132.82 49.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.0 110.069 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 2.2 t . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.075 0.464 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.428 ' C ' ' HB2' ' A' ' 7' ' ' ALA . . . -88.05 -75.16 1.28 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.8 -156.68 18.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -88.65 -4.21 58.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.444 -1.033 . . . . 0.0 110.992 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.96 40.97 1.27 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.105 -0.997 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 3' ' ' GLY . . . -82.71 -157.62 0.23 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 110.385 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.45 100.15 0.76 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 t -74.24 -76.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.48 -1.012 . . . . 0.0 110.358 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 t70 52.32 61.34 3.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 163.56 142.32 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -10.36 59.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.547 -0.972 . . . . 0.0 110.87 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -142.07 49.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 t -69.05 176.48 3.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.421 -0.8 . . . . 0.0 110.545 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.26 104.26 11.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -0.8 . . . . 0.0 110.144 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -86.39 -149.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.782 . . . . 0.0 109.575 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 1.5 t -79.24 -56.68 4.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 -81.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.15 -27.2 28.89 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 4.0 m-85 -48.44 124.45 8.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.635 -0.92 . . . . 0.0 110.605 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.2 t30 -89.57 -169.99 2.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.447 -0.783 . . . . 0.0 109.628 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 110.275 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -112.11 133.14 21.75 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.676 . . . . 0.0 110.048 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.907 1.478 . . . . 0.0 111.197 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -74.86 -21.08 59.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.497 -0.752 . . . . 0.0 110.73 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.569 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 41.7 m95 -101.1 -16.5 17.05 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.439 -0.788 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm 59.06 22.62 10.71 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.508 -0.745 . . . . 0.0 112.707 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.569 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.54 161.33 39.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.706 -1.246 . . . . 0.0 110.616 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 91.8 m -69.49 138.57 53.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.353 -0.842 . . . . 0.0 110.286 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.69 170.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.682 -0.636 . . . . 0.0 109.93 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.3 p90 -61.55 173.36 0.97 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.408 -0.807 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.111 -0.993 . . . . 0.0 110.709 179.792 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.172 0.511 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.26 -121.13 1.45 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.35 -155.71 26.89 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -8.02 52.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.453 -1.028 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.73 31.7 0.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.45 120.28 29.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -0.771 . . . . 0.0 110.436 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.48 111.15 2.97 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.0 p -84.7 -35.86 22.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.518 -0.99 . . . . 0.0 110.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 9.4 t70 54.35 70.08 0.65 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.646 -0.659 . . . . 0.0 111.122 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.34 134.08 3.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -6.76 44.3 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.541 -0.976 . . . . 0.0 110.763 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 m -106.16 29.36 6.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.396 -0.815 . . . . 0.0 110.117 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.909 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.93 162.54 26.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.517 -0.739 . . . . 0.0 110.462 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.74 99.33 5.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 110.03 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.39 -157.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.296 -0.878 . . . . 0.0 110.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -78.92 0.07 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.122 -0.986 . . . . 0.0 110.321 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -165.48 114.73 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.671 -0.643 . . . . 0.0 109.606 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.75 24.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.537 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 39.5 m-85 -129.48 118.21 21.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.385 -1.068 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 30' ' ' VAL . 8.6 t30 -108.76 156.65 19.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.81 . . . . 0.0 110.419 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.4 t -89.46 134.47 34.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 110.508 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 8.5 t -80.59 141.92 52.88 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.673 -0.642 . . . . 0.0 110.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.17 -18.65 23.48 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.931 1.49 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 m -106.1 -25.85 11.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.203 -0.935 . . . . 0.0 111.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 28.8 m0 -95.2 -18.89 20.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 0.0 111.16 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.53 12.06 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.525 -0.735 . . . . 0.0 112.451 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -129.44 164.98 22.5 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.71 -1.244 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -74.82 142.21 44.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.387 -0.82 . . . . 0.0 110.535 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 21' ' ' ASN . 29.2 m -129.11 168.99 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.726 -0.609 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.46 121.68 26.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.267 -0.896 . . . . 0.0 110.42 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.842 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 17.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.821 0.343 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.32 -105.95 0.05 OUTLIER Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.56 -171.25 23.85 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 69.1 mt -76.12 -9.01 58.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.489 -1.006 . . . . 0.0 111.459 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.3 ttt -144.09 42.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.802 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.28 102.87 15.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.34 119.23 13.82 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.0 p -117.21 -46.8 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.538 -0.978 . . . . 0.0 110.833 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 51.79 67.22 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.563 -0.711 . . . . 0.0 110.468 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.38 127.38 0.91 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -66.12 -13.13 59.59 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.679 -0.895 . . . . 0.0 111.078 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.16 21.43 11.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.104 -0.998 . . . . 0.0 110.674 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 9' ' ' CYS . 9.1 t -81.1 169.7 17.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.131 -0.981 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -128.58 142.31 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.3 m -126.88 -151.35 0.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.611 -0.681 . . . . 0.0 110.038 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -68.09 -66.93 0.5 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.186 -0.946 . . . . 0.0 110.791 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -150.66 -76.37 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . -98.81 13.28 62.42 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 4.9 m-85 -73.51 119.62 17.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -1.222 . . . . 0.0 109.695 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 30' ' ' VAL . 4.5 t30 -106.07 153.82 21.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.466 -0.771 . . . . 0.0 110.5 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 m -89.41 135.8 33.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.341 -0.849 . . . . 0.0 110.75 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.2 t -86.29 140.47 34.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.72 -25.9 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.827 1.435 . . . . 0.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.752 HG23 ' CD1' ' A' ' 26' ' ' TRP . 9.8 t -91.04 -23.92 20.21 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.317 -0.864 . . . . 0.0 111.236 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.752 ' CD1' HG23 ' A' ' 25' ' ' THR . 34.0 m0 -101.37 -22.12 14.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.123 -0.986 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER 69.96 9.34 7.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.964 -0.46 . . . . 0.0 112.025 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -126.19 171.6 10.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.848 -1.157 . . . . 0.0 110.435 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -82.21 147.42 28.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.408 -0.807 . . . . 0.0 110.929 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' ASN . 19.1 m -136.23 -169.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' HB2' HD21 ' A' ' 5' ' ' LEU . 33.3 t80 -93.96 138.46 32.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 110.33 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.132 0.491 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.55 -149.14 24.45 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 -113.03 0.34 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -109.54 -15.88 14.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.476 -1.014 . . . . 0.0 111.07 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt -150.48 32.44 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.369 -0.832 . . . . 0.0 109.707 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -71.68 -163.71 0.11 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.496 -0.752 . . . . 0.0 110.245 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.31 116.23 5.45 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -111.5 42.8 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.768 -0.842 . . . . 0.0 110.272 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.4 m-20 -71.9 81.39 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.227 -0.921 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.79 124.76 1.39 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -10.41 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.497 -1.002 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -110.06 28.2 8.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.22 -0.925 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.435 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.9 t -90.97 154.31 19.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.91 155.09 28.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.42 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.1 m -103.54 -165.51 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.586 -0.696 . . . . 0.0 110.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 -70.26 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.363 -0.835 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.9 124.33 1.55 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.0 30.61 60.98 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.9 m-85 -129.79 132.23 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -97.79 140.24 32.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.728 . . . . 0.0 109.874 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 40.6 t -88.8 132.58 34.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.92 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.11 120.03 49.19 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.674 -0.641 . . . . 0.0 109.858 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.84 -31.01 10.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.806 1.424 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.5 m -78.9 -28.73 44.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.745 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.509 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 76.3 m95 -96.87 -12.89 22.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 111.089 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 5.6 tptt 64.06 27.6 14.18 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.372 -0.83 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.524 ' CA ' ' HB2' ' A' ' 9' ' ' CYS . 1.5 p90 -157.69 150.36 22.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.04 -1.038 . . . . 0.0 109.84 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.4 t -82.07 146.84 29.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.216 -0.928 . . . . 0.0 110.161 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 34.8 m -129.99 -167.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.39 151.3 47.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.344 -0.847 . . . . 0.0 109.871 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.758 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 120.991 0.424 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.84 -87.4 0.42 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.36 -161.77 28.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -92.93 -2.71 55.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.491 -1.006 . . . . 0.0 111.282 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 34.75 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 109.793 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.91 104.93 15.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 110.555 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.32 113.53 3.84 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.59 ' HB2' HG21 ' A' ' 14' ' ' THR . 28.6 p -104.7 -36.18 7.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.4 -1.059 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t70 55.16 77.44 0.22 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.624 -0.673 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.28 5.95 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -1.32 57.02 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.487 -1.008 . . . . 0.0 110.911 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 p -148.56 49.57 1.01 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.294 -0.879 . . . . 0.0 109.76 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.7 t -74.62 -169.46 0.86 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.656 -0.652 . . . . 0.0 110.767 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.96 100.05 6.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 1.1 t -98.67 -146.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 0.0 109.752 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -94.49 -105.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.009 -1.057 . . . . 0.0 110.003 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 21.18 2.07 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.859 -1.151 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.22 42.06 0.15 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 79.8 m-85 -138.08 138.85 39.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.961 . . . . 0.0 110.07 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -121.1 153.37 37.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 14' ' ' THR . 16.4 m -89.11 134.98 33.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.184 -0.948 . . . . 0.0 110.822 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -91.82 146.81 33.72 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.768 -0.583 . . . . 0.0 110.187 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 -35.57 3.95 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.911 1.479 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 m -87.49 -37.11 17.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 110.417 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.739 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 35.5 m0 -82.68 -29.71 29.75 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 19.0 tptt 69.07 11.2 8.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.959 -0.463 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.739 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.83 167.09 17.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.808 -1.182 . . . . 0.0 111.064 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -77.54 129.79 36.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.698 -0.626 . . . . 0.0 111.154 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 ' CE3' ' A' ' 26' ' ' TRP . 21.4 m -129.55 169.63 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.777 -0.577 . . . . 0.0 109.478 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' CD2' HD21 ' A' ' 5' ' ' LEU . 14.0 p90 -52.92 155.17 2.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.355 -0.841 . . . . 0.0 110.453 -179.824 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.035 0.445 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.94 -124.56 1.55 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -134.36 3.0 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -7.29 25.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.596 -0.943 . . . . 0.0 111.358 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.8 ttm -149.93 32.85 0.68 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.15 -0.968 . . . . 0.0 110.122 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.23 136.91 44.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.69 119.81 19.39 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' A' ' 14' ' ' THR . 7.0 t -95.33 -77.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.676 -0.897 . . . . 0.0 109.851 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.55 73.94 0.28 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.761 -0.587 . . . . 0.0 111.119 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.38 120.7 1.6 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -14.26 44.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.866 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -105.88 27.44 8.52 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 0.0 110.454 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.532 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -69.4 -178.2 1.33 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.245 -0.91 . . . . 0.0 110.462 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.99 146.74 45.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -131.98 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.68 -0.637 . . . . 0.0 110.005 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -67.88 0.73 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 p -168.51 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.568 -0.708 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.07 28.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 53.6 m-85 -122.86 129.9 52.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.291 -1.123 . . . . 0.0 109.872 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.64 163.11 16.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.461 -0.774 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -89.23 137.24 32.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.362 -0.836 . . . . 0.0 110.801 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -93.22 143.18 26.31 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.48 -0.763 . . . . 0.0 110.099 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.83 -21.81 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.916 1.482 . . . . 0.0 111.665 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 m -109.59 -38.67 5.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.171 -0.956 . . . . 0.0 111.369 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.713 ' CE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -72.64 -20.59 61.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 65.02 15.66 10.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.707 -0.62 . . . . 0.0 111.869 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.705 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -141.02 162.89 34.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.777 -1.202 . . . . 0.0 110.704 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.76 138.65 46.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.49 -0.756 . . . . 0.0 110.546 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.713 HG11 ' CE3' ' A' ' 26' ' ' TRP . 5.3 m -136.1 -178.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -58.55 153.48 16.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.348 -0.845 . . . . 0.0 110.464 -179.388 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.058 0.456 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 7' ' ' ALA . . . -78.59 -152.09 6.02 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.86 46.82 0.06 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.42 -7.37 1.02 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.899 -0.765 . . . . 0.0 112.512 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.87 25.81 0.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.945 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . . . -64.66 114.22 4.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.9 120.12 15.92 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 14' ' ' THR . 19.7 m -79.32 -73.53 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.986 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 50.51 56.5 7.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.491 0.663 . . . . 0.0 109.744 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.13 123.78 1.2 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -14.73 52.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.999 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.31 14.0 23.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 110.8 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.6 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -71.11 146.76 49.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.101 -0.999 . . . . 0.0 110.25 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -126.36 137.85 53.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.395 -0.816 . . . . 0.0 110.677 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.09 -154.28 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.648 -0.657 . . . . 0.0 109.73 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -73.04 0.35 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 110.436 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.3 -44.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 0.0 110.526 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.56 28.7 14.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 30.0 m-85 -124.62 131.83 53.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.979 . . . . 0.0 110.078 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -109.74 149.95 29.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.327 -0.858 . . . . 0.0 109.777 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.8 t -88.91 136.0 33.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.187 -0.945 . . . . 0.0 111.012 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.35 130.5 23.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.634 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.04 -31.39 9.8 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.887 1.467 . . . . 0.0 111.521 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -81.68 -31.96 31.98 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.897 . . . . 0.0 110.684 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.653 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -91.25 -17.73 25.52 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.381 -0.825 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tptm 67.7 17.35 9.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.689 -0.632 . . . . 0.0 111.656 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -144.66 168.39 20.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 110.549 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -84.56 150.95 24.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.515 -0.741 . . . . 0.0 111.041 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 28.2 m -140.15 178.63 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -58.06 151.74 18.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.356 -0.84 . . . . 0.0 110.312 -179.674 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 9.1 t . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 121.31 0.576 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 7' ' ' ALA . . . -82.52 -80.67 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.09 -133.63 4.22 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.76 -5.01 21.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.453 -1.028 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 ttm -149.59 33.87 0.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' TRP . . . -74.05 -167.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.393 -0.817 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.31 88.58 0.47 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB2' HG21 ' A' ' 14' ' ' THR . 17.5 p -99.61 53.31 0.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.93 . . . . 0.0 110.029 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.87 100.0 2.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.6 126.51 1.36 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -63.53 -14.38 50.56 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.585 -0.95 . . . . 0.0 111.028 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -108.62 30.0 6.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.5 t -96.49 169.12 10.12 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.358 -0.839 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.57 145.86 27.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -90.19 -144.29 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.376 -0.827 . . . . 0.0 110.027 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' CA ' ' HA ' ' A' ' 2' ' ' CYS . 1.7 t -81.8 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.951 -1.093 . . . . 0.0 110.795 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 t -164.92 -48.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.441 -0.787 . . . . 0.0 110.494 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 23.93 33.79 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 145.07 50.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.314 -1.11 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' VAL . 5.8 m120 -122.42 157.95 30.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 t -88.48 141.26 28.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.957 -1.089 . . . . 0.0 110.551 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.94 133.48 20.26 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -29.46 10.52 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.97 1.51 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 m -87.13 -37.08 17.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.398 -0.814 . . . . 0.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.648 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 70.7 m95 -89.63 -15.04 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.486 -0.758 . . . . 0.0 111.013 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 60.33 14.27 4.57 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.612 -0.68 . . . . 0.0 112.672 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.648 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -135.43 159.17 42.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.778 -1.201 . . . . 0.0 110.537 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.5 m -67.38 132.35 47.49 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.446 -0.784 . . . . 0.0 110.081 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 21' ' ' ASN . 23.7 m -116.9 179.73 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.678 . . . . 0.0 109.815 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -76.19 142.66 41.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.802 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.019 0.438 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.76 -88.18 0.65 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.27 -144.98 14.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.68 -4.34 33.95 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.511 -0.994 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -149.94 41.78 0.85 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -72.53 -165.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.507 -0.746 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 112.73 2.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -80.32 -77.52 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.458 -1.025 . . . . 0.0 110.018 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.94 68.16 0.79 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.677 -0.64 . . . . 0.0 110.483 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.9 121.52 1.92 Allowed Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -61.97 -15.88 47.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.93 . . . . 0.0 110.536 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.37 9.46 41.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.385 -0.822 . . . . 0.0 110.953 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.403 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 12.2 t -72.0 158.37 36.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.029 -1.045 . . . . 0.0 110.042 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.64 143.32 41.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.307 -0.871 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -95.31 -138.59 0.24 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.728 . . . . 0.0 109.98 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -91.3 -85.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 110.779 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 m -146.86 -47.63 0.18 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.162 -0.961 . . . . 0.0 110.773 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.77 25.88 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 85.8 m-85 -135.1 133.87 39.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -1.006 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.77 149.86 26.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.357 -0.839 . . . . 0.0 109.195 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.0 124.21 33.5 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.909 -1.119 . . . . 0.0 110.334 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.36 128.35 40.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.786 -0.571 . . . . 0.0 110.443 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.97 -37.02 3.04 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.941 1.495 . . . . 0.0 110.661 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.6 m -71.81 -37.75 70.32 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.59 -0.694 . . . . 0.0 110.402 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.9 m95 -90.74 -12.06 37.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.588 -0.695 . . . . 0.0 110.64 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 61.38 19.34 10.13 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.561 -0.712 . . . . 0.0 112.256 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.514 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -147.58 157.7 43.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.81 -1.182 . . . . 0.0 110.838 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 67.3 m -67.2 136.02 54.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.677 -0.639 . . . . 0.0 110.798 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -123.2 -172.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -69.54 148.63 49.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 110.278 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.227 0.537 . . . . 0.0 110.284 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.54 -119.03 4.55 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.09 -126.65 1.34 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 4.1 mp -104.54 -2.79 24.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.57 -0.959 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.73 31.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 109.944 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 130.16 35.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 109.727 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.27 118.43 10.27 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.76 -74.44 0.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.911 . . . . 0.0 109.935 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.09 92.08 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.419 0.628 . . . . 0.0 110.561 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . 142.5 -13.18 2.49 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 2.5 mtmp? 60.6 20.11 10.0 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.387 -1.067 . . . . 0.0 110.976 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -170.31 48.02 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 22' ' ' CYS . 5.3 t -83.72 158.3 21.83 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.23 120.41 34.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.399 -0.813 . . . . 0.0 110.199 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -100.77 -170.26 1.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.499 -0.751 . . . . 0.0 110.354 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 2' ' ' CYS . 57.6 m -64.31 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.397 -0.814 . . . . 0.0 110.424 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 p -158.99 88.77 0.91 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.418 -0.801 . . . . 0.0 109.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.06 8.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 32.1 m-85 -84.5 145.3 28.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -1.122 . . . . 0.0 109.91 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 17.0 t-20 -125.22 154.69 41.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.737 . . . . 0.0 110.235 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB2' HG22 ' A' ' 14' ' ' THR . 1.7 t -88.11 134.25 33.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.543 -0.723 . . . . 0.0 110.334 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -100.86 133.39 21.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.754 -0.591 . . . . 0.0 110.089 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.25 -28.12 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.9 1.474 . . . . 0.0 110.953 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -88.4 -36.48 16.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 0.0 110.544 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.727 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.9 m0 -88.3 -14.64 37.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 110.55 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 1.4 mmpp? 60.82 20.44 10.61 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.687 -0.633 . . . . 0.0 111.967 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.727 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -145.25 168.8 19.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.933 -1.105 . . . . 0.0 111.0 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -78.6 150.61 32.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.585 -0.697 . . . . 0.0 110.92 -179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 11.9 m -149.39 172.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.702 -0.624 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -69.06 135.26 50.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 0.0 109.858 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 110.172 -179.598 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.069 0.461 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.86 -136.62 5.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.43 -141.47 5.52 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.633 HD21 ' HD2' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -93.97 -12.14 29.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.592 -0.946 . . . . 0.0 111.114 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mtt -150.22 32.45 0.66 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.214 -0.929 . . . . 0.0 110.145 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.38 147.52 42.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.75 123.13 28.03 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 t -90.66 -71.33 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.48 99.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.333 0.587 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.14 -11.57 6.85 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm 59.57 19.96 8.5 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.287 -1.125 . . . . 0.0 110.736 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -170.22 45.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.36 -0.837 . . . . 0.0 110.0 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.52 HG22 ' HB2' ' A' ' 22' ' ' CYS . 6.4 t -82.47 165.43 20.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.465 -0.772 . . . . 0.0 110.833 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.37 105.34 15.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.01 -141.78 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.549 -0.72 . . . . 0.0 110.31 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -75.59 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.235 -0.916 . . . . 0.0 110.076 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -145.25 63.96 1.27 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 109.939 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . 154.42 -46.18 0.55 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.564 ' HD1' ' HA ' ' A' ' 31' ' ' TYR . 22.3 m-85 -55.96 128.5 35.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.606 -0.938 . . . . 0.0 110.242 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -106.12 159.24 16.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.773 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HB2' HG22 ' A' ' 14' ' ' THR . 5.3 t -89.27 132.67 34.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 110.714 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.12 128.47 36.92 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.9 -25.17 16.87 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.803 1.423 . . . . 0.0 111.169 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 m -87.82 -30.0 20.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.324 -0.86 . . . . 0.0 110.812 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.6 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 29.9 m0 -98.48 -15.25 19.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.285 -0.884 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.64 14.73 9.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.564 -0.71 . . . . 0.0 112.075 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.6 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -136.21 165.27 26.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.762 -1.211 . . . . 0.0 110.602 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 t -79.65 136.1 36.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.764 . . . . 0.0 110.542 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.597 HG11 ' CZ3' ' A' ' 26' ' ' TRP . 33.9 m -113.68 -167.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.06 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.633 ' HD2' HD21 ' A' ' 5' ' ' LEU . 24.0 p90 -88.29 165.08 15.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.442 -0.787 . . . . 0.0 110.261 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.515 -0.741 . . . . 0.0 110.213 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.167 0.508 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.93 173.0 55.21 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 -119.62 1.08 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.3 7.16 22.94 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.491 -1.006 . . . . 0.0 111.474 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.31 29.98 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -75.96 119.06 19.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.214 -0.929 . . . . 0.0 110.046 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.06 128.53 17.19 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -109.44 23.72 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.741 -0.858 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.38 -21.01 66.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -76.31 -3.79 77.68 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 4.4 mtmp? 59.57 23.15 11.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -1.073 . . . . 0.0 111.02 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -176.3 38.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.382 -0.824 . . . . 0.0 110.702 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t -71.14 105.96 3.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.127 -0.983 . . . . 0.0 110.078 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.03 104.8 2.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.93 -166.25 1.08 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 0.0 110.62 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -65.8 0.63 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.318 -0.864 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.29 -45.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.552 -0.718 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.12 30.69 9.86 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 48.7 m-85 -123.16 120.74 34.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -1.007 . . . . 0.0 110.284 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.461 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 t30 -110.99 167.37 10.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.47 144.16 26.26 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.827 -1.171 . . . . 0.0 110.948 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -90.37 147.65 37.17 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.595 -0.691 . . . . 0.0 110.136 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.88 -24.56 11.37 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.876 1.461 . . . . 0.0 111.634 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -111.32 -30.74 7.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.259 -0.901 . . . . 0.0 111.462 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -80.57 -20.53 43.16 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.166 -0.959 . . . . 0.0 110.842 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.59 21.41 11.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.612 -0.68 . . . . 0.0 112.113 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.667 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -143.75 166.81 23.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.737 -1.227 . . . . 0.0 110.932 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 2.3 t -69.9 138.06 52.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.572 -0.705 . . . . 0.0 111.013 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG11 ' HE3' ' A' ' 26' ' ' TRP . 27.2 m -134.66 -179.94 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -61.36 158.87 13.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.0 109.982 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.336 -0.852 . . . . 0.0 110.084 179.847 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.019 0.438 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.95 -118.12 4.11 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.17 -127.9 1.48 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.89 -7.4 17.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -1.0 . . . . 0.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.8 29.41 0.83 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.95 146.61 27.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 0.0 110.2 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.04 124.31 36.3 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.718 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.8 p -125.34 20.41 8.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.489 -1.006 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -49.79 106.53 0.12 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.406 -0.809 . . . . 0.0 110.757 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.09 2.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -12.97 61.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.484 -1.009 . . . . 0.0 111.066 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.59 38.05 3.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.29 -0.881 . . . . 0.0 110.64 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.1 t -69.16 151.04 46.84 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.729 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -109.4 127.34 54.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.357 -0.84 . . . . 0.0 110.598 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.19 -156.55 0.57 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.17 -0.956 . . . . 0.0 110.405 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -169.39 127.88 0.98 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.496 -0.753 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.92 21.96 79.44 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.9 m-85 -131.18 131.26 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.253 -1.145 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.624 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 4.3 t-20 -117.83 164.86 14.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.346 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.41 ' HB2' HG21 ' A' ' 14' ' ' THR . 34.8 t -88.79 137.76 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.59 135.3 19.76 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.688 -0.632 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.81 -34.44 3.18 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.829 1.436 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.26 -35.36 61.39 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.0 110.71 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.0 m95 -97.98 -20.02 17.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.734 . . . . 0.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.43 12.64 8.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.716 -0.615 . . . . 0.0 112.376 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -135.02 164.23 28.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.235 . . . . 0.0 110.676 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -68.21 137.77 55.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.747 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 26.7 m -136.14 -176.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.733 -0.604 . . . . 0.0 109.472 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 137.65 50.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.207 -0.933 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.0 110.123 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.04 0.448 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.91 -113.15 0.69 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 -114.34 0.52 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.48 10.43 19.7 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.56 -0.965 . . . . 0.0 111.034 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.2 ttt -148.58 35.87 0.79 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.225 -0.922 . . . . 0.0 110.078 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -73.21 125.48 27.85 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.14 115.71 6.46 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -93.57 -82.8 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.927 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.05 59.59 4.43 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.573 -0.704 . . . . 0.0 110.593 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.71 -142.99 3.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.15 5.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.44 -1.035 . . . . 0.0 111.108 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.35 58.75 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.955 . . . . 0.0 110.013 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 22' ' ' CYS . 12.8 t -59.16 147.24 35.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.52 129.78 34.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -126.02 -162.7 1.15 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.78 -0.575 . . . . 0.0 110.194 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.3 m -80.91 -86.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 125.67 4.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.314 -0.867 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.56 60.67 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.1 m120 -112.04 167.64 10.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.8 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 t -88.7 134.71 33.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.418 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 134.11 19.9 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.52 -33.83 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.794 1.418 . . . . 0.0 110.786 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.0 m -74.44 -44.78 50.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.66 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 85.8 m95 -88.27 -13.47 40.83 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.587 -0.696 . . . . 0.0 110.592 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.39 19.22 10.04 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.631 -0.668 . . . . 0.0 112.4 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.66 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.12 166.04 26.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.877 -1.14 . . . . 0.0 110.713 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -67.18 133.52 49.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.44 -0.787 . . . . 0.0 111.103 -178.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.89 176.88 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.13 137.16 58.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 0.0 110.502 -179.825 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.159 0.504 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.02 -95.77 1.57 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.6 -131.94 5.04 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 -5.76 20.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.975 . . . . 0.0 110.839 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.6 ttm -145.61 36.79 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -73.29 -165.71 0.27 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.386 -0.822 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.65 96.32 0.54 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' THR . 77.8 m -70.92 -77.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.913 . . . . 0.0 110.427 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.09 58.16 5.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.674 -0.641 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.78 139.07 2.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -8.29 55.47 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.421 -1.046 . . . . 0.0 110.727 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 2.31 39.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.329 -0.857 . . . . 0.0 110.657 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 9' ' ' CYS . 11.2 t -66.72 146.63 54.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.32 127.25 48.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -0.792 . . . . 0.0 110.335 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -87.31 -155.24 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 110.051 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.66 -92.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.14 123.26 14.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 109.844 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.33 35.56 76.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -130.05 120.8 25.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -1.044 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.7 t-20 -98.01 -170.95 2.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.3 m -118.68 139.02 52.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.15 -0.969 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 3.1 t -84.79 140.11 37.7 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.775 . . . . 0.0 110.028 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.48 -25.52 25.16 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.945 1.497 . . . . 0.0 111.297 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 m -103.29 -36.63 7.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.261 -0.899 . . . . 0.0 111.242 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 32.1 m0 -79.88 -21.27 44.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.253 -0.904 . . . . 0.0 111.093 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.4 OUTLIER 63.34 11.59 5.57 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.495 -0.753 . . . . 0.0 112.408 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.713 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -125.98 160.79 29.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.7 -1.25 . . . . 0.0 110.572 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 69.4 m -66.13 138.81 57.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.72 . . . . 0.0 111.438 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG11 ' HE3' ' A' ' 26' ' ' TRP . 25.4 m -139.17 -179.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.56 135.09 57.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.086 -1.009 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 110.349 -179.471 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 120.924 0.392 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' CYS . . . -55.46 117.02 7.74 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.08 47.13 0.95 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER 68.26 -3.96 1.18 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.876 -0.779 . . . . 0.0 112.113 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.42 27.68 0.66 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.914 -1.116 . . . . 0.0 110.277 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 142.67 27.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.344 -0.848 . . . . 0.0 110.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 119.27 14.79 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.878 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.9 p -123.76 28.59 6.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.497 -1.002 . . . . 0.0 110.91 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.91 112.09 0.72 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.873 . . . . 0.0 110.282 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.08 137.35 3.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -8.06 49.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.454 -1.027 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -139.86 47.44 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.878 HG21 ' HB2' ' A' ' 9' ' ' CYS . 12.7 t -76.71 -176.23 3.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.482 -0.762 . . . . 0.0 110.578 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.29 147.88 51.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 73.4 m -129.5 -162.33 1.19 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.593 -0.692 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -76.99 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 110.567 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 p -158.2 123.7 4.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.19 31.36 63.95 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.491 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 23.4 m-85 -124.8 132.06 53.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -1.141 . . . . 0.0 110.123 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.9 t-20 -112.42 159.32 18.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.0 110.127 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.1 t -89.56 137.57 32.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.006 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 m -103.21 128.91 26.57 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.613 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.57 -27.1 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.877 1.462 . . . . 0.0 111.196 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.4 m -84.12 -35.5 23.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.274 -0.891 . . . . 0.0 110.653 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 39.0 m0 -94.46 -13.06 26.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.363 -0.836 . . . . 0.0 111.0 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.08 11.75 7.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.525 -0.734 . . . . 0.0 112.234 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.638 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.96 166.45 23.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.792 -1.192 . . . . 0.0 110.803 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.5 t -75.37 143.64 42.71 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.513 -0.742 . . . . 0.0 110.51 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.526 HG11 ' CE3' ' A' ' 26' ' ' TRP . 33.9 m -124.38 -169.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 109.932 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 20.7 t80 -93.34 133.85 36.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 110.326 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.605 -0.685 . . . . 0.0 110.432 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.439 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 116.63 25.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -1.013 . . . . 0.0 110.2 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.678 ' CA ' ' HB2' ' A' ' 7' ' ' ALA . . . -81.49 116.17 4.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.04 -102.26 2.55 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 30' ' ' VAL . 1.4 mt -104.05 -5.03 22.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.523 -0.986 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -143.0 47.62 1.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.096 -1.003 . . . . 0.0 110.022 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' ' CA ' ' A' ' 3' ' ' GLY . . . -76.1 -157.89 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.567 -0.708 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 117.82 3.81 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -104.42 24.17 12.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.639 -0.918 . . . . 0.0 110.189 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 30.8 t70 -69.77 -28.94 66.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.15 -13.78 76.42 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.66 9.65 6.1 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.012 0.906 . . . . 0.0 111.156 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -159.42 36.78 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.001 -1.062 . . . . 0.0 110.678 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 14.9 t -76.28 164.99 25.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.236 -0.915 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.48 8.49 16.5 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.23 -0.919 . . . . 0.0 111.162 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 m 50.74 -152.57 0.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 t -102.68 -72.92 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 0.0 110.157 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -159.84 114.51 2.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.081 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.23 45.45 8.85 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -144.94 120.27 10.25 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.477 -1.014 . . . . 0.0 110.115 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -90.55 151.47 21.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.369 -0.832 . . . . 0.0 109.383 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -89.05 142.06 27.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.07 -1.018 . . . . 0.0 110.816 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -110.25 127.68 26.63 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.784 -0.572 . . . . 0.0 110.297 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.2 -31.17 6.17 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.99 1.521 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -77.05 -29.36 55.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.463 -0.773 . . . . 0.0 110.701 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.643 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 59.8 m95 -100.69 -18.36 16.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.347 -0.846 . . . . 0.0 110.935 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 16.0 tptt 67.41 32.93 5.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.52 -0.737 . . . . 0.0 112.009 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.643 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -159.75 158.17 30.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.054 -1.029 . . . . 0.0 110.53 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.558 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 67.9 m -69.43 139.06 54.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.915 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 25.9 m -132.65 -168.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -66.44 140.1 58.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.53 150.6 22.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.431 -0.793 . . . . 0.0 110.713 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.46 65.64 60.18 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.645 -0.659 . . . . 0.0 110.098 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.253 0 O-C-N 123.644 1.339 . . . . 0.0 110.655 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.2 125.65 14.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.488 -1.007 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.54 -77.39 0.53 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.81 -149.84 17.12 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -95.04 -1.53 52.07 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.492 -1.005 . . . . 0.0 111.132 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.78 42.05 1.45 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.22 -161.68 0.53 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.551 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.96 117.93 4.17 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 51.5 m -108.27 48.6 0.85 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.99 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.55 91.15 3.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.422 -0.799 . . . . 0.0 110.008 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.36 137.3 4.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -71.17 -4.7 26.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.384 -1.068 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -115.27 31.97 6.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.077 -1.015 . . . . 0.0 110.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -84.89 179.78 7.24 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.197 -0.939 . . . . 0.0 110.682 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.26 150.31 39.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -0.85 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.2 m -112.75 -145.2 0.4 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.559 -0.713 . . . . 0.0 109.747 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -91.02 -60.14 1.98 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.044 -1.035 . . . . 0.0 110.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -123.41 -126.64 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.634 -0.666 . . . . 0.0 109.47 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.46 -11.91 65.73 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 26.1 m-85 -38.81 112.45 0.24 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.799 -0.824 . . . . 0.0 111.297 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -89.61 -176.41 4.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.2 m -111.05 147.59 34.46 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.748 -1.22 . . . . 0.0 110.204 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -85.95 144.51 39.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.376 -0.827 . . . . 0.0 110.189 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -23.54 19.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 124.025 1.54 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.832 HG23 ' CD1' ' A' ' 26' ' ' TRP . 3.1 t -116.94 -25.19 7.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.247 -0.908 . . . . 0.0 111.683 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.832 ' CD1' HG23 ' A' ' 25' ' ' THR . 38.3 m0 -85.6 -18.1 34.3 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.012 -1.055 . . . . 0.0 111.197 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt 60.2 21.93 11.27 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.594 -0.691 . . . . 0.0 112.092 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.652 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.03 159.18 41.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.168 . . . . 0.0 110.37 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 96.1 m -68.79 135.35 51.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 110.915 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 34.4 m -124.5 163.84 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.681 -0.637 . . . . 0.0 109.568 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.13 145.73 52.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.62 99.93 9.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -0.779 . . . . 0.0 110.294 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.58 125.56 1.25 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.76 . . . . 0.0 110.634 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.314 -1.268 0 O-C-N 123.711 1.374 . . . . 0.0 110.672 179.658 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.7 t -145.97 139.0 25.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.978 . . . . 0.0 110.094 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.49 -113.39 3.75 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.84 -138.6 8.16 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 ' HE2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -100.24 -15.35 18.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.535 -0.98 . . . . 0.0 110.558 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.56 43.96 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -161.97 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.388 -0.82 . . . . 0.0 110.593 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.91 100.46 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.572 ' CA ' HG21 ' A' ' 14' ' ' THR . 18.9 p -108.71 40.18 1.85 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.51 -0.994 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.621 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 20.6 t70 -67.02 163.38 20.04 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.078 -1.014 . . . . 0.0 110.206 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.47 -13.43 18.39 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? 58.07 19.88 6.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.499 -1.001 . . . . 0.0 110.587 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -172.58 37.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.441 -0.787 . . . . 0.0 110.355 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.572 HG21 ' CA ' ' A' ' 9' ' ' CYS . 7.2 t -99.92 176.03 5.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -129.27 137.11 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 m -80.93 -144.46 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -71.45 0.47 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.013 -1.054 . . . . 0.0 110.061 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -167.42 112.15 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.765 -0.584 . . . . 0.0 110.088 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.4 21.33 38.21 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HE2' HD23 ' A' ' 5' ' ' LEU . 38.3 m-85 -130.7 137.96 49.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.4 -1.059 . . . . 0.0 109.538 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 6.4 t30 -108.78 175.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -113.27 138.64 49.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 45.5 t -91.02 137.26 26.65 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.393 -0.817 . . . . 0.0 110.076 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 -18.5 22.95 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.941 1.495 . . . . 0.0 111.468 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -106.52 -29.06 9.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.113 -0.992 . . . . 0.0 111.11 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 31.1 m0 -89.43 -26.07 21.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.238 -0.914 . . . . 0.0 110.565 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.35 9.68 7.04 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.837 -0.539 . . . . 0.0 111.886 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.672 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -124.59 161.24 26.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.878 -1.139 . . . . 0.0 110.009 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 16.7 m -75.16 147.01 40.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.143 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 5' ' ' LEU . 27.0 m -139.03 -174.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.76 132.21 47.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 109.968 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.91 132.67 35.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.697 -0.627 . . . . 0.0 110.376 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -74.12 115.29 41.33 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 109.712 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 O-C-N 123.823 1.433 . . . . 0.0 110.693 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 m -107.88 157.9 17.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.569 -0.959 . . . . 0.0 110.174 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -93.03 0.09 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.3 -159.34 27.11 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.19 -4.16 49.56 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.985 . . . . 0.0 110.598 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.9 mtt -150.85 29.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.387 -0.821 . . . . 0.0 109.739 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.6 33.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -0.852 . . . . 0.0 110.716 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.93 122.61 30.76 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.764 ' HB3' HG21 ' A' ' 14' ' ' THR . 99.2 m -84.13 -59.74 2.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.64 -0.918 . . . . 0.0 109.899 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.6 t70 51.15 78.68 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.253 0.549 . . . . 0.0 111.031 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.2 141.97 4.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 2.4 24.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -1.024 . . . . 0.0 110.747 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.86 23.66 9.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.276 -0.89 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 9' ' ' CYS . 10.9 t -73.76 165.27 25.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.876 . . . . 0.0 109.943 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.03 149.81 50.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.0 111.054 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.65 -150.42 0.46 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.665 -0.647 . . . . 0.0 109.445 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -91.4 -70.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.029 -1.044 . . . . 0.0 110.273 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -172.17 92.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 117.91 -35.56 4.01 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -70.35 125.08 25.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.405 -1.056 . . . . 0.0 110.15 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.8 m120 -107.89 166.55 10.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.998 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.7 m -88.76 132.12 34.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.132 -0.98 . . . . 0.0 110.571 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 26' ' ' TRP . 11.9 p -67.76 142.91 96.2 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.65 -19.03 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.808 1.425 . . . . 0.0 111.887 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.1 m -122.54 -33.35 3.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.965 -1.084 . . . . 0.0 111.858 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.611 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 48.1 m0 -79.04 -12.84 60.03 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.013 . . . . 0.0 111.466 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? 66.16 11.09 7.6 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.474 -0.766 . . . . 0.0 113.002 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.611 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.8 164.2 23.55 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.448 -1.408 . . . . 0.0 111.126 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -70.38 147.45 49.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.448 -0.783 . . . . 0.0 110.922 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.61 169.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.766 -0.584 . . . . 0.0 109.428 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -66.25 132.82 49.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.0 110.069 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . -114.21 168.97 9.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.67 82.58 0.22 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.628 -0.67 . . . . 0.0 110.583 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 C--N 1.314 -1.255 0 O-C-N 123.792 1.417 . . . . 0.0 110.604 179.727 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 2.2 t -93.87 131.08 39.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.518 -0.99 . . . . 0.0 110.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.428 ' C ' ' HB2' ' A' ' 7' ' ' ALA . . . -88.05 -75.16 1.28 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.8 -156.68 18.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -88.65 -4.21 58.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.444 -1.033 . . . . 0.0 110.992 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.96 40.97 1.27 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.105 -0.997 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 3' ' ' GLY . . . -82.71 -157.62 0.23 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 110.385 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.45 100.15 0.76 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 t -74.24 -76.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.48 -1.012 . . . . 0.0 110.358 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 t70 52.32 61.34 3.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 163.56 142.32 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -10.36 59.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.547 -0.972 . . . . 0.0 110.87 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -142.07 49.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 t -69.05 176.48 3.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.421 -0.8 . . . . 0.0 110.545 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.26 104.26 11.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -0.8 . . . . 0.0 110.144 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -86.39 -149.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.782 . . . . 0.0 109.575 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 1.5 t -79.24 -56.68 4.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 -81.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.15 -27.2 28.89 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 4.0 m-85 -48.44 124.45 8.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.635 -0.92 . . . . 0.0 110.605 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.2 t30 -89.57 -169.99 2.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.447 -0.783 . . . . 0.0 109.628 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 110.275 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -112.11 133.14 21.75 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.676 . . . . 0.0 110.048 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.907 1.478 . . . . 0.0 111.197 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -74.86 -21.08 59.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.497 -0.752 . . . . 0.0 110.73 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.569 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 41.7 m95 -101.1 -16.5 17.05 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.439 -0.788 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm 59.06 22.62 10.71 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.508 -0.745 . . . . 0.0 112.707 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.569 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.54 161.33 39.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.706 -1.246 . . . . 0.0 110.616 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 91.8 m -69.49 138.57 53.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.353 -0.842 . . . . 0.0 110.286 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.69 170.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.682 -0.636 . . . . 0.0 109.93 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.3 p90 -61.55 173.36 0.97 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.408 -0.807 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.19 47.94 2.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.111 -0.993 . . . . 0.0 110.709 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 47.58 80.4 0.3 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.911 -0.493 . . . . 0.0 110.948 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.313 -1.319 0 O-C-N 123.87 1.458 . . . . 0.0 110.624 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 t -155.73 138.91 15.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -1.042 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.26 -121.13 1.45 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.35 -155.71 26.89 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -8.02 52.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.453 -1.028 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.73 31.7 0.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.45 120.28 29.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -0.771 . . . . 0.0 110.436 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.48 111.15 2.97 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.0 p -84.7 -35.86 22.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.518 -0.99 . . . . 0.0 110.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 9.4 t70 54.35 70.08 0.65 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.646 -0.659 . . . . 0.0 111.122 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.34 134.08 3.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -6.76 44.3 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.541 -0.976 . . . . 0.0 110.763 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 m -106.16 29.36 6.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.396 -0.815 . . . . 0.0 110.117 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.909 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.93 162.54 26.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.517 -0.739 . . . . 0.0 110.462 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.74 99.33 5.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 110.03 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.39 -157.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.296 -0.878 . . . . 0.0 110.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -78.92 0.07 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.122 -0.986 . . . . 0.0 110.321 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -165.48 114.73 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.671 -0.643 . . . . 0.0 109.606 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.75 24.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.537 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 39.5 m-85 -129.48 118.21 21.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.385 -1.068 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 30' ' ' VAL . 8.6 t30 -108.76 156.65 19.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.81 . . . . 0.0 110.419 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.4 t -89.46 134.47 34.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 110.508 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 8.5 t -80.59 141.92 52.88 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.673 -0.642 . . . . 0.0 110.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.17 -18.65 23.48 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.931 1.49 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 m -106.1 -25.85 11.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.203 -0.935 . . . . 0.0 111.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 28.8 m0 -95.2 -18.89 20.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 0.0 111.16 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.53 12.06 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.525 -0.735 . . . . 0.0 112.451 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -129.44 164.98 22.5 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.71 -1.244 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -74.82 142.21 44.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.387 -0.82 . . . . 0.0 110.535 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 21' ' ' ASN . 29.2 m -129.11 168.99 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.726 -0.609 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.46 121.68 26.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.267 -0.896 . . . . 0.0 110.42 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.8 69.42 6.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.842 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.81 70.35 36.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 109.736 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.275 0 O-C-N 123.755 1.397 . . . . 0.0 110.729 -179.537 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.537 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 17.9 p -86.63 -155.75 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.468 -1.019 . . . . 0.0 110.225 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.32 -105.95 0.05 OUTLIER Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.56 -171.25 23.85 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 69.1 mt -76.12 -9.01 58.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.489 -1.006 . . . . 0.0 111.459 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.3 ttt -144.09 42.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.802 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.28 102.87 15.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.34 119.23 13.82 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.0 p -117.21 -46.8 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.538 -0.978 . . . . 0.0 110.833 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 51.79 67.22 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.563 -0.711 . . . . 0.0 110.468 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.38 127.38 0.91 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -66.12 -13.13 59.59 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.679 -0.895 . . . . 0.0 111.078 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.16 21.43 11.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.104 -0.998 . . . . 0.0 110.674 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 9' ' ' CYS . 9.1 t -81.1 169.7 17.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.131 -0.981 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -128.58 142.31 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.3 m -126.88 -151.35 0.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.611 -0.681 . . . . 0.0 110.038 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -68.09 -66.93 0.5 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.186 -0.946 . . . . 0.0 110.791 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -150.66 -76.37 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . -98.81 13.28 62.42 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 4.9 m-85 -73.51 119.62 17.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -1.222 . . . . 0.0 109.695 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 30' ' ' VAL . 4.5 t30 -106.07 153.82 21.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.466 -0.771 . . . . 0.0 110.5 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 m -89.41 135.8 33.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.341 -0.849 . . . . 0.0 110.75 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.2 t -86.29 140.47 34.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.72 -25.9 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.827 1.435 . . . . 0.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.752 HG23 ' CD1' ' A' ' 26' ' ' TRP . 9.8 t -91.04 -23.92 20.21 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.317 -0.864 . . . . 0.0 111.236 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.752 ' CD1' HG23 ' A' ' 25' ' ' THR . 34.0 m0 -101.37 -22.12 14.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.123 -0.986 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER 69.96 9.34 7.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.964 -0.46 . . . . 0.0 112.025 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -126.19 171.6 10.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.848 -1.157 . . . . 0.0 110.435 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -82.21 147.42 28.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.408 -0.807 . . . . 0.0 110.929 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' ASN . 19.1 m -136.23 -169.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' HB2' HD21 ' A' ' 5' ' ' LEU . 33.3 t80 -93.96 138.46 32.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . -90.0 143.68 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 110.33 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' HB2' ' HD3' ' A' ' 34' ' ' PRO . 2.8 mmt180 -52.31 -54.82 37.7 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.692 -0.63 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 33' ' ' ARG . 45.0 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.541 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 p -94.98 -176.54 3.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.515 -0.991 . . . . 0.0 110.444 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.55 -149.14 24.45 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 -113.03 0.34 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -109.54 -15.88 14.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.476 -1.014 . . . . 0.0 111.07 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt -150.48 32.44 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.369 -0.832 . . . . 0.0 109.707 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -71.68 -163.71 0.11 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.496 -0.752 . . . . 0.0 110.245 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.31 116.23 5.45 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -111.5 42.8 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.768 -0.842 . . . . 0.0 110.272 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.4 m-20 -71.9 81.39 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.227 -0.921 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.79 124.76 1.39 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -10.41 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.497 -1.002 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -110.06 28.2 8.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.22 -0.925 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.435 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.9 t -90.97 154.31 19.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.91 155.09 28.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.42 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.1 m -103.54 -165.51 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.586 -0.696 . . . . 0.0 110.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 -70.26 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.363 -0.835 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.9 124.33 1.55 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.0 30.61 60.98 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.9 m-85 -129.79 132.23 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -97.79 140.24 32.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.728 . . . . 0.0 109.874 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 40.6 t -88.8 132.58 34.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.92 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.11 120.03 49.19 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.674 -0.641 . . . . 0.0 109.858 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.84 -31.01 10.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.806 1.424 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.5 m -78.9 -28.73 44.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.745 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.509 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 76.3 m95 -96.87 -12.89 22.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 111.089 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 5.6 tptt 64.06 27.6 14.18 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.372 -0.83 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.524 ' CA ' ' HB2' ' A' ' 9' ' ' CYS . 1.5 p90 -157.69 150.36 22.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.04 -1.038 . . . . 0.0 109.84 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.4 t -82.07 146.84 29.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.216 -0.928 . . . . 0.0 110.161 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 34.8 m -129.99 -167.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.39 151.3 47.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.344 -0.847 . . . . 0.0 109.871 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.34 120.43 30.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 92.1 44.03 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.314 -1.265 0 O-C-N 123.822 1.433 . . . . 0.0 110.475 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.5 m -85.8 143.52 28.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.986 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.84 -87.4 0.42 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.36 -161.77 28.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -92.93 -2.71 55.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.491 -1.006 . . . . 0.0 111.282 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 34.75 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 109.793 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.91 104.93 15.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 110.555 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.32 113.53 3.84 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.59 ' HB2' HG21 ' A' ' 14' ' ' THR . 28.6 p -104.7 -36.18 7.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.4 -1.059 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t70 55.16 77.44 0.22 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.624 -0.673 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.28 5.95 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -1.32 57.02 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.487 -1.008 . . . . 0.0 110.911 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 p -148.56 49.57 1.01 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.294 -0.879 . . . . 0.0 109.76 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.7 t -74.62 -169.46 0.86 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.656 -0.652 . . . . 0.0 110.767 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.96 100.05 6.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 1.1 t -98.67 -146.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 0.0 109.752 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -94.49 -105.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.009 -1.057 . . . . 0.0 110.003 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 21.18 2.07 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.859 -1.151 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.22 42.06 0.15 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 79.8 m-85 -138.08 138.85 39.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.961 . . . . 0.0 110.07 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -121.1 153.37 37.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 14' ' ' THR . 16.4 m -89.11 134.98 33.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.184 -0.948 . . . . 0.0 110.822 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -91.82 146.81 33.72 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.768 -0.583 . . . . 0.0 110.187 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 -35.57 3.95 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.911 1.479 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 m -87.49 -37.11 17.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 110.417 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.739 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 35.5 m0 -82.68 -29.71 29.75 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 19.0 tptt 69.07 11.2 8.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.959 -0.463 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.739 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.83 167.09 17.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.808 -1.182 . . . . 0.0 111.064 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -77.54 129.79 36.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.698 -0.626 . . . . 0.0 111.154 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 ' CE3' ' A' ' 26' ' ' TRP . 21.4 m -129.55 169.63 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.777 -0.577 . . . . 0.0 109.478 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' CD2' HD21 ' A' ' 5' ' ' LEU . 14.0 p90 -52.92 155.17 2.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.86 123.54 47.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.355 -0.841 . . . . 0.0 110.453 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.58 124.98 32.3 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.582 -0.699 . . . . 0.0 110.198 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.313 -1.309 0 O-C-N 123.883 1.465 . . . . 0.0 111.007 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t -78.57 135.43 37.28 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.407 -1.055 . . . . 0.0 110.034 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.94 -124.56 1.55 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -134.36 3.0 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -7.29 25.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.596 -0.943 . . . . 0.0 111.358 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.8 ttm -149.93 32.85 0.68 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.15 -0.968 . . . . 0.0 110.122 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.23 136.91 44.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.69 119.81 19.39 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' A' ' 14' ' ' THR . 7.0 t -95.33 -77.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.676 -0.897 . . . . 0.0 109.851 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.55 73.94 0.28 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.761 -0.587 . . . . 0.0 111.119 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.38 120.7 1.6 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -14.26 44.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.866 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -105.88 27.44 8.52 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 0.0 110.454 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.532 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -69.4 -178.2 1.33 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.245 -0.91 . . . . 0.0 110.462 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.99 146.74 45.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -131.98 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.68 -0.637 . . . . 0.0 110.005 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -67.88 0.73 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 p -168.51 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.568 -0.708 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.07 28.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 53.6 m-85 -122.86 129.9 52.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.291 -1.123 . . . . 0.0 109.872 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.64 163.11 16.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.461 -0.774 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -89.23 137.24 32.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.362 -0.836 . . . . 0.0 110.801 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -93.22 143.18 26.31 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.48 -0.763 . . . . 0.0 110.099 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.83 -21.81 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.916 1.482 . . . . 0.0 111.665 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 m -109.59 -38.67 5.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.171 -0.956 . . . . 0.0 111.369 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.713 ' CE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -72.64 -20.59 61.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 65.02 15.66 10.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.707 -0.62 . . . . 0.0 111.869 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.705 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -141.02 162.89 34.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.777 -1.202 . . . . 0.0 110.704 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.76 138.65 46.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.49 -0.756 . . . . 0.0 110.546 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.713 HG11 ' CE3' ' A' ' 26' ' ' TRP . 5.3 m -136.1 -178.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -58.55 153.48 16.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.85 122.19 31.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.348 -0.845 . . . . 0.0 110.464 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.49 143.11 14.6 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.71 -0.619 . . . . 0.0 110.216 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 O-C-N 123.779 1.41 . . . . 0.0 110.975 -179.743 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.3 t -122.81 149.35 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.559 -0.965 . . . . 0.0 110.106 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 7' ' ' ALA . . . -78.59 -152.09 6.02 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.86 46.82 0.06 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.42 -7.37 1.02 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.899 -0.765 . . . . 0.0 112.512 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.87 25.81 0.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.945 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . . . -64.66 114.22 4.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.9 120.12 15.92 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 14' ' ' THR . 19.7 m -79.32 -73.53 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.986 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 50.51 56.5 7.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.491 0.663 . . . . 0.0 109.744 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.13 123.78 1.2 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -14.73 52.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.999 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.31 14.0 23.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 110.8 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.6 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -71.11 146.76 49.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.101 -0.999 . . . . 0.0 110.25 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -126.36 137.85 53.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.395 -0.816 . . . . 0.0 110.677 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.09 -154.28 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.648 -0.657 . . . . 0.0 109.73 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -73.04 0.35 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 110.436 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.3 -44.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 0.0 110.526 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.56 28.7 14.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 30.0 m-85 -124.62 131.83 53.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.979 . . . . 0.0 110.078 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -109.74 149.95 29.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.327 -0.858 . . . . 0.0 109.777 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.8 t -88.91 136.0 33.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.187 -0.945 . . . . 0.0 111.012 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.35 130.5 23.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.634 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.04 -31.39 9.8 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.887 1.467 . . . . 0.0 111.521 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -81.68 -31.96 31.98 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.897 . . . . 0.0 110.684 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.653 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -91.25 -17.73 25.52 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.381 -0.825 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tptm 67.7 17.35 9.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.689 -0.632 . . . . 0.0 111.656 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -144.66 168.39 20.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 110.549 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -84.56 150.95 24.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.515 -0.741 . . . . 0.0 111.041 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 28.2 m -140.15 178.63 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -58.06 151.74 18.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.91 127.7 43.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.356 -0.84 . . . . 0.0 110.312 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -155.31 133.65 7.07 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.58 -0.7 . . . . 0.0 110.208 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--N 1.313 -1.3 0 O-C-N 123.908 1.478 . . . . 0.0 110.847 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 9.1 t 54.24 75.84 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.856 -0.791 . . . . 0.0 110.808 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 7' ' ' ALA . . . -82.52 -80.67 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.09 -133.63 4.22 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.76 -5.01 21.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.453 -1.028 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 ttm -149.59 33.87 0.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' TRP . . . -74.05 -167.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.393 -0.817 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.31 88.58 0.47 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB2' HG21 ' A' ' 14' ' ' THR . 17.5 p -99.61 53.31 0.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.93 . . . . 0.0 110.029 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.87 100.0 2.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.6 126.51 1.36 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -63.53 -14.38 50.56 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.585 -0.95 . . . . 0.0 111.028 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -108.62 30.0 6.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.5 t -96.49 169.12 10.12 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.358 -0.839 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.57 145.86 27.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -90.19 -144.29 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.376 -0.827 . . . . 0.0 110.027 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' CA ' ' HA ' ' A' ' 2' ' ' CYS . 1.7 t -81.8 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.951 -1.093 . . . . 0.0 110.795 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 t -164.92 -48.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.441 -0.787 . . . . 0.0 110.494 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 23.93 33.79 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 145.07 50.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.314 -1.11 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' VAL . 5.8 m120 -122.42 157.95 30.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 t -88.48 141.26 28.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.957 -1.089 . . . . 0.0 110.551 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.94 133.48 20.26 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -29.46 10.52 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.97 1.51 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 m -87.13 -37.08 17.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.398 -0.814 . . . . 0.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.648 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 70.7 m95 -89.63 -15.04 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.486 -0.758 . . . . 0.0 111.013 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 60.33 14.27 4.57 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.612 -0.68 . . . . 0.0 112.672 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.648 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -135.43 159.17 42.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.778 -1.201 . . . . 0.0 110.537 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.5 m -67.38 132.35 47.49 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.446 -0.784 . . . . 0.0 110.081 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 21' ' ' ASN . 23.7 m -116.9 179.73 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.678 . . . . 0.0 109.815 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -76.19 142.66 41.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.55 90.46 8.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.802 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -78.43 135.69 60.9 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 O-C-N 123.93 1.489 . . . . 0.0 110.763 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.485 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 m -130.03 128.18 41.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.516 -0.991 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.76 -88.18 0.65 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.27 -144.98 14.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.68 -4.34 33.95 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.511 -0.994 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -149.94 41.78 0.85 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -72.53 -165.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.507 -0.746 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 112.73 2.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -80.32 -77.52 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.458 -1.025 . . . . 0.0 110.018 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.94 68.16 0.79 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.677 -0.64 . . . . 0.0 110.483 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.9 121.52 1.92 Allowed Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -61.97 -15.88 47.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.93 . . . . 0.0 110.536 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.37 9.46 41.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.385 -0.822 . . . . 0.0 110.953 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.403 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 12.2 t -72.0 158.37 36.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.029 -1.045 . . . . 0.0 110.042 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.64 143.32 41.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.307 -0.871 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -95.31 -138.59 0.24 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.728 . . . . 0.0 109.98 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -91.3 -85.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 110.779 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 m -146.86 -47.63 0.18 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.162 -0.961 . . . . 0.0 110.773 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.77 25.88 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 85.8 m-85 -135.1 133.87 39.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -1.006 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.77 149.86 26.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.357 -0.839 . . . . 0.0 109.195 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.0 124.21 33.5 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.909 -1.119 . . . . 0.0 110.334 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.36 128.35 40.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.786 -0.571 . . . . 0.0 110.443 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.97 -37.02 3.04 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.941 1.495 . . . . 0.0 110.661 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.6 m -71.81 -37.75 70.32 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.59 -0.694 . . . . 0.0 110.402 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.9 m95 -90.74 -12.06 37.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.588 -0.695 . . . . 0.0 110.64 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 61.38 19.34 10.13 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.561 -0.712 . . . . 0.0 112.256 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.514 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -147.58 157.7 43.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.81 -1.182 . . . . 0.0 110.838 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 67.3 m -67.2 136.02 54.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.677 -0.639 . . . . 0.0 110.798 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -123.2 -172.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -69.54 148.63 49.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.19 133.01 52.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -66.4 -55.52 19.24 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.473 -0.767 . . . . 0.0 110.644 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 33' ' ' ARG . 46.7 Cg_endo . . . . . 0 N--CA 1.487 1.1 0 O-C-N 123.63 1.331 . . . . 0.0 110.603 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -156.1 103.69 2.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -1.026 . . . . 0.0 110.284 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.54 -119.03 4.55 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.09 -126.65 1.34 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 4.1 mp -104.54 -2.79 24.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.57 -0.959 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.73 31.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 109.944 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 130.16 35.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 109.727 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.27 118.43 10.27 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.76 -74.44 0.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.911 . . . . 0.0 109.935 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.09 92.08 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.419 0.628 . . . . 0.0 110.561 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . 142.5 -13.18 2.49 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 2.5 mtmp? 60.6 20.11 10.0 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.387 -1.067 . . . . 0.0 110.976 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -170.31 48.02 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 22' ' ' CYS . 5.3 t -83.72 158.3 21.83 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.23 120.41 34.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.399 -0.813 . . . . 0.0 110.199 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -100.77 -170.26 1.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.499 -0.751 . . . . 0.0 110.354 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 2' ' ' CYS . 57.6 m -64.31 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.397 -0.814 . . . . 0.0 110.424 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 p -158.99 88.77 0.91 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.418 -0.801 . . . . 0.0 109.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.06 8.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 32.1 m-85 -84.5 145.3 28.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -1.122 . . . . 0.0 109.91 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 17.0 t-20 -125.22 154.69 41.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.737 . . . . 0.0 110.235 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB2' HG22 ' A' ' 14' ' ' THR . 1.7 t -88.11 134.25 33.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.543 -0.723 . . . . 0.0 110.334 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -100.86 133.39 21.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.754 -0.591 . . . . 0.0 110.089 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.25 -28.12 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.9 1.474 . . . . 0.0 110.953 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -88.4 -36.48 16.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 0.0 110.544 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.727 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.9 m0 -88.3 -14.64 37.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 110.55 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 1.4 mmpp? 60.82 20.44 10.61 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.687 -0.633 . . . . 0.0 111.967 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.727 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -145.25 168.8 19.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.933 -1.105 . . . . 0.0 111.0 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -78.6 150.61 32.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.585 -0.697 . . . . 0.0 110.92 -179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 11.9 m -149.39 172.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.702 -0.624 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -69.06 135.26 50.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 0.0 109.858 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.36 104.17 16.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 110.172 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ptt85 -140.01 159.19 65.37 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.533 -0.729 . . . . 0.0 110.515 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--N 1.314 -1.282 0 O-C-N 123.792 1.417 . . . . 0.0 110.627 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 139.19 41.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.501 -0.999 . . . . 0.0 110.048 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.86 -136.62 5.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.43 -141.47 5.52 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.633 HD21 ' HD2' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -93.97 -12.14 29.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.592 -0.946 . . . . 0.0 111.114 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mtt -150.22 32.45 0.66 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.214 -0.929 . . . . 0.0 110.145 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.38 147.52 42.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.75 123.13 28.03 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 t -90.66 -71.33 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.48 99.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.333 0.587 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.14 -11.57 6.85 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm 59.57 19.96 8.5 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.287 -1.125 . . . . 0.0 110.736 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -170.22 45.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.36 -0.837 . . . . 0.0 110.0 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.52 HG22 ' HB2' ' A' ' 22' ' ' CYS . 6.4 t -82.47 165.43 20.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.465 -0.772 . . . . 0.0 110.833 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.37 105.34 15.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.01 -141.78 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.549 -0.72 . . . . 0.0 110.31 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -75.59 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.235 -0.916 . . . . 0.0 110.076 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -145.25 63.96 1.27 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 109.939 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . 154.42 -46.18 0.55 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.564 ' HD1' ' HA ' ' A' ' 31' ' ' TYR . 22.3 m-85 -55.96 128.5 35.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.606 -0.938 . . . . 0.0 110.242 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -106.12 159.24 16.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.773 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HB2' HG22 ' A' ' 14' ' ' THR . 5.3 t -89.27 132.67 34.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 110.714 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.12 128.47 36.92 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.9 -25.17 16.87 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.803 1.423 . . . . 0.0 111.169 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 m -87.82 -30.0 20.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.324 -0.86 . . . . 0.0 110.812 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.6 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 29.9 m0 -98.48 -15.25 19.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.285 -0.884 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.64 14.73 9.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.564 -0.71 . . . . 0.0 112.075 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.6 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -136.21 165.27 26.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.762 -1.211 . . . . 0.0 110.602 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 t -79.65 136.1 36.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.764 . . . . 0.0 110.542 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.597 HG11 ' CZ3' ' A' ' 26' ' ' TRP . 33.9 m -113.68 -167.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.06 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.633 ' HD2' HD21 ' A' ' 5' ' ' LEU . 24.0 p90 -88.29 165.08 15.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.442 -0.787 . . . . 0.0 110.261 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . -106.08 -172.56 2.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.515 -0.741 . . . . 0.0 110.213 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.78 70.77 9.89 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.377 -0.827 . . . . 0.0 110.03 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.315 -1.211 0 O-C-N 123.719 1.379 . . . . 0.0 110.738 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 p -94.12 -170.54 2.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.533 -0.981 . . . . 0.0 110.659 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.93 173.0 55.21 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 -119.62 1.08 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.3 7.16 22.94 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.491 -1.006 . . . . 0.0 111.474 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.31 29.98 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -75.96 119.06 19.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.214 -0.929 . . . . 0.0 110.046 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.06 128.53 17.19 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -109.44 23.72 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.741 -0.858 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.38 -21.01 66.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -76.31 -3.79 77.68 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 4.4 mtmp? 59.57 23.15 11.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -1.073 . . . . 0.0 111.02 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -176.3 38.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.382 -0.824 . . . . 0.0 110.702 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t -71.14 105.96 3.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.127 -0.983 . . . . 0.0 110.078 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.03 104.8 2.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.93 -166.25 1.08 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 0.0 110.62 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -65.8 0.63 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.318 -0.864 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.29 -45.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.552 -0.718 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.12 30.69 9.86 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 48.7 m-85 -123.16 120.74 34.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -1.007 . . . . 0.0 110.284 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.461 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 t30 -110.99 167.37 10.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.47 144.16 26.26 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.827 -1.171 . . . . 0.0 110.948 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -90.37 147.65 37.17 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.595 -0.691 . . . . 0.0 110.136 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.88 -24.56 11.37 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.876 1.461 . . . . 0.0 111.634 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -111.32 -30.74 7.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.259 -0.901 . . . . 0.0 111.462 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -80.57 -20.53 43.16 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.166 -0.959 . . . . 0.0 110.842 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.59 21.41 11.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.612 -0.68 . . . . 0.0 112.113 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.667 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -143.75 166.81 23.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.737 -1.227 . . . . 0.0 110.932 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 2.3 t -69.9 138.06 52.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.572 -0.705 . . . . 0.0 111.013 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG11 ' HE3' ' A' ' 26' ' ' TRP . 27.2 m -134.66 -179.94 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -61.36 158.87 13.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.0 109.982 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.24 172.81 11.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.336 -0.852 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -114.93 147.21 37.78 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 O-C-N 123.918 1.483 . . . . 0.0 110.607 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.5 t -151.3 127.13 10.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.54 -0.976 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.95 -118.12 4.11 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.17 -127.9 1.48 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.89 -7.4 17.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -1.0 . . . . 0.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.8 29.41 0.83 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.95 146.61 27.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 0.0 110.2 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.04 124.31 36.3 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.718 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.8 p -125.34 20.41 8.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.489 -1.006 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -49.79 106.53 0.12 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.406 -0.809 . . . . 0.0 110.757 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.09 2.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -12.97 61.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.484 -1.009 . . . . 0.0 111.066 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.59 38.05 3.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.29 -0.881 . . . . 0.0 110.64 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.1 t -69.16 151.04 46.84 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.729 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -109.4 127.34 54.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.357 -0.84 . . . . 0.0 110.598 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.19 -156.55 0.57 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.17 -0.956 . . . . 0.0 110.405 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -169.39 127.88 0.98 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.496 -0.753 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.92 21.96 79.44 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.9 m-85 -131.18 131.26 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.253 -1.145 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.624 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 4.3 t-20 -117.83 164.86 14.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.346 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.41 ' HB2' HG21 ' A' ' 14' ' ' THR . 34.8 t -88.79 137.76 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.59 135.3 19.76 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.688 -0.632 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.81 -34.44 3.18 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.829 1.436 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.26 -35.36 61.39 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.0 110.71 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.0 m95 -97.98 -20.02 17.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.734 . . . . 0.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.43 12.64 8.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.716 -0.615 . . . . 0.0 112.376 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -135.02 164.23 28.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.235 . . . . 0.0 110.676 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -68.21 137.77 55.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.747 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 26.7 m -136.14 -176.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.733 -0.604 . . . . 0.0 109.472 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 137.65 50.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.207 -0.933 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . -106.54 117.99 35.5 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.21 152.84 8.59 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.425 -0.797 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.312 -1.35 0 O-C-N 123.913 1.48 . . . . 0.0 110.729 179.791 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -85.19 -173.17 4.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.467 -1.019 . . . . 0.0 110.665 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.91 -113.15 0.69 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 -114.34 0.52 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.48 10.43 19.7 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.56 -0.965 . . . . 0.0 111.034 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.2 ttt -148.58 35.87 0.79 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.225 -0.922 . . . . 0.0 110.078 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -73.21 125.48 27.85 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.14 115.71 6.46 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -93.57 -82.8 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.927 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.05 59.59 4.43 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.573 -0.704 . . . . 0.0 110.593 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.71 -142.99 3.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.15 5.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.44 -1.035 . . . . 0.0 111.108 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.35 58.75 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.955 . . . . 0.0 110.013 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 22' ' ' CYS . 12.8 t -59.16 147.24 35.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.52 129.78 34.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -126.02 -162.7 1.15 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.78 -0.575 . . . . 0.0 110.194 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.3 m -80.91 -86.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 125.67 4.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.314 -0.867 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.56 60.67 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.1 m120 -112.04 167.64 10.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.8 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 t -88.7 134.71 33.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.418 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 134.11 19.9 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.52 -33.83 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.794 1.418 . . . . 0.0 110.786 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.0 m -74.44 -44.78 50.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.66 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 85.8 m95 -88.27 -13.47 40.83 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.587 -0.696 . . . . 0.0 110.592 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.39 19.22 10.04 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.631 -0.668 . . . . 0.0 112.4 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.66 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.12 166.04 26.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.877 -1.14 . . . . 0.0 110.713 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -67.18 133.52 49.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.44 -0.787 . . . . 0.0 111.103 -178.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.89 176.88 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.13 137.16 58.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.48 155.89 18.42 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 0.0 110.502 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 122.62 10.24 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 O-C-N 123.869 1.457 . . . . 0.0 110.598 179.53 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -155.95 119.2 4.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.97 . . . . 0.0 110.284 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.02 -95.77 1.57 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.6 -131.94 5.04 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 -5.76 20.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.975 . . . . 0.0 110.839 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.6 ttm -145.61 36.79 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -73.29 -165.71 0.27 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.386 -0.822 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.65 96.32 0.54 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' THR . 77.8 m -70.92 -77.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.913 . . . . 0.0 110.427 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.09 58.16 5.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.674 -0.641 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.78 139.07 2.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -8.29 55.47 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.421 -1.046 . . . . 0.0 110.727 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 2.31 39.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.329 -0.857 . . . . 0.0 110.657 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 9' ' ' CYS . 11.2 t -66.72 146.63 54.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.32 127.25 48.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -0.792 . . . . 0.0 110.335 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -87.31 -155.24 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 110.051 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.66 -92.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.14 123.26 14.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 109.844 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.33 35.56 76.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -130.05 120.8 25.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -1.044 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.7 t-20 -98.01 -170.95 2.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.3 m -118.68 139.02 52.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.15 -0.969 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 3.1 t -84.79 140.11 37.7 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.775 . . . . 0.0 110.028 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.48 -25.52 25.16 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.945 1.497 . . . . 0.0 111.297 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 m -103.29 -36.63 7.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.261 -0.899 . . . . 0.0 111.242 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 32.1 m0 -79.88 -21.27 44.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.253 -0.904 . . . . 0.0 111.093 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.4 OUTLIER 63.34 11.59 5.57 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.495 -0.753 . . . . 0.0 112.408 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.713 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -125.98 160.79 29.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.7 -1.25 . . . . 0.0 110.572 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 69.4 m -66.13 138.81 57.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.72 . . . . 0.0 111.438 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG11 ' HE3' ' A' ' 26' ' ' TRP . 25.4 m -139.17 -179.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.56 135.09 57.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.086 -1.009 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.11 107.73 19.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 110.349 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.7 tpt85 -155.36 66.95 4.92 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.358 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.314 -1.274 0 O-C-N 123.821 1.432 . . . . 0.0 110.682 179.817 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 t -75.34 164.36 26.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.56 -0.965 . . . . 0.0 110.385 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' CYS . . . -55.46 117.02 7.74 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.08 47.13 0.95 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER 68.26 -3.96 1.18 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.876 -0.779 . . . . 0.0 112.113 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.42 27.68 0.66 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.914 -1.116 . . . . 0.0 110.277 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 142.67 27.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.344 -0.848 . . . . 0.0 110.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 119.27 14.79 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.878 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.9 p -123.76 28.59 6.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.497 -1.002 . . . . 0.0 110.91 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.91 112.09 0.72 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.873 . . . . 0.0 110.282 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.08 137.35 3.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -8.06 49.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.454 -1.027 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -139.86 47.44 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.878 HG21 ' HB2' ' A' ' 9' ' ' CYS . 12.7 t -76.71 -176.23 3.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.482 -0.762 . . . . 0.0 110.578 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.29 147.88 51.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 73.4 m -129.5 -162.33 1.19 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.593 -0.692 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -76.99 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 110.567 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 p -158.2 123.7 4.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.19 31.36 63.95 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.491 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 23.4 m-85 -124.8 132.06 53.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -1.141 . . . . 0.0 110.123 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.9 t-20 -112.42 159.32 18.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.0 110.127 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.1 t -89.56 137.57 32.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.006 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 m -103.21 128.91 26.57 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.613 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.57 -27.1 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.877 1.462 . . . . 0.0 111.196 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.4 m -84.12 -35.5 23.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.274 -0.891 . . . . 0.0 110.653 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 39.0 m0 -94.46 -13.06 26.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.363 -0.836 . . . . 0.0 111.0 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.08 11.75 7.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.525 -0.734 . . . . 0.0 112.234 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.638 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.96 166.45 23.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.792 -1.192 . . . . 0.0 110.803 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.5 t -75.37 143.64 42.71 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.513 -0.742 . . . . 0.0 110.51 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.526 HG11 ' CE3' ' A' ' 26' ' ' TRP . 33.9 m -124.38 -169.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 109.932 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 20.7 t80 -93.34 133.85 36.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 110.326 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.16 179.26 4.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.605 -0.685 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.499 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -162.62 -62.41 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 110.583 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 33' ' ' ARG . 45.9 Cg_endo . . . . . 0 N--CA 1.487 1.143 0 O-C-N 123.319 1.168 . . . . 0.0 110.74 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.169 0.509 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.678 ' CA ' ' HB2' ' A' ' 7' ' ' ALA . . . -81.49 116.17 4.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.04 -102.26 2.55 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 30' ' ' VAL . 1.4 mt -104.05 -5.03 22.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.523 -0.986 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -143.0 47.62 1.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.096 -1.003 . . . . 0.0 110.022 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' ' CA ' ' A' ' 3' ' ' GLY . . . -76.1 -157.89 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.567 -0.708 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 117.82 3.81 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -104.42 24.17 12.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.639 -0.918 . . . . 0.0 110.189 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 30.8 t70 -69.77 -28.94 66.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.15 -13.78 76.42 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.66 9.65 6.1 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.012 0.906 . . . . 0.0 111.156 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -159.42 36.78 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.001 -1.062 . . . . 0.0 110.678 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 14.9 t -76.28 164.99 25.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.236 -0.915 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.48 8.49 16.5 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.23 -0.919 . . . . 0.0 111.162 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 m 50.74 -152.57 0.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 t -102.68 -72.92 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 0.0 110.157 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -159.84 114.51 2.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.081 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.23 45.45 8.85 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -144.94 120.27 10.25 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.477 -1.014 . . . . 0.0 110.115 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -90.55 151.47 21.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.369 -0.832 . . . . 0.0 109.383 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -89.05 142.06 27.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.07 -1.018 . . . . 0.0 110.816 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -110.25 127.68 26.63 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.784 -0.572 . . . . 0.0 110.297 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.2 -31.17 6.17 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.99 1.521 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -77.05 -29.36 55.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.463 -0.773 . . . . 0.0 110.701 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.643 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 59.8 m95 -100.69 -18.36 16.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.347 -0.846 . . . . 0.0 110.935 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 16.0 tptt 67.41 32.93 5.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.52 -0.737 . . . . 0.0 112.009 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.643 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -159.75 158.17 30.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.054 -1.029 . . . . 0.0 110.53 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.558 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 67.9 m -69.43 139.06 54.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.915 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 25.9 m -132.65 -168.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -66.44 140.1 58.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.431 -0.793 . . . . 0.0 110.713 -179.253 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.929 0.395 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.54 -77.39 0.53 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.81 -149.84 17.12 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -95.04 -1.53 52.07 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.492 -1.005 . . . . 0.0 111.132 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.78 42.05 1.45 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.22 -161.68 0.53 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.551 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.96 117.93 4.17 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 51.5 m -108.27 48.6 0.85 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.99 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.55 91.15 3.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.422 -0.799 . . . . 0.0 110.008 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.36 137.3 4.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -71.17 -4.7 26.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.384 -1.068 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -115.27 31.97 6.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.077 -1.015 . . . . 0.0 110.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -84.89 179.78 7.24 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.197 -0.939 . . . . 0.0 110.682 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.26 150.31 39.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -0.85 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.2 m -112.75 -145.2 0.4 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.559 -0.713 . . . . 0.0 109.747 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -91.02 -60.14 1.98 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.044 -1.035 . . . . 0.0 110.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -123.41 -126.64 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.634 -0.666 . . . . 0.0 109.47 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.46 -11.91 65.73 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 26.1 m-85 -38.81 112.45 0.24 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.799 -0.824 . . . . 0.0 111.297 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -89.61 -176.41 4.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.2 m -111.05 147.59 34.46 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.748 -1.22 . . . . 0.0 110.204 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -85.95 144.51 39.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.376 -0.827 . . . . 0.0 110.189 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -23.54 19.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 124.025 1.54 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.832 HG23 ' CD1' ' A' ' 26' ' ' TRP . 3.1 t -116.94 -25.19 7.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.247 -0.908 . . . . 0.0 111.683 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.832 ' CD1' HG23 ' A' ' 25' ' ' THR . 38.3 m0 -85.6 -18.1 34.3 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.012 -1.055 . . . . 0.0 111.197 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt 60.2 21.93 11.27 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.594 -0.691 . . . . 0.0 112.092 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.652 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.03 159.18 41.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.168 . . . . 0.0 110.37 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 96.1 m -68.79 135.35 51.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 110.915 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 34.4 m -124.5 163.84 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.681 -0.637 . . . . 0.0 109.568 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.13 145.73 52.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.453 -0.779 . . . . 0.0 110.294 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.083 0.468 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.49 -113.39 3.75 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.84 -138.6 8.16 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 ' HE2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -100.24 -15.35 18.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.535 -0.98 . . . . 0.0 110.558 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.56 43.96 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -161.97 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.388 -0.82 . . . . 0.0 110.593 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.91 100.46 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.572 ' CA ' HG21 ' A' ' 14' ' ' THR . 18.9 p -108.71 40.18 1.85 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.51 -0.994 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.621 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 20.6 t70 -67.02 163.38 20.04 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.078 -1.014 . . . . 0.0 110.206 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.47 -13.43 18.39 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? 58.07 19.88 6.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.499 -1.001 . . . . 0.0 110.587 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -172.58 37.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.441 -0.787 . . . . 0.0 110.355 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.572 HG21 ' CA ' ' A' ' 9' ' ' CYS . 7.2 t -99.92 176.03 5.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -129.27 137.11 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 m -80.93 -144.46 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -71.45 0.47 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.013 -1.054 . . . . 0.0 110.061 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -167.42 112.15 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.765 -0.584 . . . . 0.0 110.088 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.4 21.33 38.21 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HE2' HD23 ' A' ' 5' ' ' LEU . 38.3 m-85 -130.7 137.96 49.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.4 -1.059 . . . . 0.0 109.538 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 6.4 t30 -108.78 175.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -113.27 138.64 49.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 45.5 t -91.02 137.26 26.65 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.393 -0.817 . . . . 0.0 110.076 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 -18.5 22.95 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.941 1.495 . . . . 0.0 111.468 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -106.52 -29.06 9.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.113 -0.992 . . . . 0.0 111.11 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 31.1 m0 -89.43 -26.07 21.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.238 -0.914 . . . . 0.0 110.565 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.35 9.68 7.04 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.837 -0.539 . . . . 0.0 111.886 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.672 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -124.59 161.24 26.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.878 -1.139 . . . . 0.0 110.009 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 16.7 m -75.16 147.01 40.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.143 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 5' ' ' LEU . 27.0 m -139.03 -174.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.76 132.21 47.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 109.968 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.697 -0.627 . . . . 0.0 110.376 -179.684 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.004 0.43 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -93.03 0.09 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.3 -159.34 27.11 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.19 -4.16 49.56 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.985 . . . . 0.0 110.598 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.9 mtt -150.85 29.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.387 -0.821 . . . . 0.0 109.739 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.6 33.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -0.852 . . . . 0.0 110.716 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.93 122.61 30.76 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.764 ' HB3' HG21 ' A' ' 14' ' ' THR . 99.2 m -84.13 -59.74 2.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.64 -0.918 . . . . 0.0 109.899 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.6 t70 51.15 78.68 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.253 0.549 . . . . 0.0 111.031 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.2 141.97 4.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 2.4 24.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -1.024 . . . . 0.0 110.747 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.86 23.66 9.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.276 -0.89 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 9' ' ' CYS . 10.9 t -73.76 165.27 25.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.876 . . . . 0.0 109.943 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.03 149.81 50.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.0 111.054 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.65 -150.42 0.46 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.665 -0.647 . . . . 0.0 109.445 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -91.4 -70.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.029 -1.044 . . . . 0.0 110.273 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -172.17 92.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 117.91 -35.56 4.01 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -70.35 125.08 25.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.405 -1.056 . . . . 0.0 110.15 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.8 m120 -107.89 166.55 10.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.998 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.7 m -88.76 132.12 34.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.132 -0.98 . . . . 0.0 110.571 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 26' ' ' TRP . 11.9 p -67.76 142.91 96.2 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.65 -19.03 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.808 1.425 . . . . 0.0 111.887 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.1 m -122.54 -33.35 3.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.965 -1.084 . . . . 0.0 111.858 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.611 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 48.1 m0 -79.04 -12.84 60.03 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.013 . . . . 0.0 111.466 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? 66.16 11.09 7.6 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.474 -0.766 . . . . 0.0 113.002 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.611 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.8 164.2 23.55 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.448 -1.408 . . . . 0.0 111.126 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -70.38 147.45 49.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.448 -0.783 . . . . 0.0 110.922 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.61 169.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.766 -0.584 . . . . 0.0 109.428 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -66.25 132.82 49.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.0 110.069 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 2.2 t . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.075 0.464 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.428 ' C ' ' HB2' ' A' ' 7' ' ' ALA . . . -88.05 -75.16 1.28 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.8 -156.68 18.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -88.65 -4.21 58.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.444 -1.033 . . . . 0.0 110.992 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.96 40.97 1.27 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.105 -0.997 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 3' ' ' GLY . . . -82.71 -157.62 0.23 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 110.385 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.45 100.15 0.76 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 t -74.24 -76.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.48 -1.012 . . . . 0.0 110.358 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 t70 52.32 61.34 3.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 163.56 142.32 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -10.36 59.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.547 -0.972 . . . . 0.0 110.87 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -142.07 49.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 t -69.05 176.48 3.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.421 -0.8 . . . . 0.0 110.545 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.26 104.26 11.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -0.8 . . . . 0.0 110.144 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -86.39 -149.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.782 . . . . 0.0 109.575 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 1.5 t -79.24 -56.68 4.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 -81.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.15 -27.2 28.89 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 4.0 m-85 -48.44 124.45 8.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.635 -0.92 . . . . 0.0 110.605 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.2 t30 -89.57 -169.99 2.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.447 -0.783 . . . . 0.0 109.628 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 110.275 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -112.11 133.14 21.75 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.676 . . . . 0.0 110.048 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.907 1.478 . . . . 0.0 111.197 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -74.86 -21.08 59.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.497 -0.752 . . . . 0.0 110.73 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.569 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 41.7 m95 -101.1 -16.5 17.05 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.439 -0.788 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm 59.06 22.62 10.71 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.508 -0.745 . . . . 0.0 112.707 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.569 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.54 161.33 39.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.706 -1.246 . . . . 0.0 110.616 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 91.8 m -69.49 138.57 53.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.353 -0.842 . . . . 0.0 110.286 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.69 170.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.682 -0.636 . . . . 0.0 109.93 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.3 p90 -61.55 173.36 0.97 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.408 -0.807 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.111 -0.993 . . . . 0.0 110.709 179.792 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.172 0.511 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.26 -121.13 1.45 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.35 -155.71 26.89 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -8.02 52.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.453 -1.028 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.73 31.7 0.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.45 120.28 29.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -0.771 . . . . 0.0 110.436 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.48 111.15 2.97 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.0 p -84.7 -35.86 22.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.518 -0.99 . . . . 0.0 110.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 9.4 t70 54.35 70.08 0.65 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.646 -0.659 . . . . 0.0 111.122 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.34 134.08 3.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -6.76 44.3 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.541 -0.976 . . . . 0.0 110.763 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 m -106.16 29.36 6.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.396 -0.815 . . . . 0.0 110.117 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.909 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.93 162.54 26.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.517 -0.739 . . . . 0.0 110.462 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.74 99.33 5.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 110.03 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.39 -157.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.296 -0.878 . . . . 0.0 110.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -78.92 0.07 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.122 -0.986 . . . . 0.0 110.321 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -165.48 114.73 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.671 -0.643 . . . . 0.0 109.606 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.75 24.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.537 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 39.5 m-85 -129.48 118.21 21.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.385 -1.068 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 30' ' ' VAL . 8.6 t30 -108.76 156.65 19.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.81 . . . . 0.0 110.419 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.4 t -89.46 134.47 34.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 110.508 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 8.5 t -80.59 141.92 52.88 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.673 -0.642 . . . . 0.0 110.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.17 -18.65 23.48 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.931 1.49 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 m -106.1 -25.85 11.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.203 -0.935 . . . . 0.0 111.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 28.8 m0 -95.2 -18.89 20.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 0.0 111.16 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.53 12.06 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.525 -0.735 . . . . 0.0 112.451 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -129.44 164.98 22.5 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.71 -1.244 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -74.82 142.21 44.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.387 -0.82 . . . . 0.0 110.535 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 21' ' ' ASN . 29.2 m -129.11 168.99 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.726 -0.609 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.46 121.68 26.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.267 -0.896 . . . . 0.0 110.42 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.842 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 17.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 120.821 0.343 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.32 -105.95 0.05 OUTLIER Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.56 -171.25 23.85 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 69.1 mt -76.12 -9.01 58.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.489 -1.006 . . . . 0.0 111.459 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.3 ttt -144.09 42.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.802 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.28 102.87 15.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.34 119.23 13.82 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.0 p -117.21 -46.8 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.538 -0.978 . . . . 0.0 110.833 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 51.79 67.22 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.563 -0.711 . . . . 0.0 110.468 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.38 127.38 0.91 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -66.12 -13.13 59.59 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.679 -0.895 . . . . 0.0 111.078 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.16 21.43 11.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.104 -0.998 . . . . 0.0 110.674 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 9' ' ' CYS . 9.1 t -81.1 169.7 17.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.131 -0.981 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -128.58 142.31 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.3 m -126.88 -151.35 0.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.611 -0.681 . . . . 0.0 110.038 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -68.09 -66.93 0.5 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.186 -0.946 . . . . 0.0 110.791 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -150.66 -76.37 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . -98.81 13.28 62.42 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 4.9 m-85 -73.51 119.62 17.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -1.222 . . . . 0.0 109.695 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 30' ' ' VAL . 4.5 t30 -106.07 153.82 21.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.466 -0.771 . . . . 0.0 110.5 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 m -89.41 135.8 33.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.341 -0.849 . . . . 0.0 110.75 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.2 t -86.29 140.47 34.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.72 -25.9 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.827 1.435 . . . . 0.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.752 HG23 ' CD1' ' A' ' 26' ' ' TRP . 9.8 t -91.04 -23.92 20.21 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.317 -0.864 . . . . 0.0 111.236 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.752 ' CD1' HG23 ' A' ' 25' ' ' THR . 34.0 m0 -101.37 -22.12 14.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.123 -0.986 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER 69.96 9.34 7.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.964 -0.46 . . . . 0.0 112.025 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -126.19 171.6 10.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.848 -1.157 . . . . 0.0 110.435 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -82.21 147.42 28.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.408 -0.807 . . . . 0.0 110.929 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' ASN . 19.1 m -136.23 -169.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' HB2' HD21 ' A' ' 5' ' ' LEU . 33.3 t80 -93.96 138.46 32.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 110.33 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.132 0.491 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.55 -149.14 24.45 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 -113.03 0.34 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -109.54 -15.88 14.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.476 -1.014 . . . . 0.0 111.07 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt -150.48 32.44 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.369 -0.832 . . . . 0.0 109.707 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -71.68 -163.71 0.11 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.496 -0.752 . . . . 0.0 110.245 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.31 116.23 5.45 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -111.5 42.8 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.768 -0.842 . . . . 0.0 110.272 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.4 m-20 -71.9 81.39 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.227 -0.921 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.79 124.76 1.39 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -10.41 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.497 -1.002 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -110.06 28.2 8.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.22 -0.925 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.435 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.9 t -90.97 154.31 19.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.91 155.09 28.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.42 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.1 m -103.54 -165.51 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.586 -0.696 . . . . 0.0 110.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 -70.26 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.363 -0.835 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.9 124.33 1.55 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.0 30.61 60.98 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.9 m-85 -129.79 132.23 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -97.79 140.24 32.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.728 . . . . 0.0 109.874 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 40.6 t -88.8 132.58 34.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.92 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.11 120.03 49.19 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.674 -0.641 . . . . 0.0 109.858 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.84 -31.01 10.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.806 1.424 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.5 m -78.9 -28.73 44.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.745 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.509 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 76.3 m95 -96.87 -12.89 22.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 111.089 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 5.6 tptt 64.06 27.6 14.18 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.372 -0.83 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.524 ' CA ' ' HB2' ' A' ' 9' ' ' CYS . 1.5 p90 -157.69 150.36 22.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.04 -1.038 . . . . 0.0 109.84 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.4 t -82.07 146.84 29.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.216 -0.928 . . . . 0.0 110.161 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 34.8 m -129.99 -167.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.39 151.3 47.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.344 -0.847 . . . . 0.0 109.871 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.758 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 120.991 0.424 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.84 -87.4 0.42 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.36 -161.77 28.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -92.93 -2.71 55.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.491 -1.006 . . . . 0.0 111.282 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 34.75 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 109.793 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.91 104.93 15.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 110.555 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.32 113.53 3.84 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.59 ' HB2' HG21 ' A' ' 14' ' ' THR . 28.6 p -104.7 -36.18 7.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.4 -1.059 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t70 55.16 77.44 0.22 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.624 -0.673 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.28 5.95 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -1.32 57.02 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.487 -1.008 . . . . 0.0 110.911 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 p -148.56 49.57 1.01 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.294 -0.879 . . . . 0.0 109.76 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.7 t -74.62 -169.46 0.86 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.656 -0.652 . . . . 0.0 110.767 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.96 100.05 6.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 1.1 t -98.67 -146.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 0.0 109.752 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -94.49 -105.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.009 -1.057 . . . . 0.0 110.003 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 21.18 2.07 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.859 -1.151 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.22 42.06 0.15 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 79.8 m-85 -138.08 138.85 39.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.961 . . . . 0.0 110.07 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -121.1 153.37 37.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 14' ' ' THR . 16.4 m -89.11 134.98 33.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.184 -0.948 . . . . 0.0 110.822 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -91.82 146.81 33.72 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.768 -0.583 . . . . 0.0 110.187 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 -35.57 3.95 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.911 1.479 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 m -87.49 -37.11 17.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 110.417 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.739 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 35.5 m0 -82.68 -29.71 29.75 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 19.0 tptt 69.07 11.2 8.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.959 -0.463 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.739 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.83 167.09 17.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.808 -1.182 . . . . 0.0 111.064 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -77.54 129.79 36.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.698 -0.626 . . . . 0.0 111.154 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 ' CE3' ' A' ' 26' ' ' TRP . 21.4 m -129.55 169.63 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.777 -0.577 . . . . 0.0 109.478 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' CD2' HD21 ' A' ' 5' ' ' LEU . 14.0 p90 -52.92 155.17 2.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.355 -0.841 . . . . 0.0 110.453 -179.824 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.035 0.445 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.94 -124.56 1.55 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -134.36 3.0 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -7.29 25.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.596 -0.943 . . . . 0.0 111.358 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.8 ttm -149.93 32.85 0.68 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.15 -0.968 . . . . 0.0 110.122 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.23 136.91 44.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.69 119.81 19.39 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' A' ' 14' ' ' THR . 7.0 t -95.33 -77.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.676 -0.897 . . . . 0.0 109.851 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.55 73.94 0.28 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.761 -0.587 . . . . 0.0 111.119 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.38 120.7 1.6 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -14.26 44.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.866 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -105.88 27.44 8.52 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 0.0 110.454 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.532 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -69.4 -178.2 1.33 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.245 -0.91 . . . . 0.0 110.462 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.99 146.74 45.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -131.98 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.68 -0.637 . . . . 0.0 110.005 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -67.88 0.73 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 p -168.51 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.568 -0.708 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.07 28.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 53.6 m-85 -122.86 129.9 52.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.291 -1.123 . . . . 0.0 109.872 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.64 163.11 16.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.461 -0.774 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -89.23 137.24 32.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.362 -0.836 . . . . 0.0 110.801 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -93.22 143.18 26.31 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.48 -0.763 . . . . 0.0 110.099 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.83 -21.81 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.916 1.482 . . . . 0.0 111.665 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 m -109.59 -38.67 5.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.171 -0.956 . . . . 0.0 111.369 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.713 ' CE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -72.64 -20.59 61.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 65.02 15.66 10.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.707 -0.62 . . . . 0.0 111.869 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.705 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -141.02 162.89 34.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.777 -1.202 . . . . 0.0 110.704 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.76 138.65 46.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.49 -0.756 . . . . 0.0 110.546 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.713 HG11 ' CE3' ' A' ' 26' ' ' TRP . 5.3 m -136.1 -178.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -58.55 153.48 16.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.348 -0.845 . . . . 0.0 110.464 -179.388 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.058 0.456 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 7' ' ' ALA . . . -78.59 -152.09 6.02 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.86 46.82 0.06 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.42 -7.37 1.02 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.899 -0.765 . . . . 0.0 112.512 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.87 25.81 0.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.945 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . . . -64.66 114.22 4.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.9 120.12 15.92 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 14' ' ' THR . 19.7 m -79.32 -73.53 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.986 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 50.51 56.5 7.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.491 0.663 . . . . 0.0 109.744 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.13 123.78 1.2 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -14.73 52.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.999 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.31 14.0 23.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 110.8 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.6 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -71.11 146.76 49.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.101 -0.999 . . . . 0.0 110.25 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -126.36 137.85 53.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.395 -0.816 . . . . 0.0 110.677 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.09 -154.28 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.648 -0.657 . . . . 0.0 109.73 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -73.04 0.35 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 110.436 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.3 -44.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 0.0 110.526 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.56 28.7 14.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 30.0 m-85 -124.62 131.83 53.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.979 . . . . 0.0 110.078 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -109.74 149.95 29.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.327 -0.858 . . . . 0.0 109.777 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.8 t -88.91 136.0 33.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.187 -0.945 . . . . 0.0 111.012 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.35 130.5 23.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.634 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.04 -31.39 9.8 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.887 1.467 . . . . 0.0 111.521 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -81.68 -31.96 31.98 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.897 . . . . 0.0 110.684 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.653 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -91.25 -17.73 25.52 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.381 -0.825 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tptm 67.7 17.35 9.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.689 -0.632 . . . . 0.0 111.656 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -144.66 168.39 20.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 110.549 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -84.56 150.95 24.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.515 -0.741 . . . . 0.0 111.041 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 28.2 m -140.15 178.63 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -58.06 151.74 18.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.356 -0.84 . . . . 0.0 110.312 -179.674 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 9.1 t . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 121.31 0.576 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 7' ' ' ALA . . . -82.52 -80.67 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.09 -133.63 4.22 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.76 -5.01 21.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.453 -1.028 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 ttm -149.59 33.87 0.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' TRP . . . -74.05 -167.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.393 -0.817 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.31 88.58 0.47 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB2' HG21 ' A' ' 14' ' ' THR . 17.5 p -99.61 53.31 0.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.93 . . . . 0.0 110.029 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.87 100.0 2.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.6 126.51 1.36 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -63.53 -14.38 50.56 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.585 -0.95 . . . . 0.0 111.028 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -108.62 30.0 6.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.5 t -96.49 169.12 10.12 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.358 -0.839 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.57 145.86 27.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -90.19 -144.29 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.376 -0.827 . . . . 0.0 110.027 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' CA ' ' HA ' ' A' ' 2' ' ' CYS . 1.7 t -81.8 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.951 -1.093 . . . . 0.0 110.795 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 t -164.92 -48.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.441 -0.787 . . . . 0.0 110.494 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 23.93 33.79 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 145.07 50.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.314 -1.11 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' VAL . 5.8 m120 -122.42 157.95 30.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 t -88.48 141.26 28.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.957 -1.089 . . . . 0.0 110.551 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.94 133.48 20.26 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -29.46 10.52 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.97 1.51 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 m -87.13 -37.08 17.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.398 -0.814 . . . . 0.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.648 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 70.7 m95 -89.63 -15.04 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.486 -0.758 . . . . 0.0 111.013 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 60.33 14.27 4.57 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.612 -0.68 . . . . 0.0 112.672 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.648 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -135.43 159.17 42.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.778 -1.201 . . . . 0.0 110.537 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.5 m -67.38 132.35 47.49 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.446 -0.784 . . . . 0.0 110.081 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 21' ' ' ASN . 23.7 m -116.9 179.73 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.678 . . . . 0.0 109.815 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -76.19 142.66 41.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.802 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.019 0.438 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.76 -88.18 0.65 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.27 -144.98 14.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.68 -4.34 33.95 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.511 -0.994 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -149.94 41.78 0.85 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -72.53 -165.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.507 -0.746 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 112.73 2.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -80.32 -77.52 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.458 -1.025 . . . . 0.0 110.018 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.94 68.16 0.79 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.677 -0.64 . . . . 0.0 110.483 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.9 121.52 1.92 Allowed Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -61.97 -15.88 47.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.93 . . . . 0.0 110.536 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.37 9.46 41.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.385 -0.822 . . . . 0.0 110.953 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.403 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 12.2 t -72.0 158.37 36.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.029 -1.045 . . . . 0.0 110.042 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.64 143.32 41.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.307 -0.871 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -95.31 -138.59 0.24 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.728 . . . . 0.0 109.98 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -91.3 -85.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 110.779 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 m -146.86 -47.63 0.18 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.162 -0.961 . . . . 0.0 110.773 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.77 25.88 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 85.8 m-85 -135.1 133.87 39.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -1.006 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.77 149.86 26.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.357 -0.839 . . . . 0.0 109.195 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.0 124.21 33.5 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.909 -1.119 . . . . 0.0 110.334 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.36 128.35 40.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.786 -0.571 . . . . 0.0 110.443 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.97 -37.02 3.04 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.941 1.495 . . . . 0.0 110.661 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.6 m -71.81 -37.75 70.32 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.59 -0.694 . . . . 0.0 110.402 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.9 m95 -90.74 -12.06 37.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.588 -0.695 . . . . 0.0 110.64 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 61.38 19.34 10.13 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.561 -0.712 . . . . 0.0 112.256 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.514 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -147.58 157.7 43.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.81 -1.182 . . . . 0.0 110.838 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 67.3 m -67.2 136.02 54.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.677 -0.639 . . . . 0.0 110.798 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -123.2 -172.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -69.54 148.63 49.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 110.278 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.227 0.537 . . . . 0.0 110.284 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.54 -119.03 4.55 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.09 -126.65 1.34 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 4.1 mp -104.54 -2.79 24.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.57 -0.959 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.73 31.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 109.944 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 130.16 35.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 109.727 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.27 118.43 10.27 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.76 -74.44 0.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.911 . . . . 0.0 109.935 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.09 92.08 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.419 0.628 . . . . 0.0 110.561 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . 142.5 -13.18 2.49 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 2.5 mtmp? 60.6 20.11 10.0 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.387 -1.067 . . . . 0.0 110.976 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -170.31 48.02 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 22' ' ' CYS . 5.3 t -83.72 158.3 21.83 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.23 120.41 34.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.399 -0.813 . . . . 0.0 110.199 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -100.77 -170.26 1.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.499 -0.751 . . . . 0.0 110.354 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 2' ' ' CYS . 57.6 m -64.31 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.397 -0.814 . . . . 0.0 110.424 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 p -158.99 88.77 0.91 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.418 -0.801 . . . . 0.0 109.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.06 8.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 32.1 m-85 -84.5 145.3 28.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -1.122 . . . . 0.0 109.91 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 17.0 t-20 -125.22 154.69 41.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.737 . . . . 0.0 110.235 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB2' HG22 ' A' ' 14' ' ' THR . 1.7 t -88.11 134.25 33.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.543 -0.723 . . . . 0.0 110.334 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -100.86 133.39 21.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.754 -0.591 . . . . 0.0 110.089 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.25 -28.12 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.9 1.474 . . . . 0.0 110.953 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -88.4 -36.48 16.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 0.0 110.544 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.727 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.9 m0 -88.3 -14.64 37.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 110.55 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 1.4 mmpp? 60.82 20.44 10.61 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.687 -0.633 . . . . 0.0 111.967 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.727 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -145.25 168.8 19.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.933 -1.105 . . . . 0.0 111.0 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -78.6 150.61 32.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.585 -0.697 . . . . 0.0 110.92 -179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 11.9 m -149.39 172.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.702 -0.624 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -69.06 135.26 50.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 0.0 109.858 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 110.172 -179.598 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.069 0.461 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.86 -136.62 5.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.43 -141.47 5.52 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.633 HD21 ' HD2' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -93.97 -12.14 29.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.592 -0.946 . . . . 0.0 111.114 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mtt -150.22 32.45 0.66 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.214 -0.929 . . . . 0.0 110.145 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.38 147.52 42.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.75 123.13 28.03 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 t -90.66 -71.33 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.48 99.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.333 0.587 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.14 -11.57 6.85 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm 59.57 19.96 8.5 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.287 -1.125 . . . . 0.0 110.736 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -170.22 45.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.36 -0.837 . . . . 0.0 110.0 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.52 HG22 ' HB2' ' A' ' 22' ' ' CYS . 6.4 t -82.47 165.43 20.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.465 -0.772 . . . . 0.0 110.833 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.37 105.34 15.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.01 -141.78 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.549 -0.72 . . . . 0.0 110.31 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -75.59 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.235 -0.916 . . . . 0.0 110.076 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -145.25 63.96 1.27 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 109.939 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . 154.42 -46.18 0.55 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.564 ' HD1' ' HA ' ' A' ' 31' ' ' TYR . 22.3 m-85 -55.96 128.5 35.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.606 -0.938 . . . . 0.0 110.242 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -106.12 159.24 16.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.773 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HB2' HG22 ' A' ' 14' ' ' THR . 5.3 t -89.27 132.67 34.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 110.714 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.12 128.47 36.92 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.9 -25.17 16.87 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.803 1.423 . . . . 0.0 111.169 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 m -87.82 -30.0 20.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.324 -0.86 . . . . 0.0 110.812 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.6 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 29.9 m0 -98.48 -15.25 19.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.285 -0.884 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.64 14.73 9.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.564 -0.71 . . . . 0.0 112.075 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.6 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -136.21 165.27 26.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.762 -1.211 . . . . 0.0 110.602 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 t -79.65 136.1 36.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.764 . . . . 0.0 110.542 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.597 HG11 ' CZ3' ' A' ' 26' ' ' TRP . 33.9 m -113.68 -167.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.06 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.633 ' HD2' HD21 ' A' ' 5' ' ' LEU . 24.0 p90 -88.29 165.08 15.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.442 -0.787 . . . . 0.0 110.261 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.515 -0.741 . . . . 0.0 110.213 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.167 0.508 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.93 173.0 55.21 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 -119.62 1.08 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.3 7.16 22.94 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.491 -1.006 . . . . 0.0 111.474 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.31 29.98 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -75.96 119.06 19.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.214 -0.929 . . . . 0.0 110.046 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.06 128.53 17.19 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -109.44 23.72 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.741 -0.858 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.38 -21.01 66.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -76.31 -3.79 77.68 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 4.4 mtmp? 59.57 23.15 11.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -1.073 . . . . 0.0 111.02 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -176.3 38.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.382 -0.824 . . . . 0.0 110.702 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t -71.14 105.96 3.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.127 -0.983 . . . . 0.0 110.078 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.03 104.8 2.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.93 -166.25 1.08 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 0.0 110.62 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -65.8 0.63 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.318 -0.864 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.29 -45.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.552 -0.718 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.12 30.69 9.86 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 48.7 m-85 -123.16 120.74 34.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -1.007 . . . . 0.0 110.284 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.461 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 t30 -110.99 167.37 10.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.47 144.16 26.26 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.827 -1.171 . . . . 0.0 110.948 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -90.37 147.65 37.17 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.595 -0.691 . . . . 0.0 110.136 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.88 -24.56 11.37 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.876 1.461 . . . . 0.0 111.634 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -111.32 -30.74 7.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.259 -0.901 . . . . 0.0 111.462 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -80.57 -20.53 43.16 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.166 -0.959 . . . . 0.0 110.842 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.59 21.41 11.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.612 -0.68 . . . . 0.0 112.113 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.667 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -143.75 166.81 23.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.737 -1.227 . . . . 0.0 110.932 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 2.3 t -69.9 138.06 52.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.572 -0.705 . . . . 0.0 111.013 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG11 ' HE3' ' A' ' 26' ' ' TRP . 27.2 m -134.66 -179.94 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -61.36 158.87 13.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.0 109.982 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.336 -0.852 . . . . 0.0 110.084 179.847 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.019 0.438 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.95 -118.12 4.11 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.17 -127.9 1.48 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.89 -7.4 17.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -1.0 . . . . 0.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.8 29.41 0.83 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.95 146.61 27.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 0.0 110.2 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.04 124.31 36.3 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.718 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.8 p -125.34 20.41 8.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.489 -1.006 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -49.79 106.53 0.12 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.406 -0.809 . . . . 0.0 110.757 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.09 2.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -12.97 61.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.484 -1.009 . . . . 0.0 111.066 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.59 38.05 3.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.29 -0.881 . . . . 0.0 110.64 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.1 t -69.16 151.04 46.84 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.729 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -109.4 127.34 54.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.357 -0.84 . . . . 0.0 110.598 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.19 -156.55 0.57 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.17 -0.956 . . . . 0.0 110.405 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -169.39 127.88 0.98 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.496 -0.753 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.92 21.96 79.44 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.9 m-85 -131.18 131.26 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.253 -1.145 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.624 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 4.3 t-20 -117.83 164.86 14.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.346 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.41 ' HB2' HG21 ' A' ' 14' ' ' THR . 34.8 t -88.79 137.76 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.59 135.3 19.76 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.688 -0.632 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.81 -34.44 3.18 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.829 1.436 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.26 -35.36 61.39 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.0 110.71 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.0 m95 -97.98 -20.02 17.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.734 . . . . 0.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.43 12.64 8.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.716 -0.615 . . . . 0.0 112.376 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -135.02 164.23 28.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.235 . . . . 0.0 110.676 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -68.21 137.77 55.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.747 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 26.7 m -136.14 -176.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.733 -0.604 . . . . 0.0 109.472 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 137.65 50.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.207 -0.933 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.0 110.123 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.04 0.448 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.91 -113.15 0.69 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 -114.34 0.52 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.48 10.43 19.7 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.56 -0.965 . . . . 0.0 111.034 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.2 ttt -148.58 35.87 0.79 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.225 -0.922 . . . . 0.0 110.078 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -73.21 125.48 27.85 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.14 115.71 6.46 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -93.57 -82.8 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.927 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.05 59.59 4.43 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.573 -0.704 . . . . 0.0 110.593 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.71 -142.99 3.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.15 5.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.44 -1.035 . . . . 0.0 111.108 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.35 58.75 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.955 . . . . 0.0 110.013 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 22' ' ' CYS . 12.8 t -59.16 147.24 35.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.52 129.78 34.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -126.02 -162.7 1.15 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.78 -0.575 . . . . 0.0 110.194 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.3 m -80.91 -86.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 125.67 4.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.314 -0.867 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.56 60.67 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.1 m120 -112.04 167.64 10.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.8 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 t -88.7 134.71 33.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.418 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 134.11 19.9 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.52 -33.83 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.794 1.418 . . . . 0.0 110.786 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.0 m -74.44 -44.78 50.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.66 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 85.8 m95 -88.27 -13.47 40.83 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.587 -0.696 . . . . 0.0 110.592 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.39 19.22 10.04 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.631 -0.668 . . . . 0.0 112.4 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.66 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.12 166.04 26.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.877 -1.14 . . . . 0.0 110.713 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -67.18 133.52 49.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.44 -0.787 . . . . 0.0 111.103 -178.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.89 176.88 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.13 137.16 58.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 0.0 110.502 -179.825 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.159 0.504 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.02 -95.77 1.57 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.6 -131.94 5.04 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 -5.76 20.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.975 . . . . 0.0 110.839 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.6 ttm -145.61 36.79 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -73.29 -165.71 0.27 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.386 -0.822 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.65 96.32 0.54 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' THR . 77.8 m -70.92 -77.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.913 . . . . 0.0 110.427 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.09 58.16 5.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.674 -0.641 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.78 139.07 2.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -8.29 55.47 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.421 -1.046 . . . . 0.0 110.727 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 2.31 39.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.329 -0.857 . . . . 0.0 110.657 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 9' ' ' CYS . 11.2 t -66.72 146.63 54.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.32 127.25 48.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -0.792 . . . . 0.0 110.335 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -87.31 -155.24 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 110.051 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.66 -92.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.14 123.26 14.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 109.844 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.33 35.56 76.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -130.05 120.8 25.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -1.044 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.7 t-20 -98.01 -170.95 2.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.3 m -118.68 139.02 52.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.15 -0.969 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 3.1 t -84.79 140.11 37.7 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.775 . . . . 0.0 110.028 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.48 -25.52 25.16 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.945 1.497 . . . . 0.0 111.297 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 m -103.29 -36.63 7.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.261 -0.899 . . . . 0.0 111.242 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 32.1 m0 -79.88 -21.27 44.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.253 -0.904 . . . . 0.0 111.093 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.4 OUTLIER 63.34 11.59 5.57 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.495 -0.753 . . . . 0.0 112.408 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.713 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -125.98 160.79 29.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.7 -1.25 . . . . 0.0 110.572 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 69.4 m -66.13 138.81 57.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.72 . . . . 0.0 111.438 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG11 ' HE3' ' A' ' 26' ' ' TRP . 25.4 m -139.17 -179.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.56 135.09 57.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.086 -1.009 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 110.349 -179.471 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 120.924 0.392 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' CYS . . . -55.46 117.02 7.74 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.08 47.13 0.95 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER 68.26 -3.96 1.18 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.876 -0.779 . . . . 0.0 112.113 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.42 27.68 0.66 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.914 -1.116 . . . . 0.0 110.277 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 142.67 27.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.344 -0.848 . . . . 0.0 110.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 119.27 14.79 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.878 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.9 p -123.76 28.59 6.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.497 -1.002 . . . . 0.0 110.91 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.91 112.09 0.72 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.873 . . . . 0.0 110.282 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.08 137.35 3.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -8.06 49.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.454 -1.027 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -139.86 47.44 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.878 HG21 ' HB2' ' A' ' 9' ' ' CYS . 12.7 t -76.71 -176.23 3.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.482 -0.762 . . . . 0.0 110.578 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.29 147.88 51.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 73.4 m -129.5 -162.33 1.19 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.593 -0.692 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -76.99 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 110.567 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 p -158.2 123.7 4.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.19 31.36 63.95 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.491 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 23.4 m-85 -124.8 132.06 53.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -1.141 . . . . 0.0 110.123 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.9 t-20 -112.42 159.32 18.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.0 110.127 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.1 t -89.56 137.57 32.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.006 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 m -103.21 128.91 26.57 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.613 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.57 -27.1 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.877 1.462 . . . . 0.0 111.196 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.4 m -84.12 -35.5 23.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.274 -0.891 . . . . 0.0 110.653 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 39.0 m0 -94.46 -13.06 26.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.363 -0.836 . . . . 0.0 111.0 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.08 11.75 7.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.525 -0.734 . . . . 0.0 112.234 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.638 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.96 166.45 23.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.792 -1.192 . . . . 0.0 110.803 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.5 t -75.37 143.64 42.71 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.513 -0.742 . . . . 0.0 110.51 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.526 HG11 ' CE3' ' A' ' 26' ' ' TRP . 33.9 m -124.38 -169.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 109.932 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 20.7 t80 -93.34 133.85 36.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 110.326 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.605 -0.685 . . . . 0.0 110.432 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.439 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 116.63 25.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.477 -1.013 . . . . 0.0 110.2 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.678 ' CA ' ' HB2' ' A' ' 7' ' ' ALA . . . -81.49 116.17 4.16 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.04 -102.26 2.55 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 30' ' ' VAL . 1.4 mt -104.05 -5.03 22.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.523 -0.986 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -143.0 47.62 1.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.096 -1.003 . . . . 0.0 110.022 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' ' CA ' ' A' ' 3' ' ' GLY . . . -76.1 -157.89 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.567 -0.708 . . . . 0.0 110.303 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 117.82 3.81 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -104.42 24.17 12.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.639 -0.918 . . . . 0.0 110.189 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 30.8 t70 -69.77 -28.94 66.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.15 -13.78 76.42 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.66 9.65 6.1 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.012 0.906 . . . . 0.0 111.156 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -159.42 36.78 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.001 -1.062 . . . . 0.0 110.678 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 14.9 t -76.28 164.99 25.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.236 -0.915 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.48 8.49 16.5 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.23 -0.919 . . . . 0.0 111.162 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 m 50.74 -152.57 0.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 t -102.68 -72.92 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 0.0 110.157 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t -159.84 114.51 2.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 110.081 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.23 45.45 8.85 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -144.94 120.27 10.25 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.477 -1.014 . . . . 0.0 110.115 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -90.55 151.47 21.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.369 -0.832 . . . . 0.0 109.383 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -89.05 142.06 27.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.07 -1.018 . . . . 0.0 110.816 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -110.25 127.68 26.63 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.784 -0.572 . . . . 0.0 110.297 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.2 -31.17 6.17 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.99 1.521 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.6 m -77.05 -29.36 55.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.463 -0.773 . . . . 0.0 110.701 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.643 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 59.8 m95 -100.69 -18.36 16.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.347 -0.846 . . . . 0.0 110.935 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 16.0 tptt 67.41 32.93 5.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.52 -0.737 . . . . 0.0 112.009 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.643 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -159.75 158.17 30.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.054 -1.029 . . . . 0.0 110.53 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.558 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 67.9 m -69.43 139.06 54.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.915 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 25.9 m -132.65 -168.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -66.44 140.1 58.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.53 150.6 22.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.431 -0.793 . . . . 0.0 110.713 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.46 65.64 60.18 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.645 -0.659 . . . . 0.0 110.098 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.253 0 O-C-N 123.644 1.339 . . . . 0.0 110.655 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.2 125.65 14.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.488 -1.007 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.54 -77.39 0.53 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.81 -149.84 17.12 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -95.04 -1.53 52.07 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.492 -1.005 . . . . 0.0 111.132 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.78 42.05 1.45 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.22 -161.68 0.53 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.419 -0.801 . . . . 0.0 110.551 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.96 117.93 4.17 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 51.5 m -108.27 48.6 0.85 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.518 -0.99 . . . . 0.0 110.327 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.55 91.15 3.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.422 -0.799 . . . . 0.0 110.008 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.36 137.3 4.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -71.17 -4.7 26.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.384 -1.068 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -115.27 31.97 6.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.077 -1.015 . . . . 0.0 110.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -84.89 179.78 7.24 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.197 -0.939 . . . . 0.0 110.682 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -143.26 150.31 39.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -0.85 . . . . 0.0 110.597 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.2 m -112.75 -145.2 0.4 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.559 -0.713 . . . . 0.0 109.747 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -91.02 -60.14 1.98 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.044 -1.035 . . . . 0.0 110.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -123.41 -126.64 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.634 -0.666 . . . . 0.0 109.47 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.46 -11.91 65.73 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 26.1 m-85 -38.81 112.45 0.24 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.799 -0.824 . . . . 0.0 111.297 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -89.61 -176.41 4.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.2 m -111.05 147.59 34.46 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.748 -1.22 . . . . 0.0 110.204 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -85.95 144.51 39.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.376 -0.827 . . . . 0.0 110.189 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -23.54 19.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 124.025 1.54 . . . . 0.0 111.381 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.832 HG23 ' CD1' ' A' ' 26' ' ' TRP . 3.1 t -116.94 -25.19 7.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.247 -0.908 . . . . 0.0 111.683 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.832 ' CD1' HG23 ' A' ' 25' ' ' THR . 38.3 m0 -85.6 -18.1 34.3 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.012 -1.055 . . . . 0.0 111.197 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt 60.2 21.93 11.27 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.594 -0.691 . . . . 0.0 112.092 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.652 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.03 159.18 41.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.168 . . . . 0.0 110.37 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 96.1 m -68.79 135.35 51.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.492 -0.755 . . . . 0.0 110.915 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 34.4 m -124.5 163.84 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.681 -0.637 . . . . 0.0 109.568 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.13 145.73 52.52 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.62 99.93 9.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -0.779 . . . . 0.0 110.294 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.58 125.56 1.25 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.485 -0.76 . . . . 0.0 110.634 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.314 -1.268 0 O-C-N 123.711 1.374 . . . . 0.0 110.672 179.658 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.7 t -145.97 139.0 25.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.978 . . . . 0.0 110.094 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.49 -113.39 3.75 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.84 -138.6 8.16 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 ' HE2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -100.24 -15.35 18.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.535 -0.98 . . . . 0.0 110.558 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.56 43.96 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -161.97 0.82 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.388 -0.82 . . . . 0.0 110.593 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.91 100.46 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.572 ' CA ' HG21 ' A' ' 14' ' ' THR . 18.9 p -108.71 40.18 1.85 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.51 -0.994 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.621 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 20.6 t70 -67.02 163.38 20.04 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.078 -1.014 . . . . 0.0 110.206 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.47 -13.43 18.39 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? 58.07 19.88 6.41 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.499 -1.001 . . . . 0.0 110.587 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -172.58 37.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.441 -0.787 . . . . 0.0 110.355 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.572 HG21 ' CA ' ' A' ' 9' ' ' CYS . 7.2 t -99.92 176.03 5.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -129.27 137.11 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.1 m -80.93 -144.46 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -71.45 0.47 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.013 -1.054 . . . . 0.0 110.061 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -167.42 112.15 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.765 -0.584 . . . . 0.0 110.088 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.4 21.33 38.21 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HE2' HD23 ' A' ' 5' ' ' LEU . 38.3 m-85 -130.7 137.96 49.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.4 -1.059 . . . . 0.0 109.538 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 6.4 t30 -108.78 175.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -113.27 138.64 49.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 45.5 t -91.02 137.26 26.65 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.393 -0.817 . . . . 0.0 110.076 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 -18.5 22.95 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.941 1.495 . . . . 0.0 111.468 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -106.52 -29.06 9.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.113 -0.992 . . . . 0.0 111.11 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 31.1 m0 -89.43 -26.07 21.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.238 -0.914 . . . . 0.0 110.565 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.35 9.68 7.04 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.837 -0.539 . . . . 0.0 111.886 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.672 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -124.59 161.24 26.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.878 -1.139 . . . . 0.0 110.009 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 16.7 m -75.16 147.01 40.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.143 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 5' ' ' LEU . 27.0 m -139.03 -174.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -66.76 132.21 47.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 109.968 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.91 132.67 35.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.697 -0.627 . . . . 0.0 110.376 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -74.12 115.29 41.33 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 109.712 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 O-C-N 123.823 1.433 . . . . 0.0 110.693 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.5 m -107.88 157.9 17.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.569 -0.959 . . . . 0.0 110.174 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -93.03 0.09 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.3 -159.34 27.11 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.19 -4.16 49.56 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.985 . . . . 0.0 110.598 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.9 mtt -150.85 29.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.387 -0.821 . . . . 0.0 109.739 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.6 33.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -0.852 . . . . 0.0 110.716 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.93 122.61 30.76 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.764 ' HB3' HG21 ' A' ' 14' ' ' THR . 99.2 m -84.13 -59.74 2.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.64 -0.918 . . . . 0.0 109.899 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.6 t70 51.15 78.68 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.253 0.549 . . . . 0.0 111.031 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.2 141.97 4.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 2.4 24.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.459 -1.024 . . . . 0.0 110.747 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.86 23.66 9.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.276 -0.89 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 9' ' ' CYS . 10.9 t -73.76 165.27 25.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.876 . . . . 0.0 109.943 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.03 149.81 50.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.0 111.054 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.65 -150.42 0.46 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.665 -0.647 . . . . 0.0 109.445 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -91.4 -70.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.029 -1.044 . . . . 0.0 110.273 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -172.17 92.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.727 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 117.91 -35.56 4.01 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -70.35 125.08 25.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.405 -1.056 . . . . 0.0 110.15 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.8 m120 -107.89 166.55 10.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.998 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.7 m -88.76 132.12 34.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.132 -0.98 . . . . 0.0 110.571 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 26' ' ' TRP . 11.9 p -67.76 142.91 96.2 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.653 -0.654 . . . . 0.0 110.133 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.65 -19.03 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.808 1.425 . . . . 0.0 111.887 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.1 m -122.54 -33.35 3.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.965 -1.084 . . . . 0.0 111.858 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.611 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 48.1 m0 -79.04 -12.84 60.03 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.013 . . . . 0.0 111.466 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? 66.16 11.09 7.6 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.474 -0.766 . . . . 0.0 113.002 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.611 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.8 164.2 23.55 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.448 -1.408 . . . . 0.0 111.126 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -70.38 147.45 49.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.448 -0.783 . . . . 0.0 110.922 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.61 169.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.766 -0.584 . . . . 0.0 109.428 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -66.25 132.82 49.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.0 110.069 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . -114.21 168.97 9.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.67 82.58 0.22 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.628 -0.67 . . . . 0.0 110.583 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 C--N 1.314 -1.255 0 O-C-N 123.792 1.417 . . . . 0.0 110.604 179.727 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 2.2 t -93.87 131.08 39.63 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.518 -0.99 . . . . 0.0 110.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.428 ' C ' ' HB2' ' A' ' 7' ' ' ALA . . . -88.05 -75.16 1.28 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.8 -156.68 18.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -88.65 -4.21 58.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.444 -1.033 . . . . 0.0 110.992 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.96 40.97 1.27 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.105 -0.997 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 3' ' ' GLY . . . -82.71 -157.62 0.23 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 110.385 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.45 100.15 0.76 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 t -74.24 -76.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.48 -1.012 . . . . 0.0 110.358 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 t70 52.32 61.34 3.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 163.56 142.32 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -10.36 59.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.547 -0.972 . . . . 0.0 110.87 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -142.07 49.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 t -69.05 176.48 3.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.421 -0.8 . . . . 0.0 110.545 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.26 104.26 11.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -0.8 . . . . 0.0 110.144 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -86.39 -149.07 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.45 -0.782 . . . . 0.0 109.575 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 1.5 t -79.24 -56.68 4.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 -81.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.15 -27.2 28.89 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 4.0 m-85 -48.44 124.45 8.09 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.635 -0.92 . . . . 0.0 110.605 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.2 t30 -89.57 -169.99 2.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.447 -0.783 . . . . 0.0 109.628 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.6 OUTLIER -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 110.275 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -112.11 133.14 21.75 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.619 -0.676 . . . . 0.0 110.048 179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -46.97 0.18 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.907 1.478 . . . . 0.0 111.197 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.4 m -74.86 -21.08 59.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.497 -0.752 . . . . 0.0 110.73 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.569 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 41.7 m95 -101.1 -16.5 17.05 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.439 -0.788 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm 59.06 22.62 10.71 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.508 -0.745 . . . . 0.0 112.707 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.569 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.54 161.33 39.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.706 -1.246 . . . . 0.0 110.616 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 91.8 m -69.49 138.57 53.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.353 -0.842 . . . . 0.0 110.286 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.69 170.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.682 -0.636 . . . . 0.0 109.93 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.3 p90 -61.55 173.36 0.97 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.408 -0.807 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.19 47.94 2.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.111 -0.993 . . . . 0.0 110.709 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 47.58 80.4 0.3 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.911 -0.493 . . . . 0.0 110.948 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.313 -1.319 0 O-C-N 123.87 1.458 . . . . 0.0 110.624 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 t -155.73 138.91 15.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -1.042 . . . . 0.0 110.541 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.26 -121.13 1.45 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.35 -155.71 26.89 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -8.02 52.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.453 -1.028 . . . . 0.0 111.023 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.73 31.7 0.96 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.45 120.28 29.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -0.771 . . . . 0.0 110.436 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.48 111.15 2.97 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.0 p -84.7 -35.86 22.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.518 -0.99 . . . . 0.0 110.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 9.4 t70 54.35 70.08 0.65 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.646 -0.659 . . . . 0.0 111.122 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.34 134.08 3.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -6.76 44.3 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.541 -0.976 . . . . 0.0 110.763 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 m -106.16 29.36 6.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.396 -0.815 . . . . 0.0 110.117 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.909 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.93 162.54 26.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.517 -0.739 . . . . 0.0 110.462 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.74 99.33 5.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 110.03 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.39 -157.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.296 -0.878 . . . . 0.0 110.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -78.92 0.07 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.122 -0.986 . . . . 0.0 110.321 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -165.48 114.73 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.671 -0.643 . . . . 0.0 109.606 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.75 24.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.537 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 39.5 m-85 -129.48 118.21 21.74 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.385 -1.068 . . . . 0.0 109.659 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 30' ' ' VAL . 8.6 t30 -108.76 156.65 19.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.403 -0.81 . . . . 0.0 110.419 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.4 t -89.46 134.47 34.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 110.508 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 8.5 t -80.59 141.92 52.88 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.673 -0.642 . . . . 0.0 110.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.17 -18.65 23.48 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.931 1.49 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 m -106.1 -25.85 11.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.203 -0.935 . . . . 0.0 111.011 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.617 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 28.8 m0 -95.2 -18.89 20.51 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 0.0 111.16 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.53 12.06 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.525 -0.735 . . . . 0.0 112.451 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -129.44 164.98 22.5 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.71 -1.244 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -74.82 142.21 44.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.387 -0.82 . . . . 0.0 110.535 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 21' ' ' ASN . 29.2 m -129.11 168.99 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.726 -0.609 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.46 121.68 26.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.267 -0.896 . . . . 0.0 110.42 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.8 69.42 6.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.842 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.81 70.35 36.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.607 -0.683 . . . . 0.0 109.736 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.275 0 O-C-N 123.755 1.397 . . . . 0.0 110.729 -179.537 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.537 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 17.9 p -86.63 -155.75 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.468 -1.019 . . . . 0.0 110.225 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.32 -105.95 0.05 OUTLIER Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.56 -171.25 23.85 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 69.1 mt -76.12 -9.01 58.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.489 -1.006 . . . . 0.0 111.459 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.3 ttt -144.09 42.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.802 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.28 102.87 15.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.34 119.23 13.82 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.0 p -117.21 -46.8 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.538 -0.978 . . . . 0.0 110.833 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 51.79 67.22 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.563 -0.711 . . . . 0.0 110.468 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.38 127.38 0.91 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -66.12 -13.13 59.59 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.679 -0.895 . . . . 0.0 111.078 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.16 21.43 11.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.104 -0.998 . . . . 0.0 110.674 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 9' ' ' CYS . 9.1 t -81.1 169.7 17.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.131 -0.981 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -128.58 142.31 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 89.3 m -126.88 -151.35 0.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.611 -0.681 . . . . 0.0 110.038 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -68.09 -66.93 0.5 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.186 -0.946 . . . . 0.0 110.791 -179.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -150.66 -76.37 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.154 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . -98.81 13.28 62.42 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 4.9 m-85 -73.51 119.62 17.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -1.222 . . . . 0.0 109.695 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 30' ' ' VAL . 4.5 t30 -106.07 153.82 21.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.466 -0.771 . . . . 0.0 110.5 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 m -89.41 135.8 33.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.341 -0.849 . . . . 0.0 110.75 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.2 t -86.29 140.47 34.36 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.72 -25.9 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.827 1.435 . . . . 0.0 111.324 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.752 HG23 ' CD1' ' A' ' 26' ' ' TRP . 9.8 t -91.04 -23.92 20.21 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.317 -0.864 . . . . 0.0 111.236 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.752 ' CD1' HG23 ' A' ' 25' ' ' THR . 34.0 m0 -101.37 -22.12 14.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.123 -0.986 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.3 OUTLIER 69.96 9.34 7.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.964 -0.46 . . . . 0.0 112.025 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -126.19 171.6 10.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.848 -1.157 . . . . 0.0 110.435 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -82.21 147.42 28.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.408 -0.807 . . . . 0.0 110.929 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' ASN . 19.1 m -136.23 -169.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' HB2' HD21 ' A' ' 5' ' ' LEU . 33.3 t80 -93.96 138.46 32.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . -90.0 143.68 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 110.33 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' HB2' ' HD3' ' A' ' 34' ' ' PRO . 2.8 mmt180 -52.31 -54.82 37.7 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.692 -0.63 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 33' ' ' ARG . 45.0 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.541 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 p -94.98 -176.54 3.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.515 -0.991 . . . . 0.0 110.444 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.55 -149.14 24.45 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 -113.03 0.34 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -109.54 -15.88 14.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.476 -1.014 . . . . 0.0 111.07 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt -150.48 32.44 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.369 -0.832 . . . . 0.0 109.707 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -71.68 -163.71 0.11 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.496 -0.752 . . . . 0.0 110.245 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.31 116.23 5.45 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -111.5 42.8 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.768 -0.842 . . . . 0.0 110.272 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.4 m-20 -71.9 81.39 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.227 -0.921 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.79 124.76 1.39 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -10.41 52.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.497 -1.002 . . . . 0.0 111.264 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 t -110.06 28.2 8.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.22 -0.925 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.435 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.9 t -90.97 154.31 19.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.91 155.09 28.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.462 -0.774 . . . . 0.0 110.42 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.1 m -103.54 -165.51 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.586 -0.696 . . . . 0.0 110.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 -70.26 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.363 -0.835 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.9 124.33 1.55 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.0 30.61 60.98 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.9 m-85 -129.79 132.23 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -97.79 140.24 32.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.536 -0.728 . . . . 0.0 109.874 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 40.6 t -88.8 132.58 34.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.92 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.11 120.03 49.19 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.674 -0.641 . . . . 0.0 109.858 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.84 -31.01 10.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.806 1.424 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.5 m -78.9 -28.73 44.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.507 -0.745 . . . . 0.0 110.648 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.509 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 76.3 m95 -96.87 -12.89 22.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 111.089 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 5.6 tptt 64.06 27.6 14.18 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.372 -0.83 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.524 ' CA ' ' HB2' ' A' ' 9' ' ' CYS . 1.5 p90 -157.69 150.36 22.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.04 -1.038 . . . . 0.0 109.84 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.4 t -82.07 146.84 29.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.216 -0.928 . . . . 0.0 110.161 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 34.8 m -129.99 -167.6 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.39 151.3 47.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.344 -0.847 . . . . 0.0 109.871 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.34 120.43 30.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 92.1 44.03 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.577 -0.702 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.314 -1.265 0 O-C-N 123.822 1.433 . . . . 0.0 110.475 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.5 m -85.8 143.52 28.25 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.524 -0.986 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.84 -87.4 0.42 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.36 -161.77 28.85 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -92.93 -2.71 55.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.491 -1.006 . . . . 0.0 111.282 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 34.75 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.169 -0.957 . . . . 0.0 109.793 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.91 104.93 15.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 110.555 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.32 113.53 3.84 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.59 ' HB2' HG21 ' A' ' 14' ' ' THR . 28.6 p -104.7 -36.18 7.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.4 -1.059 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t70 55.16 77.44 0.22 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.624 -0.673 . . . . 0.0 110.719 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.28 5.95 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -1.32 57.02 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.487 -1.008 . . . . 0.0 110.911 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 p -148.56 49.57 1.01 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.294 -0.879 . . . . 0.0 109.76 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.7 t -74.62 -169.46 0.86 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.656 -0.652 . . . . 0.0 110.767 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.96 100.05 6.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 1.1 t -98.67 -146.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 0.0 109.752 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.0 t -94.49 -105.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.009 -1.057 . . . . 0.0 110.003 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 21.18 2.07 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.859 -1.151 . . . . 0.0 110.824 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.22 42.06 0.15 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.498 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 79.8 m-85 -138.08 138.85 39.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.961 . . . . 0.0 110.07 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -121.1 153.37 37.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 110.178 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 14' ' ' THR . 16.4 m -89.11 134.98 33.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.184 -0.948 . . . . 0.0 110.822 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -91.82 146.81 33.72 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.768 -0.583 . . . . 0.0 110.187 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 -35.57 3.95 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.911 1.479 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.9 m -87.49 -37.11 17.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 110.417 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.739 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 35.5 m0 -82.68 -29.71 29.75 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 19.0 tptt 69.07 11.2 8.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.959 -0.463 . . . . 0.0 112.187 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.739 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -128.83 167.09 17.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.808 -1.182 . . . . 0.0 111.064 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -77.54 129.79 36.12 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.698 -0.626 . . . . 0.0 111.154 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG11 ' CE3' ' A' ' 26' ' ' TRP . 21.4 m -129.55 169.63 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.777 -0.577 . . . . 0.0 109.478 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' CD2' HD21 ' A' ' 5' ' ' LEU . 14.0 p90 -52.92 155.17 2.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.86 123.54 47.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.355 -0.841 . . . . 0.0 110.453 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.58 124.98 32.3 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.582 -0.699 . . . . 0.0 110.198 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.313 -1.309 0 O-C-N 123.883 1.465 . . . . 0.0 111.007 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t -78.57 135.43 37.28 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.407 -1.055 . . . . 0.0 110.034 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.94 -124.56 1.55 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -134.36 3.0 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -7.29 25.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.596 -0.943 . . . . 0.0 111.358 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.8 ttm -149.93 32.85 0.68 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.15 -0.968 . . . . 0.0 110.122 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.23 136.91 44.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 109.741 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.69 119.81 19.39 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' A' ' 14' ' ' THR . 7.0 t -95.33 -77.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.676 -0.897 . . . . 0.0 109.851 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.55 73.94 0.28 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.761 -0.587 . . . . 0.0 111.119 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.38 120.7 1.6 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -14.26 44.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.866 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -105.88 27.44 8.52 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 0.0 110.454 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.532 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -69.4 -178.2 1.33 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.245 -0.91 . . . . 0.0 110.462 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.99 146.74 45.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' SG ' ' CB ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -131.98 -157.77 0.84 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.68 -0.637 . . . . 0.0 110.005 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -67.88 0.73 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 p -168.51 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.568 -0.708 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.07 28.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 53.6 m-85 -122.86 129.9 52.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.291 -1.123 . . . . 0.0 109.872 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.64 163.11 16.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.461 -0.774 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.6 t -89.23 137.24 32.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.362 -0.836 . . . . 0.0 110.801 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -93.22 143.18 26.31 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.48 -0.763 . . . . 0.0 110.099 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.83 -21.81 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.916 1.482 . . . . 0.0 111.665 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.7 m -109.59 -38.67 5.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.171 -0.956 . . . . 0.0 111.369 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.713 ' CE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -72.64 -20.59 61.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 65.02 15.66 10.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.707 -0.62 . . . . 0.0 111.869 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.705 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -141.02 162.89 34.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.777 -1.202 . . . . 0.0 110.704 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.76 138.65 46.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.49 -0.756 . . . . 0.0 110.546 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.713 HG11 ' CE3' ' A' ' 26' ' ' TRP . 5.3 m -136.1 -178.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -58.55 153.48 16.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.85 122.19 31.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.348 -0.845 . . . . 0.0 110.464 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.49 143.11 14.6 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.71 -0.619 . . . . 0.0 110.216 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 O-C-N 123.779 1.41 . . . . 0.0 110.975 -179.743 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.3 t -122.81 149.35 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.559 -0.965 . . . . 0.0 110.106 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 7' ' ' ALA . . . -78.59 -152.09 6.02 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.86 46.82 0.06 OUTLIER Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.42 -7.37 1.02 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.899 -0.765 . . . . 0.0 112.512 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.87 25.81 0.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.945 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . . . -64.66 114.22 4.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.9 120.12 15.92 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 14' ' ' THR . 19.7 m -79.32 -73.53 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.986 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 50.51 56.5 7.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.491 0.663 . . . . 0.0 109.744 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.13 123.78 1.2 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -14.73 52.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.999 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.31 14.0 23.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 110.8 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.6 HG21 ' SG ' ' A' ' 9' ' ' CYS . 14.0 t -71.11 146.76 49.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.101 -0.999 . . . . 0.0 110.25 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -126.36 137.85 53.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.395 -0.816 . . . . 0.0 110.677 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.09 -154.28 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.648 -0.657 . . . . 0.0 109.73 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -73.04 0.35 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.13 -0.981 . . . . 0.0 110.436 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.3 -44.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.474 -0.766 . . . . 0.0 110.526 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.56 28.7 14.81 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 30.0 m-85 -124.62 131.83 53.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.979 . . . . 0.0 110.078 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -109.74 149.95 29.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.327 -0.858 . . . . 0.0 109.777 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.8 t -88.91 136.0 33.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.187 -0.945 . . . . 0.0 111.012 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.35 130.5 23.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.634 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.04 -31.39 9.8 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.887 1.467 . . . . 0.0 111.521 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -81.68 -31.96 31.98 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.897 . . . . 0.0 110.684 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.653 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -91.25 -17.73 25.52 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.381 -0.825 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tptm 67.7 17.35 9.83 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.689 -0.632 . . . . 0.0 111.656 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.653 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -144.66 168.39 20.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 110.549 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -84.56 150.95 24.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.515 -0.741 . . . . 0.0 111.041 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 28.2 m -140.15 178.63 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -58.06 151.74 18.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.91 127.7 43.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.356 -0.84 . . . . 0.0 110.312 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -155.31 133.65 7.07 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.58 -0.7 . . . . 0.0 110.208 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--N 1.313 -1.3 0 O-C-N 123.908 1.478 . . . . 0.0 110.847 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 9.1 t 54.24 75.84 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.856 -0.791 . . . . 0.0 110.808 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 7' ' ' ALA . . . -82.52 -80.67 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.09 -133.63 4.22 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.76 -5.01 21.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.453 -1.028 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 ttm -149.59 33.87 0.7 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' TRP . . . -74.05 -167.97 0.56 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.393 -0.817 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.31 88.58 0.47 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB2' HG21 ' A' ' 14' ' ' THR . 17.5 p -99.61 53.31 0.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.93 . . . . 0.0 110.029 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.87 100.0 2.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.6 126.51 1.36 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -63.53 -14.38 50.56 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.585 -0.95 . . . . 0.0 111.028 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -108.62 30.0 6.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 9' ' ' CYS . 8.5 t -96.49 169.12 10.12 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.358 -0.839 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.57 145.86 27.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -90.19 -144.29 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.376 -0.827 . . . . 0.0 110.027 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' CA ' ' HA ' ' A' ' 2' ' ' CYS . 1.7 t -81.8 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.951 -1.093 . . . . 0.0 110.795 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 t -164.92 -48.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.441 -0.787 . . . . 0.0 110.494 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 23.93 33.79 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 145.07 50.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.314 -1.11 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 30' ' ' VAL . 5.8 m120 -122.42 157.95 30.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 t -88.48 141.26 28.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.957 -1.089 . . . . 0.0 110.551 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.94 133.48 20.26 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.75 -29.46 10.52 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.97 1.51 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 m -87.13 -37.08 17.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.398 -0.814 . . . . 0.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.648 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 70.7 m95 -89.63 -15.04 33.6 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.486 -0.758 . . . . 0.0 111.013 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 60.33 14.27 4.57 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.612 -0.68 . . . . 0.0 112.672 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.648 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -135.43 159.17 42.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.778 -1.201 . . . . 0.0 110.537 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.5 m -67.38 132.35 47.49 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.446 -0.784 . . . . 0.0 110.081 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 21' ' ' ASN . 23.7 m -116.9 179.73 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.678 . . . . 0.0 109.815 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -76.19 142.66 41.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.55 90.46 8.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.802 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -78.43 135.69 60.9 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 O-C-N 123.93 1.489 . . . . 0.0 110.763 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.485 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 m -130.03 128.18 41.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.516 -0.991 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.76 -88.18 0.65 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.27 -144.98 14.11 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.68 -4.34 33.95 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.511 -0.994 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -149.94 41.78 0.85 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.262 -0.899 . . . . 0.0 109.573 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -72.53 -165.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.507 -0.746 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 112.73 2.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -80.32 -77.52 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.458 -1.025 . . . . 0.0 110.018 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.94 68.16 0.79 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.677 -0.64 . . . . 0.0 110.483 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.9 121.52 1.92 Allowed Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -61.97 -15.88 47.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.62 -0.93 . . . . 0.0 110.536 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.37 9.46 41.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.385 -0.822 . . . . 0.0 110.953 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.403 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 12.2 t -72.0 158.37 36.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.029 -1.045 . . . . 0.0 110.042 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.64 143.32 41.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.307 -0.871 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -95.31 -138.59 0.24 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.536 -0.728 . . . . 0.0 109.98 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -91.3 -85.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 110.779 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.8 m -146.86 -47.63 0.18 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.162 -0.961 . . . . 0.0 110.773 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.77 25.88 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 85.8 m-85 -135.1 133.87 39.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -1.006 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.77 149.86 26.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.357 -0.839 . . . . 0.0 109.195 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.0 124.21 33.5 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.909 -1.119 . . . . 0.0 110.334 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.36 128.35 40.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.786 -0.571 . . . . 0.0 110.443 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.97 -37.02 3.04 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.941 1.495 . . . . 0.0 110.661 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.6 m -71.81 -37.75 70.32 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.59 -0.694 . . . . 0.0 110.402 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.9 m95 -90.74 -12.06 37.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.588 -0.695 . . . . 0.0 110.64 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 18.3 mmtm 61.38 19.34 10.13 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.561 -0.712 . . . . 0.0 112.256 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.514 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -147.58 157.7 43.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.81 -1.182 . . . . 0.0 110.838 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 7' ' ' ALA . 67.3 m -67.2 136.02 54.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.677 -0.639 . . . . 0.0 110.798 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -123.2 -172.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -69.54 148.63 49.19 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 110.195 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.19 133.01 52.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -66.4 -55.52 19.24 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.473 -0.767 . . . . 0.0 110.644 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 33' ' ' ARG . 46.7 Cg_endo . . . . . 0 N--CA 1.487 1.1 0 O-C-N 123.63 1.331 . . . . 0.0 110.603 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -156.1 103.69 2.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -1.026 . . . . 0.0 110.284 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.54 -119.03 4.55 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.09 -126.65 1.34 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 4.1 mp -104.54 -2.79 24.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.57 -0.959 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.73 31.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 109.944 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 130.16 35.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 109.727 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.27 118.43 10.27 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.76 -74.44 0.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.911 . . . . 0.0 109.935 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.09 92.08 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.419 0.628 . . . . 0.0 110.561 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . 142.5 -13.18 2.49 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 2.5 mtmp? 60.6 20.11 10.0 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.387 -1.067 . . . . 0.0 110.976 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -170.31 48.02 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.342 -0.849 . . . . 0.0 109.998 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 22' ' ' CYS . 5.3 t -83.72 158.3 21.83 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.23 120.41 34.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.399 -0.813 . . . . 0.0 110.199 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -100.77 -170.26 1.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.499 -0.751 . . . . 0.0 110.354 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 2' ' ' CYS . 57.6 m -64.31 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.397 -0.814 . . . . 0.0 110.424 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 p -158.99 88.77 0.91 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.418 -0.801 . . . . 0.0 109.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.06 8.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 32.1 m-85 -84.5 145.3 28.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -1.122 . . . . 0.0 109.91 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 17.0 t-20 -125.22 154.69 41.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.737 . . . . 0.0 110.235 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB2' HG22 ' A' ' 14' ' ' THR . 1.7 t -88.11 134.25 33.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.543 -0.723 . . . . 0.0 110.334 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -100.86 133.39 21.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.754 -0.591 . . . . 0.0 110.089 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.25 -28.12 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.9 1.474 . . . . 0.0 110.953 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -88.4 -36.48 16.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 0.0 110.544 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.727 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.9 m0 -88.3 -14.64 37.8 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 110.55 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 1.4 mmpp? 60.82 20.44 10.61 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.687 -0.633 . . . . 0.0 111.967 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.727 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -145.25 168.8 19.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.933 -1.105 . . . . 0.0 111.0 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -78.6 150.61 32.7 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.585 -0.697 . . . . 0.0 110.92 -179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 11.9 m -149.39 172.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.702 -0.624 . . . . 0.0 109.504 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -69.06 135.26 50.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 0.0 109.858 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.36 104.17 16.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 110.172 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ptt85 -140.01 159.19 65.37 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.533 -0.729 . . . . 0.0 110.515 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--N 1.314 -1.282 0 O-C-N 123.792 1.417 . . . . 0.0 110.627 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 139.19 41.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.501 -0.999 . . . . 0.0 110.048 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.86 -136.62 5.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.43 -141.47 5.52 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.633 HD21 ' HD2' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -93.97 -12.14 29.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.592 -0.946 . . . . 0.0 111.114 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mtt -150.22 32.45 0.66 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.214 -0.929 . . . . 0.0 110.145 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.38 147.52 42.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.75 123.13 28.03 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 t -90.66 -71.33 0.63 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t70 61.48 99.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.333 0.587 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.14 -11.57 6.85 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm 59.57 19.96 8.5 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.287 -1.125 . . . . 0.0 110.736 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -170.22 45.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.36 -0.837 . . . . 0.0 110.0 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.52 HG22 ' HB2' ' A' ' 22' ' ' CYS . 6.4 t -82.47 165.43 20.2 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.465 -0.772 . . . . 0.0 110.833 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.37 105.34 15.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.503 -0.748 . . . . 0.0 109.755 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.01 -141.78 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.549 -0.72 . . . . 0.0 110.31 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -75.59 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.235 -0.916 . . . . 0.0 110.076 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -145.25 63.96 1.27 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 109.939 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 32' ' ' ALA . . . 154.42 -46.18 0.55 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.564 ' HD1' ' HA ' ' A' ' 31' ' ' TYR . 22.3 m-85 -55.96 128.5 35.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.606 -0.938 . . . . 0.0 110.242 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -106.12 159.24 16.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.773 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HB2' HG22 ' A' ' 14' ' ' THR . 5.3 t -89.27 132.67 34.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 110.714 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.12 128.47 36.92 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.9 -25.17 16.87 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.803 1.423 . . . . 0.0 111.169 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 m -87.82 -30.0 20.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.324 -0.86 . . . . 0.0 110.812 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.6 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 29.9 m0 -98.48 -15.25 19.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.285 -0.884 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.64 14.73 9.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.564 -0.71 . . . . 0.0 112.075 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.6 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -136.21 165.27 26.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.762 -1.211 . . . . 0.0 110.602 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 t -79.65 136.1 36.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.764 . . . . 0.0 110.542 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.597 HG11 ' CZ3' ' A' ' 26' ' ' TRP . 33.9 m -113.68 -167.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.06 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.633 ' HD2' HD21 ' A' ' 5' ' ' LEU . 24.0 p90 -88.29 165.08 15.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.442 -0.787 . . . . 0.0 110.261 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 19' ' ' GLY . . . -106.08 -172.56 2.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.515 -0.741 . . . . 0.0 110.213 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.78 70.77 9.89 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.377 -0.827 . . . . 0.0 110.03 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.315 -1.211 0 O-C-N 123.719 1.379 . . . . 0.0 110.738 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 p -94.12 -170.54 2.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.533 -0.981 . . . . 0.0 110.659 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.93 173.0 55.21 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 -119.62 1.08 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.3 7.16 22.94 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.491 -1.006 . . . . 0.0 111.474 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.31 29.98 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -75.96 119.06 19.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.214 -0.929 . . . . 0.0 110.046 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.06 128.53 17.19 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.3 t -109.44 23.72 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.741 -0.858 . . . . 0.0 110.38 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.38 -21.01 66.49 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -76.31 -3.79 77.68 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 4.4 mtmp? 59.57 23.15 11.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.377 -1.073 . . . . 0.0 111.02 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -176.3 38.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.382 -0.824 . . . . 0.0 110.702 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t -71.14 105.96 3.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.127 -0.983 . . . . 0.0 110.078 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.03 104.8 2.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.93 -166.25 1.08 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 0.0 110.62 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -65.8 0.63 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.318 -0.864 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.29 -45.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.552 -0.718 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.12 30.69 9.86 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 48.7 m-85 -123.16 120.74 34.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.488 -1.007 . . . . 0.0 110.284 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.461 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 t30 -110.99 167.37 10.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.47 144.16 26.26 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.827 -1.171 . . . . 0.0 110.948 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -90.37 147.65 37.17 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.595 -0.691 . . . . 0.0 110.136 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.88 -24.56 11.37 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.876 1.461 . . . . 0.0 111.634 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -111.32 -30.74 7.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.259 -0.901 . . . . 0.0 111.462 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HE3' HG11 ' A' ' 30' ' ' VAL . 40.8 m0 -80.57 -20.53 43.16 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.166 -0.959 . . . . 0.0 110.842 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.59 21.41 11.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.612 -0.68 . . . . 0.0 112.113 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.667 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -143.75 166.81 23.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.737 -1.227 . . . . 0.0 110.932 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 2.3 t -69.9 138.06 52.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.572 -0.705 . . . . 0.0 111.013 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG11 ' HE3' ' A' ' 26' ' ' TRP . 27.2 m -134.66 -179.94 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -61.36 158.87 13.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.0 109.982 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.24 172.81 11.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.336 -0.852 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -114.93 147.21 37.78 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 O-C-N 123.918 1.483 . . . . 0.0 110.607 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.5 t -151.3 127.13 10.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.54 -0.976 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.95 -118.12 4.11 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.17 -127.9 1.48 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.89 -7.4 17.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.5 -1.0 . . . . 0.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.8 29.41 0.83 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.95 146.61 27.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 0.0 110.2 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.04 124.31 36.3 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.718 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.8 p -125.34 20.41 8.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.489 -1.006 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -49.79 106.53 0.12 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.406 -0.809 . . . . 0.0 110.757 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.09 2.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -12.97 61.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.484 -1.009 . . . . 0.0 111.066 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.59 38.05 3.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.29 -0.881 . . . . 0.0 110.64 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.1 t -69.16 151.04 46.84 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.729 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -109.4 127.34 54.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.357 -0.84 . . . . 0.0 110.598 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.19 -156.55 0.57 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.549 -0.719 . . . . 0.0 109.968 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 -68.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.17 -0.956 . . . . 0.0 110.405 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -169.39 127.88 0.98 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.496 -0.753 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.92 21.96 79.44 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.9 m-85 -131.18 131.26 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.253 -1.145 . . . . 0.0 110.108 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.624 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 4.3 t-20 -117.83 164.86 14.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.478 -0.764 . . . . 0.0 110.346 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.41 ' HB2' HG21 ' A' ' 14' ' ' THR . 34.8 t -88.79 137.76 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.59 135.3 19.76 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.688 -0.632 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.81 -34.44 3.18 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.829 1.436 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -75.26 -35.36 61.39 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.0 110.71 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.0 m95 -97.98 -20.02 17.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.734 . . . . 0.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.43 12.64 8.79 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.716 -0.615 . . . . 0.0 112.376 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -135.02 164.23 28.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.235 . . . . 0.0 110.676 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -68.21 137.77 55.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.536 -0.728 . . . . 0.0 110.747 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 26.7 m -136.14 -176.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.733 -0.604 . . . . 0.0 109.472 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 137.65 50.87 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.207 -0.933 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . -106.54 117.99 35.5 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.21 152.84 8.59 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.425 -0.797 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.312 -1.35 0 O-C-N 123.913 1.48 . . . . 0.0 110.729 179.791 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -85.19 -173.17 4.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.467 -1.019 . . . . 0.0 110.665 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.91 -113.15 0.69 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 -114.34 0.52 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.48 10.43 19.7 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.56 -0.965 . . . . 0.0 111.034 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.2 ttt -148.58 35.87 0.79 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.225 -0.922 . . . . 0.0 110.078 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -73.21 125.48 27.85 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.14 115.71 6.46 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -93.57 -82.8 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.927 . . . . 0.0 110.364 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.05 59.59 4.43 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.573 -0.704 . . . . 0.0 110.593 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.71 -142.99 3.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.15 5.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.44 -1.035 . . . . 0.0 111.108 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.35 58.75 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.955 . . . . 0.0 110.013 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 22' ' ' CYS . 12.8 t -59.16 147.24 35.94 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.52 129.78 34.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -126.02 -162.7 1.15 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.78 -0.575 . . . . 0.0 110.194 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.3 m -80.91 -86.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 125.67 4.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.314 -0.867 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.56 60.67 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.0 130.31 53.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.1 m120 -112.04 167.64 10.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.8 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 t -88.7 134.71 33.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.418 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 134.11 19.9 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.52 -33.83 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.794 1.418 . . . . 0.0 110.786 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.0 m -74.44 -44.78 50.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.66 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 85.8 m95 -88.27 -13.47 40.83 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.587 -0.696 . . . . 0.0 110.592 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.39 19.22 10.04 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.631 -0.668 . . . . 0.0 112.4 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.66 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -144.12 166.04 26.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.877 -1.14 . . . . 0.0 110.713 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -67.18 133.52 49.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.44 -0.787 . . . . 0.0 111.103 -178.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.89 176.88 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -61.13 137.16 58.24 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.48 155.89 18.42 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 0.0 110.502 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 122.62 10.24 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 O-C-N 123.869 1.457 . . . . 0.0 110.598 179.53 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -155.95 119.2 4.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.97 . . . . 0.0 110.284 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.02 -95.77 1.57 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.6 -131.94 5.04 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 -5.76 20.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.975 . . . . 0.0 110.839 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.6 ttm -145.61 36.79 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 28' ' ' TRP . . . -73.29 -165.71 0.27 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.386 -0.822 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.65 96.32 0.54 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' THR . 77.8 m -70.92 -77.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.913 . . . . 0.0 110.427 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.09 58.16 5.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.674 -0.641 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.78 139.07 2.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -8.29 55.47 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.421 -1.046 . . . . 0.0 110.727 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 2.31 39.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.329 -0.857 . . . . 0.0 110.657 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 9' ' ' CYS . 11.2 t -66.72 146.63 54.25 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.32 127.25 48.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -0.792 . . . . 0.0 110.335 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -87.31 -155.24 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 110.051 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.66 -92.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.14 123.26 14.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 109.844 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.33 35.56 76.71 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -130.05 120.8 25.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -1.044 . . . . 0.0 110.214 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.7 t-20 -98.01 -170.95 2.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.3 m -118.68 139.02 52.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.15 -0.969 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 3.1 t -84.79 140.11 37.7 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.775 . . . . 0.0 110.028 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.48 -25.52 25.16 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.945 1.497 . . . . 0.0 111.297 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 m -103.29 -36.63 7.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.261 -0.899 . . . . 0.0 111.242 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 32.1 m0 -79.88 -21.27 44.23 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.253 -0.904 . . . . 0.0 111.093 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 0.4 OUTLIER 63.34 11.59 5.57 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.495 -0.753 . . . . 0.0 112.408 179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.713 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -125.98 160.79 29.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.7 -1.25 . . . . 0.0 110.572 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' ASN . 69.4 m -66.13 138.81 57.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.72 . . . . 0.0 111.438 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG11 ' HE3' ' A' ' 26' ' ' TRP . 25.4 m -139.17 -179.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.56 135.09 57.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.086 -1.009 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.11 107.73 19.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 110.349 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.7 tpt85 -155.36 66.95 4.92 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.358 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.314 -1.274 0 O-C-N 123.821 1.432 . . . . 0.0 110.682 179.817 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 t -75.34 164.36 26.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.56 -0.965 . . . . 0.0 110.385 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' CYS . . . -55.46 117.02 7.74 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.08 47.13 0.95 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER 68.26 -3.96 1.18 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.876 -0.779 . . . . 0.0 112.113 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.42 27.68 0.66 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.914 -1.116 . . . . 0.0 110.277 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 142.67 27.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.344 -0.848 . . . . 0.0 110.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 119.27 14.79 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.878 ' HB2' HG21 ' A' ' 14' ' ' THR . 14.9 p -123.76 28.59 6.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.497 -1.002 . . . . 0.0 110.91 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.91 112.09 0.72 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.873 . . . . 0.0 110.282 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.08 137.35 3.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -8.06 49.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.454 -1.027 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -139.86 47.44 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.878 HG21 ' HB2' ' A' ' 9' ' ' CYS . 12.7 t -76.71 -176.23 3.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.482 -0.762 . . . . 0.0 110.578 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.29 147.88 51.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 73.4 m -129.5 -162.33 1.19 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.593 -0.692 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -76.99 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 110.567 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 p -158.2 123.7 4.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.19 31.36 63.95 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.491 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 23.4 m-85 -124.8 132.06 53.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -1.141 . . . . 0.0 110.123 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.9 t-20 -112.42 159.32 18.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.0 110.127 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.1 t -89.56 137.57 32.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.006 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 m -103.21 128.91 26.57 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.643 -0.661 . . . . 0.0 109.613 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.57 -27.1 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.877 1.462 . . . . 0.0 111.196 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.4 m -84.12 -35.5 23.62 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.274 -0.891 . . . . 0.0 110.653 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 39.0 m0 -94.46 -13.06 26.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.363 -0.836 . . . . 0.0 111.0 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.08 11.75 7.39 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.525 -0.734 . . . . 0.0 112.234 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.638 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -134.96 166.45 23.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.792 -1.192 . . . . 0.0 110.803 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.5 t -75.37 143.64 42.71 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.513 -0.742 . . . . 0.0 110.51 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.526 HG11 ' CE3' ' A' ' 26' ' ' TRP . 33.9 m -124.38 -169.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.701 . . . . 0.0 109.932 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 20.7 t80 -93.34 133.85 36.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 110.326 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.16 179.26 4.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.605 -0.685 . . . . 0.0 110.432 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.499 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -162.62 -62.41 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.5 -0.75 . . . . 0.0 110.583 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 33' ' ' ARG . 45.9 Cg_endo . . . . . 0 N--CA 1.487 1.143 0 O-C-N 123.319 1.168 . . . . 0.0 110.74 179.772 . . . . . . . . 1 1 . 1 stop_ save_